HUB Cyber Security (HUBC) 20-F 16 Aug 24 2023 FY Annual report (foreign) Financial data

Document And Entity Information

Document And Entity Information - shares	12 Months Ended
	Dec. 31, 2023	Aug. 13, 2024
Document Information Line Items
Entity Registrant Name	HUB Cyber Security Ltd.
Document Type	20-F
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		30,459,736
Amendment Flag	false
Entity Central Index Key	0001905660
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Document Registration Statement	false
Document Annual Report	true
Document Transition Report	false
Document Shell Company Report	false
Entity File Number	001-41634
Entity Incorporation, State or Country Code	L3
Entity Address, Address Line One	2 Kaplan St
Entity Address, City or Town	Tel Aviv
Entity Address, Country	IL
Entity Address, Postal Zip Code	6473403
Entity Interactive Data Current	Yes
Document Financial Statement Error Correction [Flag]	false
Document Accounting Standard	International Financial Reporting Standards
Auditor Location	Israel
Auditor Name	Kost, Forer, Gabbay & Kasierer
Auditor Firm ID	1281
Business Contact
Document Information Line Items
Entity Address, Address Line One	2 Kaplan St
Entity Address, City or Town	Tel Aviv
Entity Address, Country	IL
Entity Address, Postal Zip Code	6473403
Contact Personnel Name	Noah Hershcoviz
Local Phone Number	3-791-3200
City Area Code	+972
Ordinary shares, no par value
Document Information Line Items
Trading Symbol	HUBC
Title of 12(b) Security	Ordinary shares, no par value
Security Exchange Name	NASDAQ
Warrants to purchase ordinary shares
Document Information Line Items
Trading Symbol	HUBCW
Title of 12(b) Security	Warrants to purchase ordinary shares
Security Exchange Name	NASDAQ
Warrants to purchase ordinary shares one
Document Information Line Items
Trading Symbol	HUBCZ
Title of 12(b) Security	Warrants to purchase ordinary shares
Security Exchange Name	NASDAQ

Consolidated Statements of Fina

Consolidated Statements of Financial Position - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 3,522	$ 3,994
Restricted cash and bank deposit	1,637	1,575
Trade receivables, net	9,867	24,057
Other assets	5,083	1,672
Inventories		1,900
Total current asset	20,109	33,198
NON-CURRENT ASSETS:
Long-term receivables	725	872
Long-term restricted deposit	151	3,002
Long-term deposit	177
Property and equipment, net	1,035	1,314
Right-of-use assets	2,510	6,507
Goodwill	2,467	13,702
Intangible assets, net	5,416	16,198
Total non current asset	12,481	41,595
Assets	32,590	74,793
CURRENT LIABILITIES:
Short-term loans	11,878	13,432
Convertible loans	14,449
Trade payables	9,867	13,771
Current maturities of lease liabilities	733	1,472
Current maturities of other liabilities	5,078	3,839
Other accounts payable	32,427	25,322
Total current liabilities	74,432	57,836
NON-CURRENT LIABILITIES:
Long-term liabilities	147	887
Warrants liabilities	6,047
Lease liabilities	1,712	4,995
Deferred tax liabilities	116	161
Other long-term liabilities		1,064
Net employee defined benefit liabilities	869	1,040
Total non current liabilities	8,891	8,147
EQUITY ATTRIBUTABLE TO EQUITY HOLDERS OF THE COMPANY:
Share capital and premium	103,386	81,620
Share options	10,918	10,367
Treasury shares	(1,230)	(1,230)
Other reserves	19,905	14,698
Accumulated deficit	(186,488)	(99,042)
Total equity attributable to equity holders	(53,509)	6,413
Non-controlling interests	2,776	2,397
Total shareholders’ equity (capital deficit)	(50,733)	8,810
Total liabilities and equity	$ 32,590	$ 74,793

Consolidated Statements of Prof

Consolidated Statements of Profit or Loss ₪ in Thousands, $ in Thousands		12 Months Ended
		Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares		Dec. 31, 2021 USD ($) $ / shares shares
Net Loss Per Share [Abstract]
Revenues		$ 42,657	$ 50,002		$ 29,533
Cost of revenues		41,907	45,914		24,711
Gross profit		750	4,088		4,823
Research and development expenses, net		5,886	5,574		5,796
Sales and marketing expenses	[1]	10,694	21,674		2,683
General and administrative expenses	[1]	49,172	57,271		9,313
Other expenses, net		12,723
Operating loss		(77,725)	(80,430)		(12,969)
Finance income		(484)	(469)		(5)
Finance expenses		7,194	1,384		296
Loss before taxes on income		(84,435)	(81,345)		(13,260)
Taxes on income (tax benefit)		171	(776)		262
Net loss from continuing operation		(84,606)	(80,569)		(13,522)
Net income (loss) from discontinued operation		(2,030)	569		107
Attributable to:
Equity holders of the Company		(87,446)	(81,595)		(13,030)
Non-controlling interests		810	1,595		(385)
Profit (loss)		$ (86,636)	$ (80,000)		$ (13,415)
Net loss per share attributable to equity holders of the Company ($):
Basic net loss per share from continuing operation (in Dollars per share) | $ / shares		$ (8.82)	$ (9.38)	[2]	$ (1.74)	[2]
Basic net profit (loss) per share from discontinued operation (in Dollars per share) | $ / shares		$ (0.21)	$ 0.07		$ 0.01
Weighted average number of shares outstanding used in computation of basic loss per share (in Shares) | shares		9,686,000	8,529,000	[2]	7,751,000	[2]
[1] Including $525 thousand and $57 thousand of allegedly misappropriated expenses by two former senior officers of the Company, during the years 2022 and 2021, respectively. See note 1e below. Shares and per shares amounts have been retroactively adjusted to reflect the reverse stock splits as described in note 20a.

Consolidated Statements of Pr_2

Consolidated Statements of Profit or Loss (Parentheticals) - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Net Loss Per Share [Abstract]
Diluted net loss per share from continuing operation	$ (8.65)	$ (9.38)	$ (1.74)
Diluted net profit (loss) per share from discontinued operation	$ (0.21)	$ 0.07	$ 0.01
Weighted average number of shares outstanding used in computation of diluted loss per share (in Shares)	9,686,000	8,529,000	7,751,000

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Consolidated Statements Of Comprehensive Income Loss [Abstract]
Net loss from continuing operation	$ (84,606)	$ (80,569)	$ (13,522)
Net (loss) profit from discontinued operation	(2,030)	569	107
Other comprehensive loss, net of taxes:
Foreign currency translation adjustments			(1)
Amounts that will not be reclassified subsequently to profit or loss:
Actuarial gain (loss) from defined benefit plan	92	(121)	(653)
Foreign currency translation from functional currency to presentation currency	(940)	(5,473)	2,307
Total other comprehensive income (loss)	(848)	(5,594)	1,653
Total comprehensive loss	(87,484)	(85,594)	(11,762)
Attributable to:
Equity holders of the Company	(88,232)	(87,095)	(11,327)
Non-controlling interests	748	1,501	(435)
Total comprehensive income for the year	$ (87,484)	$ (85,594)	$ (11,762)

Consolidated Statements of Chan

Consolidated Statements of Changes in Sharholders’ Capital Deficit - USD ($) $ in Thousands	Total	Share capital and premium	Treasury shares	Share options	Warrants payable	Reserve for share-based payment transactions	Reserve for remeasurement of defined benefit plan	Foreign currency translation adjustments	Accumulated deficit	Total	Non- controlling interests
Balance at Dec. 31, 2020	$ 653	$ 4,747						$ 121	$ (4,215)	$ 653
Total net loss	(13,623)								(13,232)	(13,232)	(391)
Other comprehensive income (loss)	1,861						(608)	2,513		1,905	(44)
Total comprehensive income (loss)	(11,762)						(608)	2,513	(13,232)	(11,327)	(435)
Reverse acquisition (Note 5)	27,994	21,789		1,102		3,677				26,568	1,426
Issuance of shares and options, net of issuance expenses (Note 20)	34,571	34,571								34,571
Initial consolidation of subsidiaries (Note 5)	9,655	9,655								9,655
Repurchase of shares	(1,230)		(1,230)							(1,230)
Cost of share-based payment	5,897					5,897				5,897
Balance at Dec. 31, 2021	65,778	70,762	(1,230)	1,102		9,574	(608)	2,634	(17,447)	64,787	991
Total net loss	(80,000)								(81,595)	(81,595)	1,595
Other comprehensive income (loss)	(5,594)						(154)	(5,346)		(5,500)	(94)
Total comprehensive income (loss)	(85,594)						(154)	(5,346)	(81,595)	(87,095)	1,501
Warrants exercise	370	451				(81)				370
Options exercise	716	2,553				(1,837)				716
Extension of options to equity holders of the Company (Note 18f)		(5,102)		5,102
Dividend distribution to non-controlling interests	(95)										(95)
Issuance of shares and options, net of issuance expenses (Note 20)	17,119	12,956		4,087	76					17,119
Cost of share-based payment	10,516					10,516				10,516
Balance at Dec. 31, 2022	8,810	81,620	(1,230)	10,291	76	18,172	(762)	(2,712)	(99,042)	6,413	2,397
Total net loss	(86,636)								(87,446)	(87,446)	810
Other comprehensive income (loss)	(848)						92	(878)		(786)	(62)
Total comprehensive income (loss)	(87,484)						92	(878)	(87,446)	(88,232)	748
Warrants exercise	234	286		(52)						234
Options exercise	1,771	289				(1,122)				1,771
Issuance of shares to Equity line of Credit (“ELOC’)	1,570	1,570								1,570
Conversion of convertible loans	6,143	6,143								6,143
Issuance of shares and warrants related to the PIPE, net of issuance expenses	3,557	3,557								3,557
Issuance of shares and warrants	712	110		679	(76)					712
Issuance of shares related to RNER merger transaction (Note 5)	7,208	7,208								7,208
Dividend distribution to non-controlling interests	(369)										(369)
Cost of share-based payment	7,115					7,115				7,115
Balance at Dec. 31, 2023	$ (50,733)	$ 103,386	$ (1,230)	$ 10,918		$ 24,165	$ (670)	$ (3,590)	$ (186,488)	$ (53,509)	$ 2,776

Consolidated Statements of Cash

Consolidated Statements of Cash Flows ₪ in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Cash flows from operating activities:
Net loss	$ (86,636)	$ (80,000)	$ (13,623)
Adjustments to reconcile net loss to net cash used in operating activities:
Finance expenses, net	13	896	312
Other expenses	192
Financial liabilities recorded as listing expenses	7,648
Finance expenses related to convertible loans and warrants	5,016
Revaluation of liability to Legacy	810
Equity Line of Credit (“ELOC”)	1,570
Share listing expenses	12,312
Depreciation and amortization	7,637	7,791	1,853
Impairment of goodwill and intangible assets	15,258	23,356
Change in employee benefit liabilities, net	(43)	(364)	(94)
Change in deferred tax liabilities	(39)	(1,059)	58
Cost of share-based payment	7,115	10,516	5,897
Adjustments to the profit or loss items	57,489	41,136	8,026
Changes in asset and liability items:
Decrease (increase) in trade receivables	13,242	(1,453)	(6,969)
Decrease (increase) in other assets	(4,730)	2,462	(3,463)
Decrease in receivables for construction contracts			682
Increase (decrease) in trade payables	(3,436)	544	8,879
Decrease (increase) in inventories	1,812	(288)	(1,195)
Change in balances of government grants	(824)		(186)
Increase in other accounts payable	7,980	15,216	2,884
Total Changes in asset and liability	14,044	16,481	632
Cash paid and received during the year for:
Interest paid, net	(717)	(806)	(315)
Taxes paid	(382)	(243)
Cash paid and received during the year	(1,099)	(1,049)	(315)
Net cash used in operating activities	(16,202)	(23,432)	(5,280)
Cash flows from investing activities:
Investment in restricted bank deposit		(660)	(202)
Withdrawal from restricted bank deposit	3,926
Investment in restricted cash	(1,493)	140	(210)
Change in long-term deposits			(3,096)
Purchase of property and equipment	(297)	(624)	(453)
Assets acquisition		(5,405)
Reverse acquisition (a)			605
Acquisition of newly consolidated subsidiary (b)			(12,626)
Net cash provided by (used in) investing activities	2,136	(6,549)	(15,982)
Cash flows from financing activities:
Issuance of ordinary shares, net of issuance expenses	2,379	18,836	34,571
Repurchase of shares			(1,230)
Short-term loans, net		1,780	615
Repayment of lease liabilities	(1,711)	(2,065)	(1,079)
Receipt on account of issuance of shares		2,251
Dividend distribution to non-controlling interests		(95)
Exercise of options and warrants	2,005	1,086
Government grants		77	202
Receipt of short-term loans	15,227
Repayment of short-term loans	(4,973)	(1,210)	(376)
Net cash provided by financing activities	12,927	20,660	32,703
Exchange rate differences on cash and cash equivalents	667	(659)	1,271
Increase (decrease) in cash and cash equivalents	(472)	(9,980)	12,712
Cash and cash equivalents at the beginning of the year	3,994	13,974	1,262
Cash and cash equivalents at the end of the year	3,522	3,994	13,974
Non-cash transactions:
Right-of-use asset and liability	(2,516)	1,306	5,542
Assets acquisition		4,796
Employee benefit assets and liabilities	97	121
Reclassification of deferred issuance cost to equity	1,384	1,717
Dividend distribution to non-controlling interests	369
Conversion of convertible loans	6,143
The subsidiary’s assets and liabilities on acquisition date:
Right-of-use assets	2,510	6,507
Goodwill	2,467	13,702
Intangible assets	5,416	16,198
Trade payables	(9,867)	(13,771)
Other payables	(766)	(1,361)
Liabilities for government grants	(412)
Non-controlling interests	(2,776)	(2,397)
Equity	50,733	(8,810)	(65,778)
The subsidiary’s assets and liabilities on acquisition date:
Right-of-use assets	2,510	6,507
Goodwill	2,467	13,702
Intangible assets	5,416	16,198
Trade payables	(9,867)	(13,771)
Other payables	$ (766)	$ (1,361)
Reverse Acquisition [Member]
The subsidiary’s assets and liabilities on acquisition date:
Restricted bank deposit			859
Trade receivables			10,480
Other accounts receivable			2,703
Construction contracts			682
Property, plant and equipment			489
Right-of-use assets			2,657
Goodwill			14,494
Intangible assets			7,093
Deferred tax asset			1,688
Deferred tax liability			(1,985)
Short term loans			(727)
Trade payables			(1,775)
Other payables			(5,380)
Bank loans			(108)
Liabilities for government grants			(352)
Lease liability			(2,657)
Employee benefit liabilities			(772)
Non-controlling interests			(1,427)
Equity			(26,568)
Total net cash deriving from reverse acquisition			606
The subsidiary’s assets and liabilities on acquisition date:
Trade receivables			10,480
Other accounts receivable			2,703
Property, plant and equipment			489
Right-of-use assets			2,657
Goodwill			14,494
Intangible assets			7,093
Deferred tax asset			1,688
Deferred tax liability			(1,985)
Short term loans			(727)
Trade payables			(1,775)
Other payables			(5,380)
Bank loans			(108)
Lease liability			(2,657)
Employee benefit liabilities			(772)
Initial consolidation of Comsec [Member]
The subsidiary’s assets and liabilities on acquisition date:
Trade receivables			7,735
Other accounts receivable			614
Property, plant and equipment			267
Right-of-use assets			2,381
Goodwill			17,057
Intangible assets			16,220
Deferred tax asset			1,720
Deferred tax liability			(2,729)
Short term loans			(9,894)
Trade payables			(4,101)
Other payables			(1,130)
Bank loans			(4,063)
Lease liability			(2,381)
Employee benefit liabilities			(59)
The subsidiary’s assets and liabilities on acquisition date:
Trade receivables			7,735
Other accounts receivable			614
Inventories			644
Property, plant and equipment			267
Right-of-use assets			2,381
Goodwill			17,057
Intangible assets			16,220
Deferred tax asset			1,720
Deferred tax liability			(2,729)
Short term loans			(9,894)
Trade payables			(4,101)
Other payables			(1,130)
Bank loans			(4,063)
Lease liability			(2,381)
Employee benefit liabilities			(59)
Share capital and premium			(9,655)
Total net cash paid for the acquisition			$ 12,626

General

General	12 Months Ended
	Dec. 31, 2023
General [Abstract]
GENERAL	NOTE 1:- GENERAL a. Operation: HUB Cyber Security Ltd. was incorporated under the laws of the State of Israel in 1984 and its headquarter is located in Tel-Aviv, Israel. HUB Cyber Security Ltd. (formerly: Hub Cyber Security (Israel) Ltd.) (“the Company”) was incorporated under the laws of the State of Israel in 1984 and is engaged in developing and marketing quality management software tools and professional services solutions. The Company’s software tools aim to allow their users to scientifically predict system failures and prevent them during the design stage. The Company and its subsidiaries (“the Group”) are engaged in developing reliable quality assurance systems that support process and product enhancement. The Group’s main customers are organizations and institutions operating in the security, electronics, aviation, telecommunications, banking, and other sectors in Israel and worldwide. Following the merger between the Company and HUB (see below), the Company also operates in the Confidential Computing and network security industry. The Company’s ordinary shares have been listed on the Tel-Aviv stock exchange (TASE) since January 23, 2000 and began trading on Nasdaq Capital Market since March 1, 2023. The Company was delisted from TASE on February 28, 2023. n May 20, 2024, the Company received a letter from Nasdaq regarding the Company’s failure to timely file the Form 20-F for the fiscal year ended December 31, 2023 (the “Form 20-F”) with the Securities and Exchange Commission (the “SEC”), as required by Nasdaq Listing Rule 5250(c)(1) (the “Filing Requirement”). On July 19, 2024 the Company responded to the aforementioned letter, stated its intention to comply with the Filing Requirement, and asked for an extension. On July 30, 2024 the Company received a reply from Nasdaq, granting its request for an extension to comply with the Filing Requirement until August 19, 2024. b. Merger between the Company and HUB Cyber Security TLV Ltd.: In June 2021 the Company completed a merger between the Company and HUB Cyber Security Ltd (“HUB”) According to the business combination agreement, HUB became a wholly owned subsidiary of the Company and the Company allocated 51% of its issued and outstanding share capital as of the merger completion date to HUB’s shareholders. From the merger completion date, the Company holds the entire equity and voting rights in HUB. c. Merger between the Company and Mount Rainier Acquisition Corp.: On March 23, 2022, the Company entered into a definitive Business Combination Agreement with Mount Rainier Acquisition Corp., a Delaware corporation (“RNER”) and Rover Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of HUB (“Merger Sub”). Pursuant to the Business Combination Agreement, Merger Sub merged with and into RNER, with RNER surviving the merger (the “ Reverse Recapitalization”) Reverse Recapitalization Prior to the Closing Date, in connection with the closing of the Transactions, the Company and its shareholders recapitalized the Company’s equity securities whereby each ordinary share of the Company was converted into 0.712434 ordinary shares (the “Share Split”). In addition, and as part of the Share Split, each outstanding option to purchase an ordinary share was converted into an option to purchase 0.712434 ordinary shares and the exercise price of such option was increased by dividing the exercise price by 0.712434. As a result of the Share Split, the ordinary shares, options for ordinary shares, exercise price and net loss per share amounts were adjusted retroactively for all periods presented in these consolidated financial statements as if the Share Split had been in effect as of the date of these consolidated financial statements. The Transactions were accounted for as a reverse recapitalization, in accordance with the relevant International Financial Reporting Standards (“IFRS”) and the Group was deemed to be the accounting acquirer. RNER did not meet the definition of a business in accordance with IFRS 3 - “Business Combinations”, and the Transactions were instead accounted for within the scope of IFRS 2 - “Share-based payment” (“IFRS 2”), as a share-based payment transaction in exchange for a public listing service. In accordance with IFRS 2 the Company recorded a one-time share-based Share listing expense of $12,312 thousand at the closing of the Reverse Recapitalization that was calculated based on the excess of the fair value of the Company issued to public investors over the fair value of the identifiable net assets of RNER that were acquired. See additional information in note 5. d. Going Concern The Company’s financial statements have been prepared on a basis that assumes that it will continue as a going concern and the ordinary course of business will continue in alignment with Management’s 2024-2025 business plan. However, the Company faces significant uncertainty regarding the adequacy of its liquidity and capital resources and its ability to repay its obligations as they become due. As of December 31, 2023, the Company has incurred accumulated losses in the amount of $186,488 thousand, and had a negative working capital in the amount of $54,323 thousand. Also, for the year ended December 31, 2023 the Company used $16,885 thousand in operating activities. The Company expects to continue to incur losses in 2024 and potentially thereafter as well. On December 31, 2023, the Company’s cash and cash equivalents position is not sufficient to fund the Company’s planned operations for at least a year beyond the date of the filing date of the consolidated financial statements and the Company requires an immediate cash injection to fund its operations. Furthermore, there are several legal claims against the Company, for addition information refer to Note 22c. Those factors raise substantial doubt about the Company’s ability to continue as a going concern. Since late 2023, the Company completed several strategic steps to improve its cash position. The Company undertook several efforts to to decreased its burn rate, including strategic layoffs and the replacement of lease contract. Additionally, the Company renegotiated key loan agreements and raised a total of more than $16,000 thousand from investors via debt structures and warrant exercise agreements, including over $5,000 thousand warrants exercised by AKINA Capital. The Company’s management is closely monitoring the situation and has been attempting to alleviate the liquidity and capital resources concerns through interim financing facilities and other capital raising efforts. However, such efforts remain uncertain and are predicated upon events and circumstances which are outside the Company’s control. The consolidated financial statements for the year ended December 31, 2023 do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from uncertainty related to the Company’s ability to continue as a going concern. Such adjustments could be material. e. Loan to a related party The Company has provided to Blackswan, a related party, an aggregated amount of $2,012 thousand under the BST Loan Agreement, of which $1,023 thousand was provided until December 31, 2023. See note 29(7). f. Internal investigation As previously disclosed, on April 20, 2023, the Company’s board of directors appointed a Special Committee of Independent Directors (the “Special Committee”) to oversee an internal investigation (the “Internal Investigation”) in order to review certain allegations of misappropriation of Company funds and other potential fraudulent actions regarding the use of Company funds by a former senior officer of the Company. During the course of the Internal Investigation, the Special Committee, together with its outside advisers, believed that it found sufficient evidence to support a determination that the Company’s former Chief Executive Officer and President of U.S. operations and former member of the board of directors (“former CEO”), and the Company’s former Chief of Staff and wife of the former CEO, misappropriated (from a Company bank account over which the Company’s former CEO had sole signatory rights) a total of approximately NIS 2,000 thousand (approximately $582 thousand) for personal use. Further, in certain instances, evidence reviewed by the Special Committee demonstrated that the Company’s former CEO authorized payments to contractors without either (i) proper documentation and signatory approval; or (ii) required budget and expense reports. The employment of the former CEO, was terminated effective July 24, 2023 for cause and the Company’s former CEO resigned from the Company’s board on August 15, 2023. Additionally, the Company has commenced two legal actions in Israel against the Company’s former Chief of Staff and against the Company’s former CEO to omitted their requests for severance payments in accordance with Israeli law in connection with these determinations by the Special Committee. Additionally, the Special Committee believed that it found sufficient evidence to determine that, one of the controllers of the Company, with the permission of the Company’s former CEO, used Company credit cards for personal use in the amount of approximately NIS 400 thousand (approximately $110 thousand). These personal expenses were neither factored into the controller’s payroll nor properly documented in the Company’s financial books and records. Additionally, the Company’s former CEO approved a bonus of NIS 250 thousand to the controller. However, this bonus was not paid to the controller but instead was paid to a third-party at the controller’s direction. Prior to the commencement of legal proceedings, the Company reached a settlement with the controller whereby the amount of the bonus in the amount of NIS 250 thousand plus VAT was repaid to the Company in 2023. The Internal Investigation is complete, although the Company continues to pursue recovery of the misappropriated funds. These events regarding the Special Committee and Internal Investigation are the subject of possible regulatory review and expose the Company and its directors and officers to possible investigations and possible enforcement actions by regulators both in Israel and the United States, including the Israel Securities Authority (“ISA”), Israel Tax Authority, U.S. Securities and Exchange Commission (“SEC”), the Nasdaq Stock Market LLC (“Nasdaq”) and/or U.S. Department of Justice (“DOJ”). The Company has provided certain information and documentation to certain regulatory authorities and is prepared to respond to any regulatory inquiry it may receive. The Company’s management and its board of directors do not currently believe there are any impacts on the Company’s financial statements. If the Company were to be subject to an investigation or enforcement action from a regulatory agency it could have a material adverse effect on the Company’s business, financial position and results of operations. If any federal authorities were to ultimately determine that the Company violated any laws or regulations, the Company may be exposed to a broad range of civil and criminal sanctions including, but not limited to, injunctive relief, disgorgement, fines, penalties, modifications to business practices including the termination or modification of existing business relationships, the imposition of compliance programs and the retention of a monitor to oversee future compliance by the Company, which could be costly and burdensome to the management, and could adversely impact the Company’s business, prospects, reputation, financial condition, liquidity, results of operations or cash flows. Even if an inquiry or investigation does not result in any adverse determinations, it potentially could create negative publicity and give rise to third-party litigation or other actions, which could also have a material adverse effect on the Company’s business, financial condition, results of operations and cash flows. The Special Committee is neither a civil nor criminal court of law and no court has yet substantiated the findings of the Special Committee. It is possible that a court of law may find differently than the Special Committee has, which could expose the Company to counterclaims from the Former Senior Officer, the former Chief of Staff or others. Additionally, while the Company has informed the Former Senior Officer that he has been summarily dismissed as an employee and has commenced a legal action in Israel against the former Chief of Staff to omitted her requests for severance payments in accordance with Israeli law, there can be no assurance that the Former Senior Officer, the former Chief of Staff or others will not bring forth any claims or commence any litigation against the Company in connection with the former Senior Officer dismissal, the Company’s challenging the former Chief of Staff severance payments or the publication of the Special Committee’s findings from the Internal Investigation. The Company have commenced legal actions in Israel against the Company’s former Chief of Staff and against the Company’s former CEO to dispute their requests for severance payments in accordance with Israeli law. Two actions were undertaken against the Company’s former Chief of Staff. In the initial action, the court granted an injunction preventing her from accessing her accumulated severance package. In the second action, it was requested that the court order that these sums be returned to the Company. In the action against the Company’s former CEO, the court was requested to grant an injunction against accessing the accumulated severance package and to order the return of the sums to the Company. These actions are time limited, so the initial action against the Company’s former Chief of Staff was initiated prior to the completion of the Special Committee Report and as such was based upon the limited information known at that time. The preliminary hearing in both of these cases is set for the coming months and both will be heard in front of the same judge who granted the injunction against the Company’s former Chief of Staff. There can be no assurance that the Company’s former CEO, the Company’s former Chief of Staff or others will not bring forth any claims or commence any litigation against us in connection with the Company’s former CEO’s dismissal, his resignation from the board, the Company’s challenging the Company’s former Chief of Staff’s severance payments or the publication of the Special Committee’s findings from the Internal Investigation. Further, the Company incurred substantial costs and diverted management resources in connection with the Internal Investigation, and the Internal Investigation itself caused us to fail to timely file the Company’s Annual Reports on Form 20-F for the fiscal years ended December 31, 2022 with the SEC. The Company may also incur material costs associated with the indemnification arrangements with the current and former directors and certain of the Company’s officers, as well as other indemnitees related to law suits or regulatory proceedings that have arisen and may arise in the future from the Internal Investigation. g. Definitions: In these financial statements: The Company - HUB Cyber Security Ltd. RNER - Mount Rainier Acquisition Corp., a Delaware corporation Subsidiaries - Companies that are controlled by the Company (as defined in IFRS 10) and whose accounts are consolidated with those of the Company. Investees - Subsidiaries. The Group - The Company and its investees. Related parties - As defined in IAS 24.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2023
Significant Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES The following accounting policies have been applied consistently in the financial statements for all periods presented, unless stated otherwise. a. Basis of presentation of the financial statements: These financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS” as issued by the International Accounting Standard Board (IASB)). The Company’s financial statements have been prepared on a cost basis, except for financial instruments measured at fair value through profit or loss. The Company has elected to present the profit or loss items using the function of expense method. b. The operating cycle: The Company’s operating cycle is one year. c. Consolidated financial statements: The consolidated financial statements comprise the financial statements of companies that are controlled by the Company (subsidiaries). Control is achieved when the Company has power over the investee, is exposed or has rights to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. In assessing control, the effect of potential voting rights is considered only if they are substantive. Non-controlling interests in subsidiaries represent the equity in subsidiaries not attributable, directly or indirectly, to a parent. Non-controlling interests are presented in equity separately from the equity attributable to the equity holders of the Company. Profit or loss and components of other comprehensive income are attributed to the Company and to non-controlling interests. Losses are attributed to non-controlling interests even if they result in a negative balance of non-controlling interests in the consolidated statement of financial position. d. Business combinations and goodwill: To determine whether a transaction is accounted for as an asset acquisition or business combination, the Company applies a concentration test to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If the test is met, the transaction is accounted for as an asset acquisition. If the concentration test is not Business combinations are accounted for by applying the acquisition method. The cost of the acquisition is measured at the fair value of the consideration transferred on the acquisition date with the addition of non-controlling interests in the acquiree. In each business combination, the Company chooses whether to measure the non-controlling interests in the acquiree based on their fair value on the acquisition date or at their proportionate share in the fair value of the acquiree’s net identifiable assets. Direct acquisition costs are carried to the statement of profit or loss as incurred. Goodwill is initially measured at cost which represents the excess of the acquisition consideration and the amount of non-controlling interests over the net identifiable assets acquired and liabilities assumed. e. Functional currency, presentation currency and foreign currency: 1. Functional currency and presentation currency: The Group determines the functional currency of each Group entity, including companies accounted for at equity. Items included in the financial statements of each of the Company’s entities are measured using the currency of the primary economic environment in which the entity operates (the “functional currency”). The Company’s functional currency is NIS. The consolidated financial statements are presented in US dollar, which is the Company’s presentation currency. The results and financial position of foreign operations (none of which has the currency of a hyperinflationary economy) that have a functional currency different from the presentational currency are translated into the presentational currency as follows: ● Assets and liabilities for each statement of financial position presented are translated at the closing rate at the date of that statement of financial position. ● Income and expenses for each statement of profit or loss and statement of comprehensive loss are translated at average exchange rates (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated at the rate on the dates of the transactions), and ● All resulting exchange differences are recognized in other comprehensive income (loss). 2. Transactions, assets and liabilities in foreign currency: Transactions denominated in foreign currency (other than the functional currency) are recorded upon initial recognition at the exchange rate at the date of the transaction. After initial recognition, monetary assets and liabilities denominated in foreign currency are translated at each reporting date into the functional currency at the exchange rate at that date. Exchange rate differences, other than those capitalized to qualifying assets or accounted for as hedging transactions in equity, are recognized in profit or loss. Non-monetary assets and liabilities denominated in foreign currency and measured at cost are translated at the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currency and measured at fair value are translated into the functional currency using the exchange rate prevailing at the date when the fair value was determined. f. Revenue recognition: Revenue from contracts with customers is recognized when the control over the goods or services is transferred to the customer. The transaction price is the amount of the consideration that is expected to be received based on the contract terms, excluding amounts collected on behalf of third parties (such as taxes). Revenue from rendering of services: Revenue from rendering of services is recognized over time, during the period the customer simultaneously receives and consumes the benefits provided by the Company’s performance. The Company charges its customers based on payment terms agreed upon in specific agreements. When payments are made before or after the service is performed, the Company recognizes the resulting contract asset or liability. Contract balances: The Company charges customers as the work progresses in accordance with the contractual terms. Amounts billed are classified as trade receivables in the statement of financial position. When revenue from performance of a contract are recognized in profit or loss before the customer is charged, the amounts recognized are recorded as trade receivables. Amounts received from customers in advance of performance by the Company are recorded as contract liabilities and recognized as revenue in profit or loss when the work is performed. Determining the transaction Price The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). Costs of obtaining a contract: The Company has elected to apply the practical expedient allowed by IFRS 15 according to which incremental costs of obtaining a contract are recognized as an expense when incurred if the amortization period of the asset is one year or less. g. Taxes on income: Deferred taxes: Deferred taxes are computed in respect of temporary differences between the carrying amounts in the financial statements and the amounts attributed for tax purposes. Deferred taxes are measured at the tax rate that is expected to apply when the asset is realized or the liability is settled, based on tax laws that have been enacted or substantively enacted by the reporting date. Deferred tax assets are reviewed at each reporting date and reduced to the extent that it is not probable that they will be utilized. Deductible carryforward losses and temporary differences for which deferred tax assets had not been recognized are reviewed at each reporting date and a respective deferred tax asset is recognized to the extent that their utilization is probable. Taxes that would apply in the event of the disposal of investments in investees have not been taken into account in computing deferred taxes, as long as the disposal of the investments in investees is not probable in the foreseeable future. Also, deferred taxes that would apply in the event of distribution of earnings by investees as dividends have not been taken into account in computing deferred taxes, since the distribution of dividends does not involve an additional tax liability or since it is the Company’s policy not to initiate distribution of dividends from a subsidiary that would trigger an additional tax liability. Deferred taxes are offset if there is a legally enforceable right to offset a current tax asset against a current tax liability and the deferred taxes relate to the same taxpayer and the same taxation authority. h. Intangible assets: Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Expenditures relating to internally generated intangible assets, are recognized in profit or loss when incurred. Intangible assets with a finite useful life are amortized over their useful life on a straight-line basis and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for an intangible asset are reviewed at least at each year end. Patents: The patents are for a period of ten years with an option for renewal at the end of the period. The useful life of intangible assets is as follows: Years Patents 10 Customer relations 3.5-10 Order backlog 1 Technology 2-4 Gains or losses from the derecognition of an intangible asset are measured as the difference between the net disposal proceeds and the cost of the asset and carried to profit or loss. i. Impairment of non-financial assets: The Company evaluates the need to record an impairment of non-financial assets whenever events or changes in circumstances indicate that the carrying amount is not recoverable. If the carrying amount of non-financial assets exceeds their recoverable amount, the assets are reduced to their recoverable amount. The recoverable amount is the higher of fair value less costs of sale and value in use. In measuring value in use, the expected future cash flows are discounted using a pre-tax discount rate that reflects the risks specific to the asset. The recoverable amount of an asset that does not generate independent cash flows is determined for the cash-generating unit to which the asset belongs. Impairment losses are recognized in profit or loss. An impairment loss of an asset, other than goodwill, is reversed only if there have been changes in the estimates used to determine the asset’s recoverable amount since the last impairment loss was recognized. Reversal of an impairment loss, as above, shall not be increased above the lower of the carrying amount that would have been determined (net of depreciation or amortization) had no impairment loss been recognized for the asset in prior years and its recoverable amount. The reversal of impairment loss of an asset presented at cost is recognized in profit or loss. A reversal of an impairment loss for each cash generating unit shall be allocated to the assets of the unit, except for goodwill, pro rata with the carrying amount to each of the assets within the measurement scope of IAS 36. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years. The following criteria are applied in assessing impairment of these specific assets: Goodwill in respect of subsidiaries: The Company reviews goodwill for impairment at least once a year, on December 31, or more frequently if events or changes in circumstances indicate that there is an impairment. Goodwill is tested for impairment by assessing the recoverable amount of the cash-generating unit (or group of cash-generating units) to which the goodwill has been allocated. Each cash-generating unit to which the goodwill is allocated shall represent the lowest level within the Company at which the goodwill is monitored for internal management purposes and not be larger than an operating segment. An impairment loss is recognized if the recoverable amount of the cash-generating unit (or group of cash-generating units) to which goodwill has been allocated is less than the carrying amount of the cash-generating unit (or group of cash-generating units). Any impairment loss is allocated first to goodwill. Impairment losses recognized for goodwill cannot be reversed in subsequent periods. j. Financial instruments: 1. Financial liabilities: a) Financial liabilities measured at amortized cost: Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability. After initial recognition, the Company measures all financial liabilities at amortized cost. b) Financial liabilities measured at fair value through profit or loss: At initial recognition, the Company measures financial liabilities that are not measured at amortized cost at fair value. Transaction costs are recognized in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss. 2. Derecognition of financial liabilities: A financial liability is derecognized only when it is extinguished, that is when the obligation specified in the contract is discharged or cancelled or expires. A financial liability is extinguished when the debtor discharges the liability by paying in cash, other financial assets, goods or services; or is legally released from the liability. When there is a modification in the terms of an existing financial liability, the Company evaluates whether the modification is substantial. If the terms of an existing financial liability are substantially modified, such modification is accounted for as an extinguishment of the original liability and the recognition of a new liability. The difference between the carrying amounts of the above liabilities is recognized in profit or loss. If the modification is not substantial, the Company recalculates the carrying amount of the liability by discounting the revised cash flows at the original effective interest rate and any resulting difference is recognized in profit or loss. When evaluating whether the modification in the terms of an existing liability is substantial, the Company considers both quantitative and qualitative factors. 3. Warrants to ordinary shares: According to IAS 32, “Financial Instruments: Presentation”, derivatives which will be settled only by the issuer exchanging fixed amounts of cash to fixed numbers of the Company’s ordinary shares will be classified as equity. Otherwise, the instrument should be classified as a financial liability. Therefore, the Group has classified such warrants as a financial liability. The warrant instrument is initially recognized at fair value, and subsequently measured at fair value. Changes in fair value are recognized in profit or loss. k. Fair value measurement: Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurement is based on the assumption that the transaction will take place in the asset’s or the liability’s principal market, or in the absence of a principal market, in the most advantageous market. The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest. Fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use. The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data is available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs. All assets and liabilities measured at fair value or for which fair value is disclosed are categorized into levels within the fair value hierarchy based on the lowest level input that is significant to the entire fair value measurement: Level 1 - quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 - inputs other than quoted prices included within Level 1 that are observable directly or indirectly. Level 3 - inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data). l. Provisions: A provision in accordance with IAS 37 is recognized when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. When the Group expects part or all of the expense to be reimbursed, for example under an insurance contract, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. The expense is recognized in the statement of profit or loss net of any reimbursement. Following are the types of provisions included in the financial statements: A provision for claims is recognized when the Group has a present legal or constructive obligation as a result of a past event, that it is more likely than not that an outflow of resources embodying economic benefits will be required by the Group to settle the obligation and a reliable estimate can be made of the amount of the obligation. m. Employee benefit liabilities: The Group has several employee benefit plans: 1. Short-term employee benefits: Short-term employee benefits are benefits that are expected to be settled wholly before twelve months after the end of the annual reporting period in which the employees render the related services. These benefits include salaries, paid annual leave, paid sick leave, recreation and social security contributions and are recognized as expenses as the services are rendered. A liability in respect of a cash bonus or a profit-sharing plan is recognized when the Group has a legal or constructive obligation to make such payment as a result of past service rendered by an employee and a reliable estimate of the amount can be made. 2. Post-employment benefits: The plans are normally financed by contributions to insurance companies and classified as defined contribution plans or as defined benefit plans. The Group has defined contribution plans pursuant to section 14 to the Severance Pay Law under which the Group usually pays fixed contributions and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient amounts to pay all employee benefits relating to employee service in the current and prior periods. Contributions to the defined contribution plan in respect of severance or retirement pay are recognized as an expense when contributed concurrently with performance of the employee’s services. The Group also operates a defined benefit plan in respect of severance pay pursuant to the Severance Pay Law. According to the Law, employees are entitled to severance pay upon dismissal or retirement. The liability for termination of employment is measured using the projected unit credit method. The actuarial assumptions include expected salary increases and rates of employee turnover based on the estimated timing of payment. The amounts are presented based on discounted expected future cash flows using a discount rate determined by reference to market yields at the reporting date on high quality corporate bonds that are linked to the Consumer Price Index with a term that is consistent with the estimated term of the severance pay obligation. In respect of its severance pay obligation to certain of its employees, the Company usually makes current deposits in severance pay funds and insurance companies (“the plan assets”). Plan assets comprise assets held by a long-term employee benefit fund or qualifying insurance policies. Plan assets are not available to the Group’s own creditors and cannot be returned directly to the Group. The liability for employee benefits shown in the statement of financial position reflects the present value of the defined benefit obligation less the fair value of the plan assets. Remeasurements of the net liability are recognized in other comprehensive income in the period in which they occur.

Significant Accounting Judgment

Significant Accounting Judgments, Estimates and Assumptions Used In the Preparation of the Financial Statements	12 Months Ended
	Dec. 31, 2023
Significant Accounting Judgments, Estimates and Assumptions Used In the Preparation of the Financial Statements [Abstract]
SIGNIFICANT ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS	NOTE 3:- SIGNIFICANT ACCOUNTING JUDGMENTS, ESTIMATES AND ASSUMPTIONS USED IN THE PREPARATION OF THE FINANCIAL STATEMENTS In the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant effect on the amounts recognized in the financial statements: a. Judgments: - Effective control: The Company evaluates whether it controls a company in which it holds less than the majority of the voting rights by, among others, reference to the size of its share of voting rights relative to the size and dispersion of voting rights held by the other shareholders, and by voting patterns at previous shareholders’ meetings. b. Estimates and assumptions: The preparation of the financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities, revenues and expenses. Changes in accounting estimates are reported in the period of the change in estimate. The key assumptions made in the financial statements concerning uncertainties at the reporting date and the critical estimates computed by the Group that may result in a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below. - Impairment of goodwill: The Group reviews goodwill for impairment at least once a year. This requires management to make an estimate of the projected future cash flows from the continuing use of the cash-generating unit (or a group of cash-generating units) to which the goodwill is allocated and also to choose a suitable discount rate for those cash flows. See more information in Note 2q above. - Impairment of other intangible assets The carrying values of the long-lived intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. If any indication exists, then the asset’s recoverable amount is estimated. Determining the recoverable amount is subjective and requires management to estimate future growth, profitability, discount and terminal growth rates, and project future cash flows, among other factors. Future events and changing market conditions may impact the assumptions as to prices, costs or other factors that may result in changes to the estimates of future cash flows. If the Company concludes that a definite or indefinite long-lived intangible asset is impaired, the company recognize a loss in an amount equal to the excess of the carrying value of the asset over its fair value at the date of impairment. The fair value at the date of the impairment becomes the new cost basis and will result in a lower depreciation expense than for periods before the asset’s impairment. - Legal claims: In estimating the likelihood of outcome of legal claims filed, threatened litigation and unasserted claim against the Company and its investees, the companies rely on the opinion of their legal counsel. These estimates are based on the legal counsel’s best professional judgment, taking into account the stage of proceedings and legal precedents in respect of the different issues. Since the outcome of the claims will be determined in courts, the results could differ from these estimates. - Deferred tax assets: Deferred tax assets are recognized for unused carryforward tax losses and deductible temporary differences to the extent that it is probable that taxable profit will be available against which the losses can be utilized. Significant management judgment is required to determine the amount of deferred tax assets that can be recognized, based upon the timing and level of future taxable profits, its source and the tax planning strategy. See also Note 2g above. - Severances and other post-employment benefits: The liability in respect of post-employment defined benefit plans is determined using actuarial valuations. The actuarial valuation involves making assumptions about, among others, the discount rate, rate of salary increases and employee turnover rate. The carrying amount of the liability may be significantly affected by changes in these estimates.

Disclosure of New Standards in

Disclosure of New Standards in the Period	12 Months Ended
	Dec. 31, 2023
Disclosure of New Standards in the Period [Abstract]
DISCLOSURE OF NEW STANDARDS IN THE PERIOD	NOTE 4:- DISCLOSURE OF NEW STANDARDS IN THE PERIOD 1. Changes in accounting policies - initial application of new financial reporting and accounting standards and amendments to existing financial reporting and accounting standards: a. Amendment to IAS 8, “Accounting Policies, Changes to Accounting Estimates and Errors”: In February 2021, the IASB issued an amendment to IAS 8, “Accounting Policies, Changes to Accounting Estimates and Errors” (“the Amendment”), in which it introduces a new definition of “accounting estimates”. Accounting estimates are defined as “monetary amounts in financial statements that are subject to measurement uncertainty”. The Amendment clarifies the distinction between changes in accounting estimates and changes in accounting policies and the correction of errors. The Amendment is applied prospectively for annual reporting periods beginning on January 1, 2023 and is applicable to changes and had no impact. b. Amendment to IAS 12, “Income Taxes”: In May 2021, the IASB issued an amendment to IAS 12, “Income Taxes” (“IAS 12”), which narrows the scope of the initial recognition exception under IAS 12.15 and IAS 12.24 (“the Amendment”). According to the recognition guidelines of deferred tax assets and liabilities, IAS 12 excludes recognition of deferred tax assets and liabilities in respect of certain temporary differences arising from the initial recognition of certain transactions. This exception is referred to as the “initial recognition exception”. The Amendment narrows the scope of the initial recognition exception and clarifies that it does not apply to the recognition of deferred tax assets and liabilities arising from transaction that are not a business combination and that give rise to equal taxable and deductible temporary differences, even if they meet the other criteria of the initial recognition exception. The Amendment applies for annual reporting periods beginning on January 1, 2023. In relation to leases and decommissioning obligations, the Amendment is applied commencing from the earliest reporting period presented in the financial statements in which the Amendment is initially applied. The cumulative effect of the initial application of the Amendment is recognized as an adjustment to the opening balance of retained earnings (or another component of equity, as appropriate) at that date. The application of the Amendment did not have a material impact on the Company’s consolidated financial statements. c. Amendment to IAS 1, “Disclosure of Accounting Policies”: In February 2021, the IASB issued an amendment to IAS 1, “Presentation of Financial Statements” (“the Amendment”), which replaces the requirement to disclose ‘significant’ accounting policies with a requirement to disclose ‘material’ accounting policies. One of the main reasons for the Amendment is the absence of a definition of the term ‘significant’ in IFRS whereas the term ‘material’ is defined in several standards and particularly in IAS 1. The Amendment is applicable for annual periods beginning on January 1, 2023. The application of the above Amendment had an effect on the disclosures of the Company’s accounting policies, but did not affect the measurement, recognition or presentation of any items in the Company’s consolidated financial statements. 2. Changes in accounting policies - initial application of new financial reporting and accounting standards and amendments to existing financial reporting and accounting standards in the period prior to their adoption: a. Amendment to IAS 1, “Presentation of Financial Statements”: In January 2020, the IASB issued an amendment to IAS 1, “Presentation of Financial Statements” regarding the criteria for determining the classification of liabilities as current or non-current (“the Original Amendment”). In October 2022, the IASB issued a subsequent amendment (“the Subsequent Amendment”). According to the Subsequent Amendment: ● Only financial covenants with which an entity must comply on or before the reporting date will affect a liability’s classification as current or non-current. ● In respect of a liability for which compliance with financial covenants is to be evaluated within twelve months from the reporting date, disclosure is required to enable users of the financial statements to assess the risks related to that liability. The Subsequent Amendment requires disclosure of the carrying amount of the liability, information about the financial covenants, and the facts and circumstances at the end of the reporting period that could result in the conclusion that the entity may have difficulty in complying with the financial covenants. According to the Original Amendment, the conversion option of a liability affects the classification of the entire liability as current or non-current unless the conversion component is an equity instrument. The Original Amendment and Subsequent Amendment are both effective for annual periods beginning on or after January 1, 2024 and must be applied retrospectively. Early adoption is permitted. As of December 31, 2023, all loans are classified to current liabilities and the Company still evaluating the impact related to other liabilities on its consolidated financial statements. b. Amendment to IFRS 16, “Leases”: In September 2022, the IASB issued an amendment to IFRS 16, “Leases” (“the Amendment”), which provides guidance on how a seller-lessee should measure the lease liability arising in a sale and leaseback transaction with variable lease payments that do not depend on an index or rate. The seller-lessee has to choose between two accounting policies for measuring the lease liability on the inception date of the lease. The accounting policy chosen must be applied consistently. The Amendment is applicable for annual periods beginning on or after January 1, 2024. Early adoption is permitted. The Amendment is to be applied retrospectively. The Company believes that the Amendment is not expected to have a material impact on its consolidated financial statements. c. Amendments to IAS 7, “Statement of Cash Flows”, and IFRS 7, “Financial Instruments: Disclosures”: In May 2023, the IASB issued amendments to IAS 7, “Statement of Cash Flows”, and IFRS 7, “Financial Instruments: Disclosures” (“the Amendments”) to address the presentation of liabilities and the associated cash flows arising out of supplier finance arrangements, as well as disclosures required for such arrangements. The disclosure requirements in the Amendments are intended to assist users of financial statements in understanding the effects of supplier finance arrangements on an entity’s liabilities, cash flows and exposure to liquidity risk. The Amendments are effective for annual reporting periods beginning on or after January 1, 2024. Early adoption is permitted but will need to be disclosed. The Company believes that the Amendments are not expected to have a material impact on its consolidated financial statements. d. Amendments to IAS 21, “The Effects of Changes in Foreign Exchange Rates”: In August 2023, the IASB issued “Amendments to IAS 21: Lack of Exchangeability (Amendments to IAS 21, “The Effects of Changes in Foreign Exchange Rates”)” (“the Amendments”) to clarify how an entity should assess whether a currency is exchangeable and how it should measure and determine a spot exchange rate when exchangeability is lacking. The Amendments set out the requirements for determining the spot exchange rate when a currency lacks exchangeability. The Amendments require disclosure of information that will enable users of financial statements to understand how a currency not being exchangeable affects or is expected to affect the entity’s financial performance, financial position and cash flows. The Amendments apply for annual reporting periods beginning on or after January 1, 2025. The Company believes that the amendments are not expected to have a material impact on its consolidated financial statements. e. IFRS 18 “Presentation and Disclosure in Financial Statements” (IFRS 18) IFRS 18 i. Improved comparability in the statement of profit or loss. IFRS 18 ii. Enhanced transparency of management-defined performance measures. IFRS 18 iii. Useful grouping of information in the financial statements. IFRS 18 IFRS 18 The Amendments apply for annual reporting periods beginning on or after January 1, 2027. Earlier adoption is permitted. The Company is still evaluating the effect of this amendment on its consolidated financial statements.

Merger Agrrement with Special P

Merger Agrrement with Special Purpose Acquisition Company (“Spac”)	12 Months Ended
	Dec. 31, 2023
Merger Agrrement with Special Purpose Acquisition Company (“Spac”) [Abstract]
MERGER AGRREMENT WITH SPECIAL PURPOSE ACQUISITION COMPANY (“SPAC”)	NOTE 5:- MERGER AGREEMENT WITH SPECIAL PURPOSE ACQUISITION COMPANY (“SPAC”) On March 22, 2022, the Company’s Board approved the Company’s engagement in a merger transaction, which consisted of signing a series of binding agreements including a merger agreement (“the merger transaction”), between the Company and Mount Rainer Acquisition Corp. (“RENR”), an unrelated third party which was traded on the Nasdaq Global Market that raised approximately $175,000 thousand as a SPAC. The Company hired A-Labs Advisory & Finance Ltd., an investment banking firm, and Oppenheimer & Co. Inc. to assist the merger transaction. The merger transaction relied on the proforma Enterprise Value of the merged company of approximately $1.28 billion (before the money), as agreed upon with Mount Rainier and with the PIPE investors (as defined below), including share options and potential free cash flows of up to approximately $225,000 thousand in the merged company (insofar as none of the SPAC shareholders redeem their investment before the merger transaction closing in keeping with their rights, see further details below). In connection with the merger transaction, qualifying Israeli and U.S. institutional investors (“the PIPE investors”) engaged to invest $50,000 thousand based on the merger company’s agreed value as described above (in a private placement) to be invested in the Company at closing. On January 11, 2023 the Company announced that all the suspending conditions for the merger transaction have been met and the completion of the merger transaction is subject only to the absence of a legal impediment. Shortly before the merger transaction closing date the Company affected a reverse stock split to cause the value of the outstanding ordinary shares immediately prior to the transaction closing date to be equal to $10 per share. (pre reverse stock split of 1:10). The Company’s shares began trading on Nasdaq on March 1, 2023. 99% of the shareholders entitled to withdraw their investment of $175,000 thousand elected to redeem their investment upon the approval of the merger. In March 2023, the Company raised $4,000 thousand from two of the PIPE investors, and, while the Company is considering possible alternatives in order to pursue the majority of the remaining funds committed as a part of the PIPE investment from the investors, it is uncertain if the Company will be able to receive the remaining PIPE funds. As of December 31, 2022, the Company recorded $872 thousand as advance issuance expense, which were classified in 2023 to premium. In December 2021 the Company entered into an agreement with Oppenheimer & Co., Inc. (“Oppenheimer”) to provide financial advisory services. In connection with the Reverse Recapitalization, the Company agreed to pay to Oppenheimer a transaction fee upon the consummation of the Reverse Recapitalization equal to 1% of the aggregate value of the Company implied by the value of the Company’s ordinary shares issued to RNER’s stockholders in the Reverse Recapitalization on a fully diluted basis, plus the principal amount of any debt or other liabilities of HUB Security outstanding as of the closing date of the Reverse Recapitalization. Based on the valuation of $1.28 billion ascribed to the shares issued to RNER’s stockholders in the Reverse Recapitalization in March 2023, the amount owed to Oppenheimer at the closing of the Reverse Recapitalization was approximately $12,800 thousand. As of December 31, 2023 and 2022, the Company recorded $12,800 thousand and $5,120 thousand as accrued expenses, respectively. On June 12, 2023 a lawsuit was filed by Oppenheimer against the Company alleging, among other things, breach of contract, breach of covenant of good faith and fair dealing and quantum meruit, in connection with investment banking advice and services provided by Oppenheimer in connection with the Company’s Reverse Recapitalization with Mount Rainier Acquisition Corp. During 2024 the parties have tried to settle the legal issue where the Company believes that those discussions will end in a positive outcome. See detailed information in Note 22(c)). The Transactions were accounted for as a reverse recapitalization, in accordance with the relevant International Financial Reporting Standards (“IFRS”) and the Group was deemed to be the accounting acquirer. RNER did not meet the definition of a business in accordance with IFRS 3 - “Business Combinations”, and the Transactions were instead accounted for within the scope of IFRS 2 - “Share-based payment” (“IFRS 2”), as a share-based payment transaction in exchange for a public listing service. In accordance with IFRS 2 the Company recorded a one-time share-based Share listing expense of $12,312 thousand at the closing of the Reverse Recapitalization that was calculated based on the excess of the fair value of the Company issued to public investors over the fair value of the identifiable net assets of RNER that were acquired: Amount Number of USD in thousands except to share amount Shares issued to RNER shareholders 453,321 Closing price of the Company’s share on Nasdaq as of March 1, 2023 ($) 15.9 (A) Fair value of the Company’s shares issued to RNER shareholders 7,208 Public Warrants issued to RNER shareholders 1,550,784 Closing price of the Company’s warrants on Nasdaq as of March 1, 2023 ($) 1.7 Private Warrants issued to RNER shareholders 53,599 Fair Value of the Company’s warrants on as of March 1, 2023 ($) 1.33 (B) Fair value of the Company’s warrants issued to RNER shareholders 2,711 RNER assets 588 RNER liabilities (2,981 ) (C) Net liabilities of RNER (2,393 ) IFRS 2 Listing expenses (A+B-C) 12,312 *) Shares and per shares amounts have been retroactively adjusted to reflect the reverse stock splits as described in note 20a.

Cash and Cash Equivalents

Cash and Cash Equivalents	12 Months Ended
	Dec. 31, 2023
Cash and Cash Equivalents [Abstract]
CASH AND CASH EQUIVALENTS	NOTE 6:- CASH AND CASH EQUIVALENTS December 31, 2023 2022 USD in thousands Cash and cash equivalents in NIS 3,201 3,112 Cash and cash equivalents in USD 227 765 Cash and cash equivalents in Euro 2 104 Cash and cash equivalents in other currency 92 13 3,522 3,994

Trade Receivables, Net

Trade Receivables, Net	12 Months Ended
	Dec. 31, 2023
Trade Receivables, Net [Abstract]
TRADE RECEIVABLES, NET	NOTE 7:- TRADE RECEIVABLES, NET December 31, 2023 2022 USD in thousands Account receivable 10,051 23,317 Unbilled receivable 902 1,020 Checks collectible 27 405 Allowance for doubtful debt (1,113 ) (685 ) Trade receivables, net 9,867 24,057 The Company grants its customers interest-free credit for an average period of 90 days. Impaired debts are accounted for through recording an allowance for doubtful accounts. The Company policy is to specifically accrue on disputed debt in a period greater of 120 days. Following is information about the credit risk exposure of the Company’s trade receivables: Past due trade receivables Not past due < 30 31-60 60-90 90-120 >120 Total USD in thousands Trade receivables before allowance for doubtful accounts 4,349 1,838 1,341 989 520 1,944 10,980 Allowance for doubtful accounts - - - - - 1,113 1,113 December 31, 2023 4,349 1,838 1,341 989 520 742 9,867 December 31, 2022 21,147 1,850 349 183 145 383 24,057

Other Assets

Other Assets	12 Months Ended
	Dec. 31, 2023
Other Assets [Abstract]
OTHER ASSETS	NOTE 8:- OTHER ASSETS December 31, 2023 2022 USD in thousands Government authorities 1,604 1,127 Prepaid expenses 1,483 460 Grants receivables (1) 1,159 - Other assets 837 85 5,083 1,672 (1) In November 2023, the Company has been granted $1,159 thousand war grants associated with Israel-Hamas war.

Leases

Leases	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
LEASES	NOTE 9:- LEASES a. Disclosures for leases in which the Company acts as lessee: 1. The Group companies have entered into leases of buildings and motor vehicles which are used for their ongoing operations. 2. The Company’s leases of buildings have a lease term of 2-10 years whereas leases of motor vehicles have lease terms of 3-4 years. 3. Information on leases: Year ended December 31, 2023 2022 2021 USD in thousands Interest expense on lease liabilities 181 258 210 Total cash outflow for leases 1,711 2,240 1,175 b. Lease extension and termination options: The Company has leases that include both extension and termination options. These options provide flexibility in managing the leased assets and align with the Company’s business needs. The Company exercises significant judgement in deciding whether it is reasonably certain that the extension and termination options will be exercised. In leases that contain noncancelable lease periods of 3-10 years, the Company did not include in the lease term the exercise of extension options existing in the lease agreements. In leases of motor vehicles, the Company does not include in the lease term the exercise of extension options since the Company does not ordinarily exercise options that extend the lease period beyond five years (without the extension option). c. Disclosures in respect of right-of-use assets, net: 2023 Office lease Motor Total USD in thousands Cost: Balance as of January 1, 2023 7,231 1,794 9,025 Additions during the year: New leases - 643 643 Terminated lease (2,961 ) (80 ) (3,041 ) Classification - 71 71 Adjustments arising from indexation 137 - 137 Other (19 ) - (19 ) Adjustments arising from translating financial statements from functional currency to presentation currency (264 ) (10 ) (274 ) Balance as of December 31, 2023 4,124 2,418 6,542 Accumulated depreciation: Balance as of January 1, 2023 1,528 990 2,518 Additions during the year: Depreciation in the year 1,033 530 1,563 Adjustments arising from translating financial statements from functional currency to presentation currency (28 ) (20 ) (49 ) Balance as of December 31, 2023 2,533 1,500 4,032 Depreciated cost as of December 31, 2023 1,591 918 2,510 2022 Office lease Motor Total USD in thousands Cost: Balance as of January 1, 2022 7,510 1,262 8,772 Additions during the year: New leases 243 711 954 Adjustments arising from indexation 379 - 379 Adjustments arising from translating financial statements from functional currency to presentation currency (901 ) (179 ) (1,080 ) Balance as of December 31, 2022 7,231 1,794 9,025 Accumulated depreciation: Balance as of January 1, 2022 168 369 537 Additions during the year: Depreciation in the year 1,445 695 2,140 Adjustments arising from translating financial statements from functional currency to presentation currency (85 ) (74 ) (159 ) Balance as of December 31, 2022 1,528 990 2,518 Depreciated cost as of December 31, 2022 5,703 804 6,507 d. As for an analysis of maturity dates of lease liabilities, see Note 16c. e. The Company has leases of motor vehicles for a period of up to 12 months and low value leases of office furniture. The Company applies the practical expedient in IFRS 16 in respect of these leases and recognizes lease payments as an expense using the straight-line method over the lease term. f. Lease commitments: 1. In May 2017, the Company entered into a lease of offices in an area of 1,600 sq.m. in the city of Or Yehuda, Israel. The lease is for a period of ten years with an option for extension by another five years. The monthly lease fees are approximately NIS 110 thousand ($30 thousand), linked to the CPI of May 2017 with the addition of VAT. The lease period began on April 1, 2018. 2. In 2019, the Company entered into an agreement for the lease of offices in Tel-Aviv for a period of two years with an option for extension by another two years. In 2022 the Company extended the agreement for two more years. The lease fees are approximately NIS 18 thousand ($5 thousand) a month linked to the CPI plus VAT. The lease period began on June 19, 2022 and early terminated on June 15, 2023. 3. In 2021, the Company entered into an agreement for the lease of offices in Tel-Aviv for a period of five years with an option for extension by another five years. The lease fees are approximately NIS 300 thousand ($81 thousand) a month linked to the CPI month plus VAT. The lease period began on August 15, 2021. The Company early terminated in September 2023.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2023
Property and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE 10:- PROPERTY AND EQUIPMENT Composition and movement: 2023 Motor Office Computers Leasehold Total USD in thousands Cost: Balance as of January 1, 2023 197 235 798 598 1,828 Purchases in the year - 8 251 38 297 Disposals during the year (156 ) - - (97 ) (253 ) Adjustments arising from translating financial statements from functional currency to presentation currency (8 ) (7 ) (19 ) (19 ) (53 ) Balance as of December 31, 2023 33 236 1,030 520 1,819 Accumulated depreciation: Balance as of January 1, 2023 53 89 296 76 514 Depreciation in the year 21 21 239 60 341 Disposals during the year (43 ) - - (18 ) (61 ) Adjustments arising from translating financial statements from functional currency to presentation currency (1 ) (2 ) (5 ) (2 ) (10 ) Balance as of December 31, 2023 30 108 530 116 784 Depreciated cost as of December 31, 2023 3 128 500 404 1,035 2022 Motor Office Computers Leasehold Total USD in thousands Cost: Balance as of January 1, 2022 258 291 572 272 1,393 Purchases in the year 1 99 412 373 885 Disposals during the year (35 ) (121 ) (105 ) - (261 ) Adjustments arising from translating financial statements from functional currency to presentation currency (27 ) (34 ) (81 ) (47 ) (189 ) Balance as of December 31, 2022 197 235 798 598 1,828 Accumulated depreciation: Balance as of January 1, 2022 19 20 180 28 247 Depreciation in the year 38 74 143 54 309 Adjustments arising from translating financial statements from functional currency to presentation currency (4 ) (5 ) (27 ) (6 ) (42 ) Balance as of December 31, 2022 53 89 296 76 514 Depreciated cost as of December 31, 2022 144 146 502 522 1,314

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Net	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets, Net [Abstract]
GOODWILL AND INTANGIBLE ASSETS, NET	NOTE 11:- GOODWILL AND INTANGIBLE ASSETS, NET a. As for charges, see Note 22a. Composition and movement: Patents Goodwill Customer Technology (2) Total USD in thousands Cost: Balance as of January 1, 2022 20 31,992 22,273 1,207 55,492 Purchases in the year 13 - 9,453 500 9,966 Impairment recognized in the year - (14,618 ) (8,300 ) (438 ) (23,356 ) Adjustments arising from translating financial statements from functional currency to presentation currency (1 ) (3,672 ) (2,603 ) (143 ) (6,419 ) Balance as of December 31, 2022 32 13,702 20,823 1,126 35,683 Impairment recognized in the year (1) - (10,643 ) (4,615 ) - (15,258 ) Adjustments arising from translating financial statements from functional currency to presentation currency (1 ) (592 ) (613 ) (34 ) (1,240 ) Balance as of December 31, 2023 31 2,467 15,595 1,092 19,185 Accumulated amortization: Balance as of January 1, 2022 7 - 801 75 883 Amortization recognized in the year (1) 2 - 4,723 623 5,348 Adjustments arising from translating financial statements from functional currency to presentation currency * - (411 ) (37 ) (448 ) Balance as of December 31, 2022 9 - 5,113 661 5,783 Amortization recognized in the year (1) 9 - 5,278 446 5,733 Adjustments arising from translating financial statements from functional currency to presentation currency * - (199 ) (15 ) (214 ) Balance as of December 31, 2023 18 - 10,192 1,092 11,302 Net balance: As of December 31, 2023 13 2,467 5,403 - 7,883 As of December 31, 2022 23 13,702 15,710 465 29,900 * Less than 1 thousand US dollars. (1) Customer relations, order backlog and brand amortization expenses are classified in the statement of profit or loss under sales and marketing expenses. (2) Technology and supplier relationships amortization expenses are classified in the statement of profit or loss under cost of sales expenses. Patents amortization expenses are classified in the statement of profit or loss under General and administrative expenses. b. For the years ended December 31, 2023 and 2022, the criteria for recognition in intangible asset related to development have not been met and therefore all development costs have been recognized as an expense in profit or loss. c. In May 2022, the Company entered into an Asset Purchase Agreement with Legacy Technologies Gmbh (“Legacy”) a European cyber firm that has an extensive EMEA distribution network of cyber solutions for major government and enterprise data centers. The acquired assets were mainly comprised of customer relationships of Legacy. The asset acquisition was completed on July 5, 2022. The total consideration for the sale and transfer of the acquired assets was $10,000 thousand in cash and additional contingent consideration of up to $12,000 thousand in restricted share units (RSUs) of the Company subject to compliance of several milestones established in the agreement. Half of the cash consideration was paid at the contract closing and the other half was scheduled to be paid in accordance with the payment terms established in the agreement over 2.5 years. The RSUs were treated as post combination transaction (refer to Note 21 – Share-Based Payment for further details). As of December 31, 2022, $3,839 thousand out of the remaining Consideration liability are classified in the balance sheet under line-item Current maturities of other liabilities. Out of this amount $375 thousand were paid after year-end. As of December 31, 2023, $5,078 thousand out of the remaining Consideration liability are classified in the balance sheet under line-item Current maturities of other liabilities. The transaction was analyzed in accordance with IFRS 3 – Business Combinations to first determine whether the acquired assets constitute a business. The Company had applied the concentration test. Based on the concentration test, substantially all of the fair value of the gross assets acquired is concentrated in the customer relationships. As a result, the transaction was treated as asset acquisition. The following represented the fair value of the identifiable assets as of the acquisition date: The purchase price allocation was as follow (in thousands): Technology 500 Customer relationships 9,453 Total consideration 9,953 As of December 31, 2022, the Company identified indicators of impairment since no binding purchase orders had been signed nor significant progress had been made on the purchased customer relationships as was expected upon the purchase date. As a result, management determined that the assets acquired should be fully impaired. As such, for the year ended December 31, 2022, the Company recorded an impairment loss of $8,738 thousand for the assets acquired from Legacy. d. Impairment loss of goodwill and intangible assets with defined useful life For annual impairment testing of goodwill and intangible assets with defined useful life the goodwill and other intangible assets of the Company were allocated to the operating segments which constitute four groups of cash generating units as follow: ● Consulting and distribution ● Dstorm (technology platform developed by Comsec) ● Professional services ● ALD Software The carrying amount as of December 31, 2023 of the goodwill and the intangible assets which were allocated to each cash-generating unit: Professional ALD Dstorm Consulting Total USD in thousands Patents 13 - - - 13 Goodwill 1,422 1,045 - - 2,467 Customer relationship, Suppliers relationship and Backlog 2,513 1,171 - 4,199 7,883 Total 13 - - - 13 The Company performed its annual impairment test in December 31, 2023 and 2022, respectively. The recoverable amount of each cash generating unit was assessed using the income approach model. ALD Software and Professional services The recoverable amount of the ALD Software and Professional services cash-generating units (“CGU”) as of December 31, 2023 have been determined based on a value in use calculation using cash flow projections from financial budgets approved by senior management covering a five-year period. The discount rate applied to cash flow projections is 20% for ALD Software and Professional services cash-generating units. Cash flows beyond the five-year period are extrapolated using a 2% growth rate for both cash generating units. As a result of this analysis, the value in use of the ALD Software and Professional services cash-generating units was determined to be lower than their carrying amounts, thus an impairment in the amount of $8,336 thousand was recognized in Professional services CGUs and an impairment in the amount of $651 thousand was recognized in ALD Software CGUs. The provision was recorded in impairment of goodwill and intangible assets expenses. Consulting and distribution and Dstorm The recoverable amount of the Consulting and distribution and Dstorm cash-generating units as of December 31, 2023 have been determined based on a value in use calculation using cash flow projections from financial budgets approved by senior management covering a five-year period. The discount rate applied to cash flow projections is 17% for both the Consulting and distribution and Dstorm cash-generating units. Cash flows beyond the five-year period are extrapolated using a 2% growth rate for both cash generating units. As a result of this analysis, the value in use of the Consulting and distribution and Dstorm cash-generating units were determined to be lower of their carrying amounts, thus impairment was recognized in the amount of $4,399 thousand in Consulting and distribution CGUs and an impairment in the amount of $1,872 thousand was recognized in Dstorm CGUs. Key assumptions The calculation of value in use for all of the cash generating units is most sensitive to the following key assumptions: ● Discount rates ● Growth rate used for the forecast period and to extrapolate cash flows beyond the forecast period. Discount rates − Discount rates represent the current market assessment of the risks specific to each cash-generating unit, taking into consideration the time value of money and individual risks of the underlying assets that have not been incorporated in the cash flow estimates. The discount rate calculation is based on the specific circumstances of the Company and its operating segments and is derived from its weighted average cost of capital (WACC). The WACC takes into account both debt and equity. A rise in the pre-tax discount rate of 20% to ALD Software and Professional services cash generating unit (i.e., +1%) would result in recognition of additional impairment of $219 thousand. A rise in the pre-tax discount rate of 17% to Consulting and distribution and Dstorm cash generating unit (i.e., +1%) would result in recognition of additional impairment of $1,047 thousand. Growth rate estimates – according to Company’s management forecast and for the terminal year, rates are based on published industry research. A reduction by 1% in the long-term growth rate to Consulting and distribution and Dstorm would result in recognition of additional impairment of $707 thousand.

Discontinued Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2023
Discontinued Operations [Abstract]
DISCONTINUED OPERATIONS	NOTE 12:- DISCONTINUED OPERATIONS In November 2021, the Company completed the acquisition of Comsec Ltd. and its subsidiaries. During 2023, one of the subsidiaries, Comsec Distribution Ltd. (“Distribution”) had financial, operational and commercials difficulties, cessation of sales starting July 2023, layoffs and departures of employees so that as of December 31, 2023 there were no employees in this activity. As of December 31, 2023, there were no business activities in Comsec Distribution. As of December 31, 2023 and based on the analysis performed by the Company’s management it has been determined that Comsec Distribution is considered as an abandoned business operation in accordance with IFRS 5, constitutes a component of the Company that represents a separate major line of business and therefore meets the criteria for classification as a discontinued operation. Prior to the classification of Distribution as a discontinued operation, the recoverable amount of certain items of account receivables and inventory were estimated and an impairment loss in an amount of $431 thousand and $1,900 thousand, respectively were recognized in order to ascertain that the carrying amount of the account receivables and inventory is not higher than their recoverable amount. Below are data of the operating results attributed to the discontinued operation: Year ended December 31, 2023 2022 2021 USD in thousands Revenues from sales 5,459 29,741 2,987 Cost of sales (5,931 ) (27,383 ) (2,713 ) Gross profit (loss) (472 ) 2,358 274 Sales and marketing expenses 351 1,126 91 General and administrative expenses 851 308 54 Operating income (loss) (1,674 ) 924 129 Finance expenses, net 356 317 22 Income before taxes on income (2,030 ) 607 107 Taxes on income - 37 - Income (loss) after taxes on income (2,030 ) 569 107 Below are data of the net cash flows provided by (used in) the discontinued operation: Year ended December 31, 2023 2022 2021 USD in thousands Net cash provided by (used in) discontinued operating activities 1,917 1,867 (638 ) Net cash provided by (used in) discontinued investing activities (1,026 ) 949 730 Net cash used in discontinued financing activities (1,375 ) (2,429 ) - Total net cash provided by (used in) discontinued operation (484 ) 387 92

Short-Term Loan

Short-Term Loan	12 Months Ended
	Dec. 31, 2023
Short-Term Loan [Abstract]
SHORT-TERM LOAN	NOTE 13:- SHORT-TERM LOAN a. Composition: December 31, 2023 2022 USD in thousands Short-term loan (1)-(8) 11,750 13,417 Accrued interest 128 15 11 ,878 13,432 (1) Loan received in July 2020, by Comsec Distribution (fully owned subsidiary), with an original principal amount of NIS 5,000 thousand $)1,452 thousand), bearing annual interest of Prime (Bank of Israel intrabank plus 1.5%) + 1.95%. and repayable in 24 instalments from July 2022. As of December 31, 2023 the remaining principal amount is $906 thousand. (2) Loan received in September 2021, by Comsec Ltd (fully owned subsidiary), with an original principal amount of NIS 980 thousand ($309 thousand), unlinked and bearing annual interest of Prime (Bank of Israel intrabank) + 1.5%. As of December 31, 2023 the remaining principal amount is $110 thousand. (3) Loan received in September 2021, by Comsec Ltd (fully owned subsidiary), with an original principal amount of NIS 6,000 thousand ($1,934 thousand) and repayable in two annual instalments from September 2023, linked and bearing annual interest of Prime (Bank of Israel intrabank plus 1.5%) + 1.95%. As of December 31, 2023 the remaining principal amount is $831 thousand. (4) Loan received in August 2022, by Aginix, a second-tier subsidiary, with an original principal amount of NIS 1,000 thousand ($274 thousand) and repayable in 10 instalments from June 2023. The loan bearing interest of 7.25%. As of December 31, 2023 the remaining principal amount is $118 thousand. (5) On-call loans received by Comsec, in an aggregate principal amount of NIS 34,106 thousand ($9,692 thousand). As of December 31, 2023 the remaining principal amount is $5,497 thousand. (6) Loan received in May 2023, by Qpoint, with an original principal amount of NIS 1,700 thousand ($469 thousand) and repayable in 12 instalments from June 2023. The loan bearing interest of Prime + 1.01%. As of December 31, 2023 the remaining principal amount is $380 thousand. (7) Loan received in January 2023, by HUB, in an aggregate principal amount of NIS 3,300 thousand ($900 thousand) and repayable in one instalment in January 2026 in an amount of $1,000 thousand. (8) See information related to a loan received from Dominion in Note 20d. Financial covenants: In connection with bank loans whose balance as of December 31, 2023 approximates NIS 428 thousand ($118 thousand), the subsidiary, Aginix, has undertaken towards the lending bank to meet the following financial covenants: the subsidiary’s adjusted equity will not be lower than NIS 500 thousand and its ratio to balance sheet will not be lower than 10%. In connection with bank loans whose balance as of December 31, 2023 approximates NIS 26,642 thousand ($7,345 thousand), the subsidiary, Comsec, has undertaken towards the lending bank to meet the following financial covenants: the subsidiary’s customer debt to on-call bank credit will not be lower than 1.2 and the ratio of long-term debt less cash to EBITDA will not be higher than 3.5 at all times. As of December 31, 2023, the subsidiary, Comsec, is not in compliance with the above financial covenants therefore the loans are classified as a short term loans. b. As for collaterals and charges, see Note 22a below.

Trade Payables

Trade Payables	12 Months Ended
	Dec. 31, 2023
Trade Payables [Abstract]
TRADE PAYABLES	NOTE 14:- TRADE PAYABLES December 31, 2023 2022 USD in thousands Open debts 9,101 12,410 Checks payable 766 1,361 9,867 13,771 Trade payables are non-interest bearing and are normally settled on average of 60-days terms.

Other Accounts Payable

Other Accounts Payable	12 Months Ended
	Dec. 31, 2023
Other Accounts Payable [Abstract]
OTHER ACCOUNTS PAYABLE	NOTE 15:- OTHER ACCOUNTS PAYABLE December 31, 2023 2022 USD in thousands Employees and payroll accruals 4,691 5,797 Accrued vacation pay 1,225 1,510 Government authorities 1,282 1,997 Accrued expenses 23,067 12,636 Current liability of government grants 265 402 Liability on account of shares issuance - 2,289 Deferred revenues 1,205 611 Other 692 80 32,42 7 25,322

Long-Term Liabilities

Long-Term Liabilities	12 Months Ended
	Dec. 31, 2023
Long-Term Liabilities [Abstract]
LONG-TERM LIABILITIES	NOTE 16:- LONG-TERM LIABILITIES a. As of December 31, 2023, the Company is not in compliance with the financial covenants described in note 13(a) therefore the loans are classified to Short-Term Loan. As for charges, see Note 22a below. b. Composition of other long-term liabilities: December 31, 2023 Effective Balance Balance % USD in thousands Liabilities for government grants 11.5 412 147 December 31, 2022 Effective Balance Balance % USD in thousands Liabilities for government grants 11.5 1,289 887 The liabilities for government grants are linked to the USD-NIS exchange rate. Government grants: December 31, 2023 2022 USD in thousands Balance as of January 1, 1,289 961 Grants received during the year - 77 Liability revaluation (877 ) 251 Balance as of December 31, 412 1,289 Presented in the statement of financial position as follows: December 31, 2023 2022 USD in thousands In current liabilities 265 402 In non-current liabilities 147 887 412 1,289 Government grants: The Company received from the Government of Israel grants for participation in research and development in return for the payment of royalties of 3.5% on sales of products resulting from the funded research and development up to 100% of the grants received. The financial statements include the liability in the amount which management expects to repay the IIA, within ten years, discounted at a rate of 11.5%. c. The maturity profile of lease liabilities and other long-term liabilities: December 31, 2023 First Second Third Fourth Fifth Sixth Total USD in thousands Lease liabilities 382 382 382 382 - - 1,528 Liabilities for government grants 265 30 21 19 18 59 412 Total 647 412 403 401 18 59 1,940 As of December 31, 2023, total grants received by HUB amount to $973 thousand and no material amount was paid. No new grants were received during 2023. As of December 31, 2023, total grants received by ALD and ALD Software, the subsidiary, amount to $1,873 thousand and the total royalties paid were $467 thousand.

Financials Liabilities

Financials Liabilities	12 Months Ended
	Dec. 31, 2023
Financials Liabilities [Abstract]
FINANCIALS LIABILITIES	NOTE 17:- FINANCIALS LIABILITIES a. Convertible loans 1. On each of February 23, 2023, June 11, 2023 and July 7, 2023, the Company entered into Convertible Loan Agreements (together the “Shayna Loan Agreements”) with Shayna LP, a Cayman Islands company(“Shayna”), in the amounts of NIS 10,000 thousand (approximately $2,800 thousand), NIS 5,000 thousand (approximately $1,400 thousand) and NIS 1,850 thousand (approximately $500 thousand) respectively (each a “Shayna Loan and, together, the “Shayna Loans”). The Shayna Loans will not bear interest unless the Company defaults in making certain payments under the Shayna Loans. In the event that the Company defaults on certain payments under the Shayna Loans, then Shayna Loans will bear interest at an annual rate of 8% until paid in full. Following an amendment that we entered into with Shayna on August 17, 2023, the Shayna Loans will each be convertible at the option of Shayna at a conversion price equal to a $2.00. On June 11, 2023, the Company entered into a second convertible loan agreement (the “Under the first Shayna Loan Agreement, the Company agreed to issue to the lender warrants to purchase a number of ordinary shares, equal to an amount of shares converted by the lender (in the event that the lender elects to convert a portion of the loan), at an exercise price equal to the conversion price determined pursuant to the first Shayna Loan Agreement, which is 35% lower than the average price of Company’s ordinary shares in the five trading days preceding a conversion notice . The warrants will be exercisable for 36 months from the signing date of the first Shayna Loan Agreement. Under the second Shayna Loan Agreement, the exercise price was amended to be equal to the conversion rate under the second Shayna Loan Agreement, which is 40% lower than the average price of Company’s ordinary shares in the (a) five trading days preceding a conversion notice, or (b) the five trading days preceding the signing date of the second Shayna Loan Agreement, whichever is lower. The expiration date was also amended to be 24 months from the date of issuance of such warrant. Under the third Shayna Loan Agreement, the exercise price was changed to be equal to the conversion rate under the third Shayna Loan Agreement, which is : 40% lower than the average price of Company’s ordinary shares in the (a) five trading days preceding a conversion notice, or (b) the five trading days preceding the date of the Company Board of Directors meeting which took place on July 8, 2023, whichever is lower. As of the date of this Annual Report, the Company has not received a conversion notice from the lender, so no warrants to purchase ordinary shares have been issued pursuant to the Shayna Loan Agreements. Pursuant to the Shayna Loan Agreements, we agreed to file a registration statement on Form F-1 (the “Registration Statement”) to register (i) the shares issuable upon conversion of the Shayna Loans; (ii) any warrants issuable under the Shayna Loan Agreements and (iii) the shares issuable upon exercisable of the warrants to be issued under the Shayna Loan Agreements, no later than 7 days following the filing our 2022 Annual Report. We also agreed to make every effort and take all the necessary actions so that the aforementioned registration statement will be declared effective by the SEC as early as possible after its submission to the SEC and in order for it to remain effective until all shares held by Shayna are sold or freely tradable under Rule 144 without giving effect to volume or manner of sale limitations. We will bear all the costs associated with such registration. In addition, Shayna will not be allowed to convert the Shayna Loans, and we will not issue shares in respect of a conversion notice, if the conversion would require the approval of our shareholders in accordance with section 270(5) and section 274 of the Companies Law, and this conversion and allocation will be postponed to the earliest date given in accordance with section 270(5) and Article 274 of the Companies Law. If, at any point following the conversion of the Loans, Shayna were to own 7% or more of our issued and outstanding shares, Shayna will be entitled to require us, to register for resale all of the Company’s shares for resale by Shayna, as well as ordinary shares that may be allocated upon exercising warrants, which Shayna will be entitled to as a result of the conversion of the Loans, on Form F-1 or Form F-3, as applicable, within 21 days after receiving a written notice from Shayna. Additionally, pursuant to the Shayna Loan Agreements, Shayna will be entitled to standard “piggyback registration rights” in any case that we submit a registration document to the SEC to register our shares for sale by us or any other party and will also be entitled to participate in any sale of shares under that registration statement. In connection with the Shayna Loans, the Company agreed to pay commission totaling NIS 467 thousand (approximately $125 thousand) to an affiliate entity of Shayna. In addition, commencing on August 10, 2023, the Company agreed to pay to Shayna a consulting fee equal to $96 thousand per month (plus value added tax) in 12 equal monthly payments, totaling $1,151 thousand for advisory services to be provided pursuant to the Shayna Loan Agreements. The Company also agreed to pay a commission equal to NIS 375 thousand (approximately $105 thousand) together with warrants to purchase the Company’s ordinary shares having a value equal to NIS 375 thousand upon the date of grant to A-Labs Finance and Advisory Ltd. Those both loans were classified as short term loans due to violation of the financial covenants in which the Company had to register the ordinary shares subject to the agreements within a period of 90 days of execution, however the Company failed to meet the legal condition. In order to guarantee Shayna’s rights under the Shayna Loans and to receive the brokerage and consulting fees set forth above, each of Vizerion Ltd., A-Labs and Uzi Moskovich (together the “Pledgors”), agreed to pledge all shares and warrants of the Company held by them in favor of Shayna. If the Company fails to register the shares issuable upon conversion of the Shayna Loans within 90 days of the signing of the Shayna Loan Agreements, then Shayna may, at its sole option, foreclose on the shares, in proportion the holding of each of the Pledgors, in exchange for assigning Shayna’s rights according to the Shayna Loan Agreement to the Pledgors for the allocation of shares in the same number that was exercised by Shayna, and all other rights of Shayna under the Shayna Loan Agreements will remain in effect. If the registration of the shares is completed and Shayna is paid in full for the consulting fee noted above, the pledges on the shares will be canceled. 2. On May 4, 2023, the Company signed a Securities Purchase Agreement (“SPA”) to issue Lind Global Asset Management VI LLC, an investment fund managed by The Lind Partners, a New York based institutional fund manager (together, “Lind”) to up to two (2) secured convertible promissory notes in three tranches (the “Notes” and each a “Note”) for proceeds up to $16,000 thousand and warrants to purchase the Company’s ordinary shares. The first tranche occurred on May 8, 2023 and consisted of the issuance and sale of a Note with a price of $6,000 thousand, a principal amount of $7,200 thousand and the issuance of Warrants to acquire 2,458,210 ordinary shares. The price for the initial Note consisted of two separate funding amounts. The initial funding of $4,500 thousand was received by the Company (less legal fees and a 3.5% commitment fee) and the funding of the remaining $1,500 thousand received during September 2023. The second tranche consisted of the issuance and sale to Lind of a Note for $10,000 thousand and a principal amount of $12,000 thousand, and the issuance of additional warrants to acquire ordinary shares. The second closing will occur sixty (60) days following the registration of the ordinary shares issuable upon conversion of the Note and the ordinary shares. The Second Closing is subject to certain conditions precedent as set forth in the SPA. As of today, the second closing hasn’t accrued. The Note issued under the SPA in the First Closing will have a maturity date of May 8, 2025, and the Note issued under the SPA in the Second Closing will have a maturity date of 2 years from the date of issuance (the “Maturity Date”). Beginning on the date that is either the earlier of (1) the Registration Statement being declared effective and (2) 120 days from the issuance date of each Note, the Company shall repay the Note in twelve consecutive monthly installments, (each, a “Payment Date” and collectively the “Monthly Payments”) an amount equal to $600 thousand (the “Repayment Amount”), with the option of Lind to increase one Monthly Payment up to $1,500 thousand by providing written notice. As of December 31, 2023 the Company does not have an effective registration statement, therefore the loan is presented in the short term. The Company has the option to make the Monthly Payments (i) in cash in the amount equal to the Repayment Amount multiplied by 1.05 (ii) ordinary shares, or (iii) a combination of cash and ordinary shares. The amount of ordinary shares to be issued upon repayment shall be calculated by dividing the Repayment Amount being paid in ordinary shares by the Repayment Share Price. The “Repayment Share Price” will be equal to ninety percent (90%) of the average of the lowest five (5) consecutive daily VWAPs during the twenty (20) Trading Days prior to the Payment Date. During November and December 2023, Lind converted an aggregated amount of $4,800 thousand into 2,215,373 ordinary shares. 3. In November and December 2023, the Company entered into Securities Purchase Agreements (the “2023 Accreditor Investor SPAs”) providing for the sale by the Company to certain accredited investors (the “2023 Accreditor Investors”), in unregistered private transactions, of convertible notes with an aggregate principal amount of $2,700 thousand (the “2023 Accreditor Investor Notes”), and warrants exercisable into one ordinary share for each ordinary share issuable to the 2023 Accredit Investors upon the conversion of the principal amount of the 2023 Accreditor Investor Notes, assuming conversion on the respective issuance dates of the Notes (the “2023 Accreditor Investor Warrants”). The aggregate principal amount of the 2023 Accreditor Investor Notes is convertible into the Company’s ordinary shares at a rate of the lower of (i) $2.50 and (ii) the product of 75% multiplied by the arithmetic average of the volume-weighted average price of the ordinary shares in the five (5) trading days prior to the date of conversion, provided that such conversion rate will not be lower than $1.50. The 2023 Accreditor Investor Notes do not bear interest and are repayable on the three-month anniversary of their issuance, subject to earlier conversion by the 2023 Accreditor Investors. The 2023 Accreditor Investors have the right to convert the 2023 Accreditor Investors Notes, in whole or in part, at any time following their issuance. As of December 31, 2023, certain 2023 Accreditor Investors have converted the 2023 Accreditor Investor Notes held thereby into the Company’s ordinary shares, pursuant to which conversions the Company issued 1,150,217 ordinary shares at a weighted average exercise price of $1.83. Pursuant to the 2023 Accreditor Investor SPAs, The Company issued 2023 Accreditor Investor Warrants which are exercisable into 1,412,925 ordinary shares. The 2023 Accreditor Investor Warrants are exercisable until January 1, 2027 for an exercise price equal to the closing price of the ordinary shares as of the respective issuance dates of the 2023 Accreditor Investor Warrants and have a weighted average exercise price of $2.43. The exercise of the 2023 Accreditor Investor Warrants will be limited to the extent that, upon their exercise, a 2023 Accreditor Investor and its affiliates would in the aggregate beneficially own more than 4.99% of the Company’s ordinary shares. The loans described above includes a conversion options. According to IAS 32, the conversion option is classified as financial liability, as the conversion rate does not comply with the fixed-to-fixed requirements since the conversion ratio to ordinary share is not fixed and depend on the share price of the Company. The instrument as a whole constitutes a hybrid contract that include non-derivative host contract (“the loan”) and embedded derivative (the conversion option). At the date of the transaction, the Company allocated the total loan consideration to the conversion options at fair value in the amount of $4,779 thousand and the remaining amount in the total amount of $10,604 thousand is attributed to the loan. Since the fair value of the embedded derivatives exceeds the total loan consideration, the difference between the fair value and the loan consideration is deferred and recognized in according to the straight-line method over the course of the loan. After the initial recognition, at each period end date, the conversion option is measured at fair value and all changes in fair value are recognized through profit or loss. The loan is measured according to the effective interest method. b. Warrants Liability In February 2023, at the effective time of the Reverse Recapitalization (the “Effective Time”), each unit of RNER (a “RNER Unit”) issued and outstanding immediately prior to the Effective Time automatically detached and the holder of each such RNER Unit became deemed to hold one RNER Share and one warrant of RNER entitling the holder to purchase three-fourths of one RNER Share per warrant at a price of $11.50 per whole share (exercisable only for whole shares) (each, a “RNER Warrant”). In addition, each RNER Share issued and outstanding immediately prior to the Effective Time automatically converted into the right to receive 0.899 Company ordinary shares, and each RNER Warrant issued and outstanding immediately prior to the Effective Time converted into the right to receive 0.899 warrants of the Company (a “New Warrant”) subject to downward adjustment to the next whole number in case of fractions of warrants. A total of 1,604,383 New Warrants to purchase three-fourths of one HUB ordinary share were issued to holders of the RNER warrants, of which 53,599 warrants are private warrants and the remaining 1,550,784 warrants are public warrants. As a result of this conversion the New Warrants’ and reverse stock split the exercise price increased to $127.9 per whole share. The warrants were classified as financial liability and measured at fair value as of the issuance date. After the initial recognition, at each period end date, the warrants measured at fair value and all changes in fair value are recognized through profit or loss. During the year ended December 31, 2023, no warrants were exercised into ordinary shares of the Company. c. Fair Value Measurement The carrying amounts of cash and cash equivalents, restricted cash, restricted bank deposit, trade receivables, other account receivables, inventories, other short term loans, trade payables, other payables and other long term loans approximate their fair values due to the short-term maturities of such instruments. The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis as of December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: December 31, 2023 Level 1 Level 2 Level 3 Public warrants 217 - - Private warrants - - 5,830 Conversion component of convertible loans - - 4,215 Total 217 - 10,045 As of December 31, 2022, the Company did not have any instrument measured at fair value. The Company classifies its Public Warrants as Level 1 based on quoted market price in active markets. The Company measures the fair value of Private Warrants by the Black-Scholes model, which are classified as Level 3. The Company measures the fair value of Conversion component of convertible loans and options by using a Black-Scholes and Monte Carlo simulation models. All of those components are classified, as Level 3, due to the use of unobservable inputs. The key inputs into the Black-Scholes model for the private warrants were as follows: December 31, Risk-free interest rate 3.91 % Expected term (years) 4.17 Expected volatility 86.60 % Exercise price 103.39 Underlying share price 2.17 The key inputs into the Black-Scholes or Monte Carlo simulation models for the Conversion component of convertible loans were as follows: Shyana- February Loan Agreement -Monte Carlo- Conversion component Input December 31, Risk-free interest rate 4.38 % Expected term (years) 1.15 Expected volatility 132.85 % Underlying share price 2.17 Shyana- February Loan Agreement -Black Scholes- option Input December 31, Risk- free interest rate 4.27 % Expected term (years) 2 Expected volatility 124.9 % Exercise price 0.5 Underlying share price 2.17 Shyana- June Loan Agreement -Monte Carlo- Conversion component Input December 31, Risk- free interest rate 4.34 % Expected term (years) 1.45 Expected volatility 122.86 % Underlying share price 2.17 Shyana- July Loan Agreement -Monte Carlo- Conversion component Input December 31, Risk- free interest rate 4.33 % Expected term (years) 1.52 Expected volatility 121.43 % Underlying share price 2.17 Shyana- July Loan Agreement -Black Scholes- option Input December 31, Risk- free interest rate 4.33 % Expected term (years) 2 Expected volatility 124.9 % Exercise price 0.76 Underlying share price 2.17 Lind- Conversion component Input December 31, Risk- free interest rate 5.09 % Expected term (years) 0.5 Expected volatility 157.17 % Underlying share price 2.17 Lind-Black Scholes- option Input December 31, Risk- free interest rate 3.9 % Expected term (years) 4.35 Expected volatility 112.38 % Exercise price 3.5 Underlying share price 2.17 AGP- Conversion component Input December 31, Risk- free interest rate 5.13%-5.19 % IRR 20.63 % Vendor- Conversion component Input December 31, Risk- free interest rate 5.13%-5.19 % IRR 20.63 % The following table presents the changes in the fair value of liabilities: Public Private Conversion Total Fair value as of December 31, 2022 - - - - Warrants issued in related to the RNER transaction 2,639 71 - 2,710 Issuance of conversion component related to the convertible loans. - - 4,779 4,779 Issuance of warrants related to the convertible loans - 3,781 - 3,781 Conversion of convertible loans into ordinary shares - - (1,427 ) (1,427 ) Change in fair value (2,466 ) 1,928 785 247 Adjustments arising from translating financial statements from functional currency to presentation currency 44 50 78 172 Fair value as of December 31, 2023 217 5,830 4,215 10,262

Financial Instruments

Financial Instruments	12 Months Ended
	Dec. 31, 2023
Financial Instruments [Abstract]
FINANCIAL INSTRUMENTS	NOTE 18:- FINANCIAL INSTRUMENTS a. Financial assets: Financial assets at amortized cost: December 31, 2023 2022 USD in thousands Trade and other assets 14,950 25,729 Restricted bank deposit 61 1,516 Total current assets 15,011 27,245 Long-term deposit 328 3,002 Total non-current assets 328 3,002 b. Other financial liabilities: Other financial liabilities at amortized cost: Short-term loans (1) 11,878 13,432 Convertible loans 14,449 - Trade payables 9,867 13,771 Other accounts payable 32,427 25,322 Liabilities for government grants 412 1,289 Total other financial liabilities at amortized cost 69,033 53,814 Total current liabilities 68,886 52,927 Total non-current liabilities 147 887 (1) The interest rate is Prime (Bank of Israel intrabank plus 1.5%) + 0.7%-4.85%. c. Financial risk management objectives and policies: The Company’s principal financial liabilities, other than derivatives, are comprised of loans and borrowings, receivables and financial guarantee contracts. The main purpose of these financial liabilities is to finance the Company’s operations and to provide guarantees to support its operations. The Company’s principal financial assets include cash and short-term deposits that derive directly from financing rounds and convertible loans. The Company is exposed to market risk, credit risk and liquidity risk. The Company’s senior management oversees the management of these risks. The Company established a financial risk committee that advises senior management on financial risks and the appropriate financial risk governance framework for the Company. The financial risk committee provides assurance to the senior management that the Company’s financial risk activities are governed by appropriate policies and procedures and that financial risks are identified, measured and managed in accordance with the Company’s policies and objectives. All derivative activities for risk management purposes are carried out by specialist teams that have the appropriate skills, experience and supervision. It is the Company’s policy that no trading in derivatives for speculative purposes may be undertaken. d. Financial risks factors: The Group’s activities expose it to various financial risks such as market risks (foreign currency risk, interest risk and price risk), credit risk and liquidity risk. The Group’s comprehensive risk management plan focuses on activities that reduce to a minimum any possible adverse effects on the Group’s financial performance. Risk management is performed by the Company’s CEO. 1. Exchange rate risk: The Group operates internationally and is therefore exposed to exchange rate risk arising from exposure to various foreign currencies, mainly the USD and the Euro. Exchange rate risk arises from future commercial contracts, recognized assets and liabilities that are denominated in a foreign currency other than the functional currency and net investments in foreign operations. 2. Credit risk: As of December 31, 2023, cash and cash equivalents amounted to $3,522 thousand. The entire cash and cash equivalents are invested with high quality financial institutions. The Company and the subsidiaries monitor customer debts on an ongoing basis and include specific allowances for doubtful accounts which adequately reflect the loss inherent in debts whose collection is doubtful as per the estimate of the Company and the subsidiaries. 3. Liquidity risk: The Group’s objective is to maintain a balance between continuity of funding and flexibility through the use of overdrafts and loans (see also Note 1d). 4. Interest rate risk: Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company’s exposure to the risk of changes in market interest rates relates primarily to the Company’s long-term liabilities with floating interest. The Company manages its interest rate risk by having a balanced portfolio of fixed and variable rate loans (see also note 1d). e. Fair value: The carrying amount of cash and cash equivalent, trade receivables, other accounts receivable, short-term bank credit, trade payables and other accounts payable approximates their fair value.

Net Employee Defined Benefit Li

Net Employee Defined Benefit Liabilities	12 Months Ended
	Dec. 31, 2023
Net Employee Defined Benefit Liabilities [Abstract]
NET EMPLOYEE DEFINED BENEFIT LIABILITIES	NOTE 19:- NET EMPLOYEE DEFINED BENEFIT LIABILITIES Employee benefits consist of post-employment benefits and other long-term benefits. Post-employment benefits: According to the labor laws and Severance Pay Law in Israel, the Company is required to pay compensation to an employee upon dismissal or retirement or to make current contributions in defined contribution plans pursuant to section 14 to the Severance Pay Law, as specified below. The Company’s liability is accounted for as a post-employment benefit. The computation of the Company’s employee benefit liability is made according to the current employment contract based on the employee’s salary and employment term which establish the entitlement to receive the compensation. The post-employment employee benefits are normally financed by contributions classified as defined benefit plan or as defined contribution plan, as detailed below. a. Defined contribution plans: Section 14 to the Severance Pay Law, 1963 applies to part of the compensation payments, pursuant to which the fixed contributions paid by the Group into severance pay funds and/or policies of insurance companies release the Group from any additional liability to employees for whom said contributions were made. These contributions and contributions for benefits represent defined contribution plans. Year ended 2023 2022 USD in thousands Expenses in respect of defined contribution plans 2,264 2,562 b. Defined benefit plans: The Group accounts for that part of the payment of compensation that is not covered by contributions in defined contribution plans, as above, as a defined benefit plan for which an employee benefit liability is recognized and for which the Group deposits amount in central severance pay funds or accrue for such provision (when the deposits are not made on time) in qualifying insurance policies. c. Changes in the defined benefit obligation and fair value of plan assets: 2023 Expenses recognized in profit or loss Gain (loss) from remeasurement Contributions Balance Current Net Past Total Payments Return Actuarial Actuarial Actuarial Total Effect of by by Balance NIS in thousands Defined benefit obligation 3,163 152 150 (212 ) 90 (36 ) - - (24 ) 36 12 (94) - - 3,135 Fair value of plan assets (2,123 ) - (104 ) 111 7 29 (109 ) - - - (109 ) 60 (130 ) - (2,266 ) Net defined benefit liability (asset) 1,040 152 46 (101 ) 97 (7 ) (109 ) - (24 ) 36 (97 ) (34 ) (130 ) - 869 Expenses recognized in profit or loss Gain (loss) from remeasurement Contributions Balance Current Net Past Total Payments Return Actuarial Actuarial Actuarial Total Effect of by by Balance NIS in thousands Defined benefit obligation 4,838 198 120 - 318 (1,376 ) - - (258 ) 151 (107 ) (511 ) - - 3,163 Fair value of plan assets (3,398 ) - (56 ) 9 (47 ) 927 228 - - - 228 355 (187 ) - (2,123 ) Net defined benefit liability (asset) 1,440 198 64 9 271 (449 ) 228 - (258 ) 151 121 (156 ) (187 ) - 1,040 d. The principal assumptions underlying the defined benefit plan: 2023 2022 % Discount rate (1) 5.57 5.22 Expected rate of salary increase 3.19 3.21 (1) The discount rate is based on high-quality CPI-linked corporate bonds. e. Amount, timing and uncertainty of future cash flows: Change in USD in thousands December 31, 2023 Sensitivity test for changes in the expected rate of salary increase: The change as a result of: 1% salary increase (28 ) 1% salary decrease 360 Sensitivity test for changes in the discount rate of the plan assets and liability: The change as a result of: 1% increase in discount rate 379 1% decrease in discount rate (49 )

Equity

Equity	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
EQUITY	NOTE 20:- EQUITY a. Effective from March 2023, the Company’s shares were split in a ratio of 1:0.712434. In addition, effective December 15, 2023, the Company’s shares were reverse split in a ratio of 10:1 As a result, all ordinary shares, options for shares, warrants to purchase ordinary shares, exercise price and net loss per share amounts were adjusted retroactively for all periods presented in these consolidated financial statements as if the stock split had been in effect as of the date of these consolidated financial statements. c. Composition of share capital: December 31, 2023 December 31, 2022 Authorized Issued and Authorized Issued and Number of shares in thousands Ordinary shares with no par value 142,487 11,853 142,487 8,879 d. Movement in share capital: 1. Issued and outstanding share capital: Number of shares of no in thousands Balance as of January 1, 2023 8,879 Issuance of shares 2,848 Exercise of options and warrants 126 Balance as of December 31, 2023 11,853 2. Shares issued : 1. SPAC As for the accounting treatment of the Reverse Recapitalization in respect of the transaction with RNER, see Note 1c above. In February 2023, at the effective date of the Reverse Recapitalization, the Company issued 453,320 ordinary shares and 1,604,383 warrants. 2. PIPE On March 23, 2022, concurrently with the execution of the business combination agreement, the Company entered into the Subscription Agreements with certain investors (the “PIPE Investors”), pursuant to which the PIPE Investors agreed to subscribe for and purchase, and the Company agreed to issue and sell to such PIPE Investors, an aggregate of 5,000,000 ordinary shares at $10.00 per share for gross proceeds of approximately $50,000 thousand (the “PIPE Financing”) on the Closing Date. The PIPE Financing did not consummate at closing of the Reverse Recapitalization as the PIPE Investors failed to remit payment for the shares to be purchased. In March 2023, the Company received approximately $4,000 thousand of the $50,000 thousand in proceeds from the PIPE Financing and issued approximately 40,000 shares in respect thereof. While the Company is considering possible alternatives in order to pursue the majority of the remaining funds committed as a part of the PIPE investment from the investors, it is uncertain if the Company will be able to receive the remaining PIPE funds. 3. 2022 Investors ● In October 2022, the Company signed investment agreements with different investors for a total of 91,192 shares in the price of NIS 86.3 ($24.7) – each unit includes 1 ordinary share with no par value and one warrant with an exercise price of NIS 94.9 ($26). The warrants vested immediately upon issuance and will be exercisable for 30 months from the respective date of issuance. The aggregate amount raised through this private offering was approximately NIS 7,900 thousand ($2,250 thousand) with an issuance cost of $224 thousand. According to the terms of the investment agreement, the Company has 45 days from the closing date to issue the shares to the investors or otherwise it would need to repay it with an additional 10% interest. The actual issuance of shares took place on February 2023, and therefore as of December 31, 2022, the total investment amount was classified as a liability. The shares were issued during February 2023. 4. Investors Settlement Agreement In order to settle various claims by the Company past investors, several allocations were made during 2023 to such past investors. Such allocations were as follows: ● Elyakim Shmuel Baruch Kislev – 20,000 shares (pre-split) were allocated. ● Lior Tamar Investments – 25,000 shares (pre-split) were allocated. 5. ELOC - Equity Line of Credit On March 28, 2023 the Company and Dominion Capital LLC (“Dominion”), the manager of RNER’s sponsor, entered into a firm commitment for an ELOC, which is an equity line instrument whereby the Company, subject to the terms in the equity purchase agreement, may issue up to $100,000 thousand of the Company’s ordinary shares over the course of 36 months. In consideration for Dominion’s commitment to purchase the Company’s ordinary shares, upon execution of the equity purchase agreement, the Company issued to Dominion 100,000 of the Company’s ordinary shares. Expense of $1,570 thousands related to these shares was recognized within other expenses in the Company’s consolidated statements of profit and loss. As of December 31, 2023 the Company did not meet the terms in the Equity purchase agreement and no shares were issued under the equity purchase agreement. In addition, Dominion advanced the Company an aggregate amount of $2,500 thousand upon closing of the Reverse Recapitalization, as the upfront commitment. In connection with the firm commitment for the equity line of credit, the Company and Dominion entered into a senior secured demand promissory note (the “Secured Promissory Note”) to evidence the Company’s obligation to repay the equity line of credit commitment. The Secured Promissory Note will bear interest at a rate of 10% per annum and is due on demand. The Company failed to meet the contractual terms of the Secured Promissory Note. As a result, the Company is required to pay Dominion an interest rate of 24% immediately. 6. Lind During November and December 2023, pursuant to Lind SPA as described in Note 17(1)(a) Lind converted an aggregated amount of $4,800 thousand into 2,215,373 ordinary shares. 7 . Accredited Investors During 2023, pursuant to Accredited Investor Notes as described in Note 17(1)(c) certain Accredited Investors converted an aggregated amount of $1,300 thousand into 1,150,217 ordinary shares. 8. Warrants exercise During the year ended December 31, 2023, 13,001 warrants were exercised into 13,001 ordinary shares of the Company for total consideration of $233 thousand. c. Rights attached to shares: i. Quoted on the TASE. As of March 1, 2023, the Company began trading on NASDAQ. ii. Voting rights at the general meeting, right to receive a dividend and rights upon liquidation of the Company. d. Warrants classified as equity: The Company has 1,507,231 registered and outstanding warrants that are exercisable into 1,507,231 ordinary shares of NIS no par value each for an average exercise increment of $22.32. These warrants are classified in equity. During the year ended December 31, 2023, 13,000 warrants were exercised into 13,000 ordinary shares for a total consideration of $234 thousand. e. Treasury shares - Company shares held by the Company: The interests of the Company in the Company’s shares are as follows: December 31, 2023 2022 % % of issued share capital 0.54 1.0 f. Capital management in the Company: The Company’s capital management objectives are: 1. To preserve the Group’s ability to ensure business continuity thereby creating a return for the shareholders, investors and other interested parties. 2. To ensure adequate return for the shareholders by pricing of products and services that is adjusted to the level of risk in the Group’s business activity. The Company manages its capital structure and makes adjustments to it in light of changes in economic conditions and risk characteristics of its activity and its current and future liquidity constraints. To maintain or adjust the required capital structure, the Company may apply various measures such as adjust the dividend payment to shareholders, raise capital by way of issue of shares, capital purchases from shareholders and disposal of assets to reduce its debts.

Share-Based Payment

Share-Based Payment	12 Months Ended
	Dec. 31, 2023
Share-Based Payment [Abstract]
SHARE-BASED PAYMENT	NOTE 21:- SHARE-BASED PAYMENT a. Expenses recognized in the financial statements: The expense recognized in the financial statements for services received from employees and officers is shown in the following table: Year ended December 31, 2023 2022 2021 USD in thousands Equity-settled share-based payment plans 7,115 10,516 5,897 b. Grants of options to employees and interested parties: As part of the business combination agreement described in Note 1b above, on June 21, 2021, the Company allocated 1,781,085 share options to senior officers, employees and consultants of the Company and to an investment bank assisting the transaction, consisting of grants to employees, key management personnel and interested parties. Following are data of the value of share options granted to key management personnel and interested parties in HUB. 1. 2022 Share option plans: The Company has authorized through its 2022 Share Option Plan (the “Plan”), an available pool of ordinary shares of the Company from which to grant options and RSUs to officers, directors, advisors, management and other key employees of up to 1,068,651 ordinary shares. The options granted generally have a four-year vesting period and expire ten years after the date of the grant, subject to the terms set forth in the Plan. Options granted under the Plan that are cancelled or forfeited before expiration become available for future grant. As of December 31, 2023 there are no options available for future grants. 2. On February 27, 2023, the Company granted to a service provider 128,238 share options for an exercise price of NIS 4.2 ($1.2) per share. The options were fully vested at the grant date, and exercisable for 36 months. The inputs used for the fair value measurement of the share options for the above grant based on the Black and Scholes model are as follows: Expected volatility of the share prices (%) 80.03 % Risk-free interest rate (%) 4.02 % Expected life of share options (years) 9.66 Share price (NIS) 8.29 $ (2.26 ) Based on the above inputs, the fair value of the options on the grant date is approximately NIS 10,378 thousand ($2,826 thousand). c. Movement of share options during the year: The following table presents the changes in the number of share options and the weighted average exercise prices of share options: 2023 2022 Number of Weighted Number of Weighted Share options outstanding at beginning of year 844,148 16.02 1,139,102 6.93 Share options granted during the year 128,238 1.14 29,650 18.61 Share options exercised during the year 145,874 12.8 161,187 4.69 Share options forfeited during the year 9,553 0.04 144,686 12.30 Share options expired during the year 445,384 17.91 18,731 0.65 Share options outstanding at end of year 371,575 10.01 844,148 15.94 Share options exercisable at end of year 359,688 9.95 781,073 16.54 Each option is exercisable into one ordinary share of no par value. The weighted average remaining contractual life for the share options outstanding as of December 31, 2023 was 4.09 years. The range of exercise prices for share options outstanding as of December 31, 2023 was NIS 0.14- NIS 67.48 ($0.04-$18.6). After the reporting date, no warrants expired. A summary of the status of RSUs under the Plan as of December 31, 2023 and changes during the relevant period ended on that date is presented below: Number of Outstanding at beginning of year 457,137 Granted* 1,697,743 Vested 278,580 Forfeited and cancelled 260,605 Outstanding at end of year 1,615,695 * This includes shares granted with performance obligations which were not fulfilled as of December 31, 2023. The total equity-based compensation expense related to all of the Company’s equity-based awards recognized for the years ended December 31, 2023, 2022 and 2021, was comprised as follows: Year ended December 31, 2023 2022 2021 Cost of revenues 35 206 - Research and development expenses 3,010 603 3,122 Sales and marketing expenses 211 1,504 2,775 General and administrative expenses 3,859 8,203 - Total share-based payment 7,115 10,516 5,897

Commitments, Guarantees, Charge

Commitments, Guarantees, Charges and Contingent Liabilities	12 Months Ended
	Dec. 31, 2023
Commitments, Guarantees, Charges and Contingent Liabilities [Abstract]
COMMITMENTS, GUARANTEES, CHARGES AND CONTINGENT LIABILITIES	NOTE 22:- COMMITMENTS, GUARANTEES, CHARGES AND CONTINGENT LIABILITIES a. Charges: To secure its liabilities to banks, the Group recorded a floating charge on its entire assets and a fixed charge on share capital and goodwill and all other assets and rights of any type or kind that the Company has or will have in the future. The balance of the amounts pledged under said charge amounts to $1,788 thousand as of December 31, 2023 (December 31, 2022 – $1,575 thousand) in order to receive guarantees in an aggregate of $1,839 thousand. The Company also recorded a charge in respect of a mortgage on vehicles, on the entire rights the mortgagers have and will have in the future from insuring the mortgaged vehicle, whether by the mortgagers or by banks, and on any right to compensation or indemnification the mortgagers will have towards a third party. Moreover, to receive credit by a subsidiary, the Company and the subsidiary recorded a senior charge on the mortgagers’ rights in connection with a contract signed on September 6, 2012 with the Israeli Ministry of Defense as a result of a tender published by the Ministry for the procurement of training courses, including the entire collaterals and guarantees granted to the mortgagers for securing the above rights and all the rights related to said rights. b. Guarantees: As of December 31, 2023, the consolidated statement of financial position includes bank guarantees totaling approximately to $1,839 thousand that have been granted to customers and suppliers in connection with tender-based performance contracts and office lease. c. Contingent liabilities: The Company is and may be subject to various legal proceedings, contingencies and claims that arise in the course of business, including some claims from current or former employees, as well as governmental and other regulatory investigations and proceedings. If determined adversely to the Company, then such claims could cause the Company to be subject to fines, penalties, and other contingencies. There is no pending litigation or proceeding against any of HUB Security’s office holders as to which indemnification is currently being sought, and, except as described below, HUB Security is not aware of any pending or threatened litigation, the outcome of which, the Company believes, if determined adversely to the Company, would individually or taken together have a material adverse effect on its business, operating results, cash flows or financial condition or may result in claims for indemnification by any office holder. Defending such proceedings is costly and can impose a significant burden on management and employees. The results of any current or future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources and other factors. The below is a brief summary of the litigation and other proceedings the Company is currently facing: 1. Insurance reimbursement claim–- During May 2018, a company named Rotem filed to the District Court in Tel Aviv an Insurance reimbursement claim against approximately 16 defendants, with HUB Security being among them, with respect to damages caused by a fire in the plaintiff’s factory. The Company’s management based on its legal advisors believes that its liability with regards to this claim seems remote and possesses insurance coverage to cover any liabilities that may arise from this case. 2. Contract Tender Litigation–- On March 29, 2022, two plaintiffs petitioned the District Court in Tel Aviv for certification of a class of plaintiffs in a class action suit against the Company and seven individuals serving as its officers and directors as of such date. The request for certification is based on a delay in HUB’s making a public announcement of the cancellation of a contract tender whose award to HUB had been previously announced. The canceled contract represented revenue to HUB of NIS 800 thousand (approximately $250 thousands) per year, and HUB’s previous announcement stated that the contract tender would have a material effect on its 2022 financial results. HUB was notified of the cancellation of the award of the tender on the afternoon of Wednesday, March 23, 2022, which was the same day that HUB announced its execution of the Business Combination Agreement. HUB reported the cancellation of the award on Sunday, March 27, 2022. The applicable rules of the Tel Aviv Stock Exchange (TASE) and the Israel Securities Authority, require announcements of this kind to be made not later than the trading day following a Company’s receipt of the relevant information. Friday is not a trading day on the TASE, so HUB’s report can be said to have been made one day late. The price of HUB’s ordinary shares on the TASE fell by approximately 35% on March 27, 2022. The plaintiff’s request to the court cites total damages at NIS 229,000 thousand (approximately $70,000 thousand). On October 20, 2022, the amount claimed was reduced from NIS 229,440 thousand to NIS 5,440 thousand (approximately $1,480 thousand). On January 30, 2023, the amount requested was increased to NIS 64,000 thousand. On February 2, 2023, a partial judgment was issued in which the motion to withdraw against the directors was approved, leaving the motion pending against the Company and its former Chief Executive Officer only. The answer to the amended approval request was submitted by September 3, 2023, and the response by the plaintiffs was submitted on October 22, 2023. Though the Company believes that the request for certification on this claim will be denied by the court, and that it has strong defenses to any class action that may ultimately be allowed to proceed, there can be no assurance that a court will not find the Company liable for significantly greater amounts. At this stage of the proceedings, it is not possible to assess the chances of the application being accepted or rejected in part or in full. A court’s finding of significant liability against us could negatively affect our share price and have a material effect on our business and financial condition. The hearings were conducted on May 22-23, 2024, and at the court’s suggestions a mediator was appointed on June 16, 2024 in order to attempt to reach a settlement between the parties. Two mediation meetings were conducted separately with each party on July 7, 2024 and on July 9, 2024. On August 7, 2024 the appointed mediator announced that the yield a settlement not yield a settlement. 3. Request for disclosure of documents according to Section 198A of the Companies Law– On February 8, 2023, Mr. Yuval Lev (the “Petitioner”) filed a motion for discovery under Section 198A of the Companies Law (the “Discovery Motion”) against the Company in the District Court in Tel Aviv in connection with a claim concerning the Company’s release of the Clover Wolf Fund from its obligation to participate in the PIPE Financing. On April 4, 2023, the Petitioner filed an amended motion for discovery (the “Amended Discovery Motion”) in which it demanded the disclosure of an exhaustive list of documents relating to the PIPE Financing, asserting that the Company’s alleged actions demonstrate a violation of the duties of care and trust imposed on the officers and the directors of the Company by the Companies Law, 1999, as well as an alleged basis for pursuing legal action against additional third parties. On April 10, 2024, the Company filed a response to the Amended Discovery Motion in which it requested that the confidentiality of certain items of its response be maintained. The court subsequently determined that temporary confidentiality would be maintained and ordered the Petitioner to respond to the Company’s response by September 8, 2024. The preliminary hearing is set for November 7, 2024. At this preliminary stage, it is not possible to assess the chances of the Amended Discovery Motion being granted. 4. A similar motion to for disclosure of documents according to section 198a of the Companies Law was filed on July 7, 2024, by Mr. Uri Dahan (the “Petitioner”) under Section 198A of the Companies Law (the “Discovery Motion”) against the Company in the District Court in Tel Aviv in connection with a claim concerning the Company’s release of the Clover Wolf Fund from its obligation to participate in the PIPE Financing. On July 8, 2024 the Court ruled that due to the similarities to the Lev motion detailed above, the Petitioner will discuss its position with the petitioner in the Lev Discovery Motion and report back to the Court. On July 28, 2024, the Court ruled that the Petitioner should provide to the court further details regarding its attempt to receive information from Lev, and stated that it is likely that the court would instruct both petitioners to share the details of their motions with each other.’ 5 . PIPE Financing Litigation–- On March 6, 2023, Mr. Maj’haj Avner (the “Applicant”) filed a class action certification motion (the “Motion to Certify”) against the Company and eight additional respondents in the District Court in Tel Aviv, alleging that the Company’s public announcement that it received irrevocable investment commitments as part of the PIPE Financing was false. The Applicant seeks to represent anyone who purchased the Company’s ordinary shares after the announcement of the Reverse Recapitalization in March 2022 until the end of February 23, 2023, which was the last trading day of the Company’s ordinary shares on the TASE. The Applicant claims personal damages in the amount of NIS 50,752, while the claim for the alleged damage for the members of the affected group was valued at a total of more than NIS 2,500 thousand. The Motion to Certify also asserts that the Company’s alleged actions demonstrate a violation of the duties of care and trust imposed on the officers and the directors of the Company by the Companies Law, a violation of disclosure obligations under the Israeli Securities Law, and a violation of other statutory duties. On January 30, 2024, eight respondents filed a motion to dismiss outright the Motion to Certify (the “Motion to Dismiss”) as well as a Motion to extend the deadline for filing the Company’s response to the Motion to Certify. The court ultimately rejected the Motion to Dismiss at a hearing on March 24, 2024. On June 2, 2024, eight respondents filed their response to the Motion to Certify in which they requested that the confidentiality of certain items of its response be maintained which request was subsequently granted by the court. On July 2, 2024, the Applicant responded to the response filed by the eight respondents and on July 9, 2024, sent the eight respondents a demand for disclosure of documents (the “Disclosure Request”). At a hearing held on July 10, 2024, the court recommended that three respondents be removed from the Motion to Certify and the Applicant waive all cause of action that do not relate to the Securities Law which recommendations the Applicant subsequently adopted. At the same hearing, the court ordered five of the respondents to respond to the Disclosure Request by August 11, 2024 and that if the Applicant does not receive a satisfactory response to the Disclosure Request by such date, the Applicant should submit to the court a motion for discovery of documents by September 1, 2024, to which the respondents would be required to respond by September 30, 2024. The Company was also instructed to inform the court by September 23, 2024, if it still stands by its motion regarding confidentiality. A preliminary hearing was set for November 4, 2024. 6 . Oppenheimer Suit - On June 12, 2023, Oppenheimer & Co., Inc. (“Oppenheimer”) filed a claim against the Company in the United States District Court for the Southern District of New York alleging, among other things, breach of contract, breach of covenant of good faith and fair dealing and quantum meruit, in connection with investment banking advice and services provided by Oppenheimer in connection with the Company’s business combination with Mount Rainier Acquisition Corp. The complaint alleges that the Company owes Oppenheimer in excess of $12,000 thousand (as well as its costs and legal fees associated with the claim) with regards to the business combination, pursuant to a financial advisory agreement entered into by and between Oppenheimer and the Company in December 2021. The Company is in discussions with Oppenheimer regarding settlement of this case. 7 . Dominion Capital Suit 8. Dominion Insolvency Petition 9. All Ways Gateport Ltd. - On November 6, 2023, All Ways Gateport Ltd submitted to the Tel Aviv District Court a petition to declare the Comsec Disribution Ltd. (a subsidiary of the Company) insolvent due to an paid debt of USD 71,615. No response has yet been filed and a hearing is scheduled for September 29, 2024. 10. Class Action Suit – HUB Cyber Security Ltd. 1:23-cv-05764 (S.D.N.Y.): This case consolidates into one securities class action the complaints filed in the cases styled Efrat Investments LLC et al. v. Hub Cyber Security Ltd., and Green v. Hub Cyber Security Ltd. f/k/a Hub Cyber Security (Israel) Ltd., et al. This action names the Company and current and former officers and directors of the Company (including Eyal Moshe, Hugo Goldman, Uzi Moscovich, Zeev Zell, Moshe Raines, Manish Agarwal, and Moti Franko, “Individual Defendants”) as defendants (collectively, “Class Action Defendants”). Certain shareholders—individuals and entities that purchased or otherwise acquired Company securities pursuant to and/or traceable to the offering materials issued in connection with the Transaction—have alleged that the Class Action Defendants made material misstatements and omissions in the offering materials issued in connection with the Transaction. The shareholders have alleged that the offering materials incorrectly stated that Hub Cyber Security (Israel) Ltd. had secured a committed financing arrangement, contained material misstatements and omissions concerning the Company’s internal controls and misuse of Company funds, and contained materially misleading information concerning the Company’s product. The shareholders seek damages from the Class Action Defendants and/or tender their shares to Class Action Defendants for recovery of the consideration paid therefor. The Company is defending itself vigorously, and has moved to dismiss the action on the grounds that the shareholders lack standing to sue and have failed to state a claim against the Company. 11. Employee Claims Additionally, a few former Israeli employees filed a claim in the Tel Aviv Labor Court: (a) A former employee filed a claim against Comsec Ltd. (a subsidiary of the Company) in the amount of NIS 847 thousand alleging unlawful termination and entitlement to various employment rights, including, but not limited to, unlawful termination compensation, severance pay, advanced notice compensation, and bonuses according to the employment agreement. On December 26, 2023, Comsec submitted its statement of defense, denied, and rejected the plaintiff’s claims and demands. A preliminary hearing occurred on March 13, 2024. The plaintiff filed an affidavit with the court on May 27, 2024 and Comsec is required to submit an affidavit by September 15, 2024. (b) An additional former Israeli employee filed a claim in the Tel Aviv Labor Court against the Company in the amount of NIS 272 thousand. The plaintiff alleges that this amount is owed to him due to violation of the employment agreement signed with him. The plaintiff claims a signing bonus that he claims was not paid to him, an unconditional quarterly bonus including social benefits for him, and the registration of 20,000 RSUs in his name, compensation for bad faith and misrepresentation. A preliminary hearing is set for February 2, 2025. The deadline for filing a statement of defense has been postponed to September 15, 2024. (c) An additional former employee filed a claim on July 23, 2024 with regards to alleged missing pension and social benefits payments, in the aggregated amount of NIS 17 thousand. A statement of defense is scheduled to be filed by the Company by October 6, 2024, and a settlement in the claim is expected to be reached by that date. d. Services Agreement: A-Labs Finance and Advisory Ltd (“ ”) In July 2021, the Company entered into a Financial Advisory Services Agreement (the “A-Labs Agreement”) with A-Labs Finance and Advisory Ltd. (“A-Labs”), pursuant to which, the Company engaged A-Labs to perform, on an exclusive basis, certain consultation services in the domain of fundraising from investors and capital markets activities. In return for these services the Company committed to pay A-Labs a fee amounting to 5% of any funds raised from investors named on a specified schedule thereto, along with warrants to purchase the Company’s ordinary shares computed as 5% of the raised amount divided by the price per share as determined in the relevant fundraising transaction. During the term of the A-Labs Agreement, the Company paid a total of $4,200 thousand to A-Labs as commission for funds raised and issued to A-Labs a total of 4,076,923 warrants to purchase the Company’s ordinary shares. In addition, pursuant to the Agreement, the Company agreed to pay to A-Labs a monthly payment of $70,000 and an additional sum designated as a “Marketing (in the sense of Capital markets fundraising activities) Budget”, of up to $280 thousand. The Marketing Budget was aimed for attracting investors to buy the Company’s shares, for capital fundraising and capital markets activities and is to be reviewed monthly based on the activities and efforts conducted by A-Labs for the Company. Additionally, pursuant to the A-Labs Agreement, for the period of 12 months following the specification of such business partner in an annex to the A-Labs Agreement, the Company is obligated to pay to A-Labs a fee equal to 5% of any non-refundable and recognized revenues that the Company received from such specified business partners. To date, A-Labs has not pursued any efforts related to the development of these business relationships and as a result no fees have been paid to A-Labs pursuant to this provision of the A-Labs Agreement. During the period from July 2021 through March 2023, the Company paid to A-Labs a total of $4,200 thousand in cash. The Company sees part of these payments as an incremental and direct cost for attracting investors and raising capital, therefore the Company capitalized the relevant portion of these payments and deduct it from the Share capital and premium in the Consolidated Statements of Changes in Equity, upon the occurrence of its financing rounds. Additionally, in March 2023, a total amount of $2,200 thousand that was owed to A-Labs pursuant to the A-Labs Agreement was converted into the Company’s ordinary shares at a conversion price of $10 per ordinary share. This conversion of amounts the Company owed to A-Labs under the A-Labs Agreement, was affected to partially satisfy the commitment that A-Labs made to purchase $20,000 thousand of the Company’s ordinary shares in the PIPE Financing. In December 2022, the Company amended the A-Labs Agreement to provide that for each financing transaction closed, in addition to paying a commission to A-Labs in cash, the Company would be required to issue warrants to purchase ordinary shares in an amount equal to the cash consideration that would otherwise be payable under the A-Labs Agreement divided by 4.81, which warrants shall be exercisable for 4 years and at an exercise price of NIS 4.81 (regardless of the price per share paid by investors in the relevant financing transaction). Additionally, the Company committed to provide compensation under the A-Labs Agreement for all investors with whom the Company would enter into a financing transaction prior to the Company’s shares being listed for trading on the Nasdaq regardless of whether such investors were introduced to the Company by A-Labs. In each of September 2022 and January 2023, the Company paid to A-Labs an additional commission of $50 thousand in exchange for extra services provided by A-Labs over the course of certain fund raising efforts and loan issuances. Additionally, as part of the Shayna Loans (as defined below), the Company paid to A-Labs commissions totaling $140 thousand for services provided as part of the fund raising efforts. The term of the A-Labs Agreement was for 12 months following the execution in July 2021, provided that the A-Labs Agreement will automatically renew for additional 12 month terms unless either Party provides written notice to the other Party of its intention not to renew at least 30 days prior to the end of such initial 12 month term or any renewed terms. Additionally, the A-Labs Agreement may be terminated by either party upon a minimum of 30 days prior written notice. In August 2023, the Company has received from A-Labs a waiver of the retainer fees for the services.

Investments in Investees

Investments in Investees	12 Months Ended
	Dec. 31, 2023
Investments in Investees [Abstract]
INVESTMENTS IN INVESTEES	NOTE 23:- INVESTMENTS IN INVESTEES a. Investment in ALD Software: On December 28, 2007, the Company signed an agreement with ALD Software whereby on the record date, January 1, 2008, the Company transferred and sold to ALD Software the software department operation, free of any debt, liability, charge, foreclosure, mortgage, lien or any third party right, other than the liability to the IIA, as a result of which on the transaction completion date, ALD Software will become the legal owner of the software department operation and its underlying rights. The Company holds 98.63% of ALD software. b. Investment in Qpoint: On May 26, 2010, the Company signed an agreement for investing in Qpoint, which is engaged in IT and software testing. According to the agreement, after the investment is made, the Company will hold 46.52% of Qpoint’s issued and outstanding share capital on a fully diluted basis and will have the power to determine Qpoint’s financial and operational policies, among others by having veto rights on budgets, capital raising, financing, dividend distribution and appointing the CEO and CFO, this since each of the two other shareholders in Qpoint had provided the Company an irrevocable proxy for about 7% each of Qpoint’s ordinary shares owned by them, conferring the Company about 60% of the voting rights in general meetings. Consequently, the Company consolidates Qpoint in its financial statements from the second quarter of that year. The Company’s total investment in Qpoint amounted to NIS 1,200 thousand ($312 thousand), paid in instalments over three quarters after the closing date. On July 1, 2010, with the completion of the Qpoint acquisition transaction, the Company was allocated 174 shares of Qpoint, conferring the Company 46.52% of Qpoint’s issued and outstanding share capital on a fully diluted basis. In April 2024, after the balance sheet date, the Company acquired the remaining shares of Qpoint. Following this acquisition, the Company holds 100% of Qpoint. As part of the investment agreement, the parties signed a service agreement according to which the Company will grant Qpoint various services such as comprehensive accounting, marketing, management, administration and office maintenance. In return, Qpoint will pay the Company management fees of 3%. This agreement remains in effect as long as the Company holds 25% of Qpoint’s share capital. f. Acquisition of Comsec Ltd.: On September 27, 2021, the Company signed an agreement for the purchase of the entire issued and outstanding share capital, on a fully diluted basis, of Comsec Ltd. (“Comsec”), including owners’ loans and capital notes (collectively – “the securities”), from Eldav Investments Ltd. (“the seller”). In return for the securities, the Company paid NIS 70,000 thousand ($21,848 thousand) (“the purchase price”), of which NIS 40,000 thousand ($12,484 thousand) in cash and NIS 30,000 thousand ($9,363 thousand) in Company shares. The purchase price was paid to the seller upon closing. Comsec was a private company that provides cybersecurity consulting, design, testing and control services and sells data security and cybersecurity software and hardware solutions by itself and through its subsidiaries in Israel and overseas. In the first half of 2021, Comsec completed the technological development of a cyber automation solution and began marketing and profiting from its internally developed D-Storm product. The acquisition transaction was completed on November 17, 2021 and from that date, the Company consolidated the financial statements of Comsec in the consolidated financial statements, see also Note 5.

Additional Information to Profi

Additional Information to Profit or Loss Items	12 Months Ended
	Dec. 31, 2023
Additional Information to Profit or Loss Items [Abstract]
ADDITIONAL INFORMATION TO PROFIT OR LOSS ITEMS	NOTE 24:- ADDITIONAL INFORMATION TO PROFIT OR LOSS ITEMS Year ended December 31, 2023 2022 2021 USD in thousands a. Cost of revenue: Salaries and related expenses 28,098 29,972 11,506 Subcontractors and consultants 8,359 12,980 8,658 Depreciation, amortization and impairment 4,757 1,659 372 Material - 461 3,701 Impairment expenses - 438 - Other 693 401 474 41,907 45,911 24,711 b. Research and development expenses: Salaries and related expenses 6,879 5,201 5,468 Other 298 406 328 7,177 5,607 5,796 Less – government grants (1,291 ) (33 ) - 5,886 5,574 5,796 c. Sales and marketing expenses: Salaries and related expenses 4,239 7,972 1,910 Advertising and public relations 236 306 37 Depreciation, amortization and impairment 6,026 12,688 727 Other 193 708 9 10,694 21,674 2,683 d. General and administrative expenses: Salaries and related expenses 8,409 16,089 4,844 Depreciation and amortization 1,463 1,680 884 Office Maintenance 1,392 1,410 303 Consulting 16,716 16,627 1,149 Legal expenses 2,713 2,157 411 Impairment expenses 10,643 14,618 - Audit and accounting 773 1,418 249 Insurance 1,622 26 (45 ) Board fees 1,168 396 131 Other 4,273 2,850 1,473 49,172 57,271 9,313 Year ended December 31, 2023 2022 2021 USD in thousands e. Other expenses, net: Governmental grants income (1,159 ) - - ELOC 1,570 RNER listing expenses 12,312 - - 12,723 - - f. Finance income and expenses: Finance income: Gain from exchange rate differences 271 19 - Interest income 213 450 5 484 469 5 Finance expenses: Loss from exchange rate differences - - 105 Bank fees 109 145 105 Changes in fair value of financial instruments 247 - - Interest expenses 6,838 1,239 86 7,194 1,384 296

Taxes on Income

Taxes on Income	12 Months Ended
	Dec. 31, 2023
Taxes on Income [Abstract]
TAXES ON INCOME	NOTE 25:- TAXES ON INCOME Tax laws applicable to the Group companies: Income Tax (Inflationary Adjustments) Law, 1985: According to the law, until 2007, the results for tax purposes were adjusted for the changes in the Israeli CPI. In February 2008, the Knesset (Israeli parliament) passed an amendment to the Income Tax (Inflationary Adjustments) Law, 1985, which limits the scope of the law starting 2008 and thereafter. Since 2008, the results for tax purposes are measured in nominal values, excluding certain adjustments for changes in the Israeli CPI carried out in the period up to December 31, 2007. Adjustments relating to capital gains such as for sale of property (betterment) and securities continue to apply until disposal. Since 2008, the amendment to the law includes, among others, the cancellation of the inflationary additions and deductions and the additional deduction for depreciation (in respect of depreciable assets purchased after the 2007 tax year). a. Tax rates applicable to the Group companies: The Israeli corporate tax rate was 23% in 2023, 2022 and 2021. A Company is taxable on its real capital gains at the corporate income tax rate in the year of sale. In August 2013, the Law for Changing National Priorities (Legislative Amendments for Achieving Budget Targets for 2013 and 2014), 2013 (“the Budget Law”) was published. The Law includes, among others, provisions for the taxation of revaluation gains effective from August 1, 2013. The provisions regarding revaluation gains will become effective only after the publication of regulations defining what should be considered as “retained earnings not subject to corporate tax” and regulations that set forth provisions for avoiding double taxation of foreign assets. As of the date of approval of these financial statements, these regulations have not been published. b. Principal tax rates applicable to subsidiaries resident outside of Israel: Company incorporated in the United States – tax rate of 25%. Company incorporated in the United Kingdom – tax rate of 19%. Company incorporated in the Netherland – tax rate of19%. c. Final tax assessments: The Company and its subsidiaries had tax assessments through the 2017 tax year, and are deemed final. d. Carryforward tax losses: The Company has business losses that can be carried forward totaling approximately $140,542 thousand. The Company did not create deferred taxes in respect of these business losses and other temporary differences as it does not expect to generate taxable income in the foreseeable future. e. Deferred taxes: Composition and movement in deferred taxes: In non-current In non-current USD in thousands Balance as of January 1, 2022 (4,734 ) 3,469 Charged to profit or loss 787 215 Adjustments arising from translating financial statements from functional currency to presentation currency 515 (413 ) Balance as of December 31, 2022 (3,432 ) 3,271 Charged to profit or loss 1,725 (1,686 ) Adjustments arising from translating financial statements from functional currency to presentation currency 132 (126 ) Balance as of December 31, 2023 (1,575 ) 1,459 As shown on balance sheet (2): (116 ) - (1) The deferred taxes are computed at a tax rate of 23%. (2) The deferred tax shown above is not netted off within companies. The balance sheet shows the net position. f. Taxes on income included in profit or loss: Year ended December 31, 2023 2022* 2021* USD in thousands Current taxes 210 131 197 Deferred taxes (39 ) (1,039 ) 65 Tax previous years - 132 - 171 (776 ) 262 * Comparative figures including the discontinued operation results. g. Theoretical tax: The reconciliation between the tax expense, assuming that all the income and expenses, gains and losses in profit or loss were taxed at the statutory tax rate and the taxes on income recorded in profit or loss, is as follows: Year ended December 31, 2023 2022 2021 USD in thousands Loss before taxes on income (84,435 ) (80,739 )* (13,153 )* Statutory tax rate 23 % 23 % 23 % Tax computed at the statutory tax rate (19,420 ) (18,570 ) (3,025 ) Increase (decrease) in taxes on income resulting from the following factors: Different tax rate applicable to foreign subsidiary (2 ) (225 ) 1 Utilization of carryforward losses for which no deferred taxes were computed in the past (98 ) - (32 ) Other losses and temporary differences for which no deferred taxes were computed 19,026 17,699 3,433 Tax previous years - 132 - Other, net 665 225 93 Taxes on income 171 (739 ) 470 * Comparative figures including the discontinued operation results.

Net Loss Per Share

Net Loss Per Share	12 Months Ended
	Dec. 31, 2023
Net Loss Per Share [Abstract]
NET LOSS PER SHARE	NOTE 26:- NET LOSS PER SHARE In computing diluted loss per share for year ended December 31, 2023, no account was taken of the potential dilution that could occur upon the exercise of employee and investors stock options, amounting to 362 thousand and 6,330 thousand, respectively, since they had an anti-dilutive effect on loss per share.

Balances and Transactions with

Balances and Transactions with Interested and Related Parties	12 Months Ended
	Dec. 31, 2023
Balances and Transactions with Interested and Related Parties [Abstract]
BALANCES AND TRANSACTIONS WITH INTERESTED AND RELATED PARTIES	NOTE 27:- BALANCES AND TRANSACTIONS WITH INTERESTED AND RELATED PARTIES a. Balances with interested and related parties: December 31, 2023 For Directors Key Note USD in thousands Other accounts payable 15 200 18 Loan 66 In addition, as described in note 29(7), the Company provided a loan to blackswan, a company that one of its board members is the Company’s Chief Executive Officer. December 31, 2022 For Controlling Key Note USD in thousands Other accounts payable 15 40 25 b. Salaries and benefits to interested and related parties: Year ended December 31, 2023 2022 2021 USD in thousands Cost of sales, research and development expenses, sales and marketing expenses and general and administrative expenses, net: Salary and related benefits to CEO and director employed by the Company (controlling shareholder) including cost of share-based payment (1) 132 - - Fees of directors not employed by the Company including cost of share-based payment (7) 566 312 289 Salary and related benefits to formerly Deputy CEO including cost of share-based payment (2) 811 3,872 1,571 Salary and related benefits to the former VP Human Resources including cost of share-based payment (4) 28 1,140 544 Salary and related benefits to formerly Chairman of the Board including cost of share-based payment (3) (6) - 2,355 832 Salary and related benefits to formerly Deputy CEO and COO including cost of share-based payment (5) (6) - 1,777 803 1,537 9,456 4,039 (1) Relates to the cost of employment of Mr. Noah Hershkovitz, director of the Company as of October 3, 2023 and CEO of the Company as of December 4, 2023. (2) Relates to the cost of employment of Mr. Uzi Moskowitz director and former CEO in the Company, who no longer serves as the CEO of Company since December 4, 2023. and Eyal Moshe former director and former CEO of the Company who is also controlling shareholder in the Company, excluding any misappropriates expenses. Mr. Moshe ceased his role as CEO on February 2, 2023, and his employment was terminated effective July 24, 2023 for cause in connection with these unauthorized expenses. (3) Relates to the cost of employment of Dr. Zigmund Bluvband, formerly the Chairman of the Company’s Board. Dr. Zigmund no longer works at the Company since April 30, 2022. (4) Relates to the cost of employment of Ms. Ayelet Bitan, Chief of Staff in the Company and the spouse of Mr. Eyal Moshe, a controlling shareholder in the Company, excluding any allegedly misappropriated expenses as detailed in Note 1e. Ms. Bitan resigned in February 2023. (5) Relates to the cost of employment of Mr. Dotan Moshe, former Deputy CEO and COO in the Company, who is also the son-in-law of Dr. Zigmund Bluvband. Mr. Dotan no longer works at the Company since May 15, 2022. In February 2023 he began consulting the Company. (6) Key management personnel. (7) Other interested and related parties. * The salary and related benefits amounts including the additional expenses of the extension in 2022 of the expiry date of options as detailed in note 18f. Mr. Hershkoviz holds 9.99% of one of the Company service providers. Therefore, any decision regarding A-Labs transactions will require special approval. c. Transactions with interested and related parties: Year ended December 31, 2023 Controlling Key Other Total USD in thousands General and administrative expenses 141 829 566 1,537 141 829 566 1,537 Year ended December 31, 2022 Controlling Key Other Total USD in thousands General and administrative expenses 5,012 4,132 312 9,456 5,012 4,132 312 9,456 Year ended December 31, 2023 For Directors Key Note USD in thousands Other accounts payable 15 223 18 Highest balance of current debts during the year - 66 - Year ended December 31, 2022 For Controlling Key Note USD in thousands Other accounts payable 15 40 25 Highest balance of current debts during the year - 0 -

Segments

Segments	12 Months Ended
	Dec. 31, 2023
Segments [Abstract]
SEGMENTS	NOTE 28:- SEGMENTS a. Business segments – chief reporting: The operating segments are identified on the basis of information that is reviewed by the chief operating decision maker (“CODM”) to make decisions about resources to be allocated and assess its performance. Accordingly, for management purposes, the Group is organized into two operating segments based on the products and services of the business units and has operating segments as follows. 1. Product and Technology Segment – the Company develop and market integrated cybersecurity hardware/software solutions that allow organizations to protect their RAM or confidential computing data to create a reliable work environment the Company offers data and cybersecurity and system security and reliability solutions and related services such as consulting, planning, training, integrating and ongoing servicing of cybersecurity, risk management, system quality, reliability and security projects and fully managed corporate cybersecurity services. 2. Professional Services Segment – the Company offers data and cybersecurity and system security and reliability solutions and related services such as consulting, planning, training, integrating and ongoing servicing of cybersecurity, risk management, system quality, reliability and security projects and fully managed corporate cybersecurity services. These segments share a unified product development, operations, and administrative resources. Revenues and part of the expenses are allocated directly to business segments whereas joint expenses are not allocated to segments. The assets and liabilities that are not allocated consist of joint operational assets and liabilities that are shared by the various operating segments. The Company deems it is impractical to separate them. Segment asset and liability performances and segment income (loss) are estimated based on the operating income (loss) presented in the financial statements. Below is data relating to business segments – before the business combination date (see Note 1 above), the Company reported its business operations under a single segment of products and technology. Year ended December 31, 2023 Professional Products Unallocated* Total USD in thousands Revenues from external customers 41,589 1,068 - 42,657 Total revenues 41,589 1,068 - 42,657 Segment results (operating loss)** (30,690 ) (33,153 ) (13,882 ) (77,725 ) Finance expenses, net 6,710 Loss before taxes on income (84,435 ) * Expenses related to RNER merger transaction)see Note 5) and ELOC (see Note 20). ** In the year ended December 31, 2023, the Company recorded impairment of goodwill and intangible assets related to professional service and product and technology segments in the amount of $12,735 thousand and $2,523 thousand, respectively. Year ended December 31, 2022 Professional Products Unallocated* Total USD in thousands Revenues from external customers 48,263 1,739 - 50,002 Total revenues 48,263 1,739 - 50,002 Segment results (operating loss) (21,582 ) (43,019 ) (15,829 ) (80,430 ) Finance expenses, net (915 ) Loss before taxes on income (81,345 ) * Expenses related to a merger transaction in 2022. b. Geographical segments: Below is revenue by country, based on customer location - before the business combination date (see Note 1 above) geographical segments were not analyzed due to immateriality (most of the Company revenues and the carrying amounts of non-current assets are in the Company’s country of domicile (Israel)): Year ended December 31, 2023 Israel America Europe Asia Pacific Total USD in thousands Revenues 40,364 334 1,669 290 42,657 Main customers: USD Turnover with main customers (1): Customer A 7,602 Customer B 4,726 12,328 (1) Customers in the professional services segment. % of Customer A 17.82 % Customer B 11.07 % 28.89 % Year ended December 31, 2022 Israel America Europe Asia Pacific Total USD in thousands Revenues 46,386 339 2,983 294 50 ,002 Main customers: Year ended USD in thousands Turnover with main customers (1): Customer A 10,257 Customer B 6,706 16,963 % of 2022 Customer A 21 % Customer B 13 % 34 %

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2023
Disclosure of New Standards in the Period [Abstract]
SUBSEQUENT EVENTS	NOTE 29:- SUBSEQUENT EVENTS 1. Tomas Gottdiener In March-June 2024, the Company sold to an accredited investor (the “March-June 2024 Investor”), in a series of unregistered private transactions, notes (the “March-June 2024 Notes”) with an aggregate principal amount of $10,000 thousand, and warrants (the “March-June 2024 Warrants”) pursuant to a Securities Purchase Agreement entered into with the March-June 2024 Investor (the “March-June 2024 Purchase Agreement”). The Company’s acquisition of Qpoint was partially funded by proceeds the Company received pursuant to the March-June 2024 Purchase Agreement. The loan amount under the March-June 2024 Notes is repayable by the Company on the earlier of (i) August 10, 2024 with respect to 40% of the loan amount and September 24, 2024 with respect to the remaining 60% of the loan amount, or (ii) five (5) business days following the closing of a financing in the Company of at least $25,000 thousand. The principal amount under the March-June 2024 Notes carries a variable interest rate based on the date of repayment as follows: (a) with respect to $8,000 thousand of the principal amount, (i) for the principal amount repaid on or prior to May 12, 2024, 7%, (ii) for the principal amount repaid following May 12, 2024 and on or prior to June 12, 2024, a rate between 7% and 8.5% of such principal amount computed by adding to 7% the result obtained by multiplying 1.5 by the quotient of the number of days elapsed in such period until (and including) the repayment date divided by the number of days in such period, and (iii) for the principal amount repaid following June 12, 2024, 8.5% of such principal amount plus 15% per annum, on the basis of the actual number of days elapsed commencing from the date following June 12, 2024 and ending on the repayment date; and (b) with respect to $2,000 thousand of the principal amount, (i) for the principal amount repaid on or prior to September 24, 2024, 10%, and (ii) for the principal amount repaid following September 24, 2024, 10% of such principal amount plus 15% per annum, on the basis of the actual number of days elapsed commencing from the date following September 24, 2024 and ending on the repayment date. If the March-June 2024 notes are not repaid prior to the applicable maturity date, the March-June 2024 Investor may convert the applicable portion of the outstanding loan amount into the Company’s ordinary shares at a rate equal to the arithmetic average of the closing price of the ordinary shares in the five trading days prior to the date of conversion, provided that such conversion rate shall not be lower than $0.50. The loan amount is secured by a pledge on the shares of the Qpoint group. Additionally, for so long as the loan amount under the March-June 2024 Notes is outstanding, the Company has undertaken to cause the Qpoint group to adopt a dividend policy and designate dividend proceeds for the repayment of the loan amount. The March-June 2024 Warrants issued under the March-June 2024 Purchase Agreement are exercisable as follows: (i) March-June 2024 Warrants exercisable into 4,444,444 ordinary shares are exercisable at an exercise price equal to $0.70 per share until March 12, 2027, (ii) March-June 2024 Warrants exercisable into 4,000,000 ordinary shares are exercisable at an exercise price equal to $0.70 per share until April 3, 2027, (iii) March-June 2024 Warrants exercisable into 1,000,000 ordinary shares are exercisable at an exercise price equal to $0.50 per share until June 26, 2027 and (iv) March-June 2024 Warrants exercisable into 2,000,000 ordinary shares are exercisable at an exercise price equal to $0.70 per share until June 26, 2027. The conversion of the March-June 2024 Notes and the exercise of the March- June 2024 Warrants will be limited to the extent that, upon the conversion or exercise, the March-June 2024 Investor and its affiliates would in aggregate beneficially own more than 4.99% of the ordinary shares. In March 2024, the Company entered into Securities Purchase Agreements (the “Second 2023-2024 Accreditor Investor SPAs”) providing for the sale by the Company to certain accredited investors (the “Second 2023-2024 Accreditor Investors”), in unregistered private transactions, of convertible notes with an aggregate principal amount of $550 thousand (the “Second 2023-2024 Accreditor Investor Notes”), and warrants exercisable into between 0.50 and one ordinary share for each ordinary share issuable to the Investors upon the conversion of the principal amount of the Second 2023-2024 Accreditor Investor Notes, assuming conversion on the respective issuance dates of the Notes (the “Second 2023-2024 Accreditor Investor Warrants”). The aggregate principal amount of the Second 2023-2024 Accreditor Investor Notes is convertible into the Company’s ordinary shares at a rate equal to the arithmetic average of the volume-weighted average price of the ordinary shares in the five (5) trading days prior to the date of conversion, provided that such conversion rate would not be lower than $1.50. The Second 2023-2024 Accreditor Investor Notes do not bear interest and are repayable on March 14, 2027, subject to earlier conversion by the Second 2023-2024 Accreditor Investors. The Second 2023-2024 Accreditor Investors have the right to convert the Second 2023-2024 Accreditor Investors Convertible Notes, in whole or in part, at any time following their issuance. Pursuant to the Second 2023-2024 Accreditor Investor SPAs, the Company issued Second 2023-2024 Accreditor Investor Warrants which are exercisable into 200,000 ordinary shares. The Second 2023-2024 Accreditor Investor Warrants are exercisable until September 14, 2025 for an exercise price of $1.50. The exercise of the Second 2023-2024 Accreditor Investor Warrants will be limited to the extent that, upon their exercise, a Second 2023-2024 Accreditor Investor and its affiliates would in the aggregate beneficially own more than 4.99% of the Company’s ordinary shares. 2. Dominion A Schedule 13D was jointly filed by (i) Dominion Capital LLC, a Connecticut limited liability Company (“Dominion”), (ii) DC Rainier SPV LLC, a Delaware limited liability Company, (iii) Dominion Capital Holdings LLC, a Delaware limited liability Company, (iv) Mikhail Gurevich and (v) Gennadiy Gurevich (collectively, the “Reporting Persons”) with the Securities and Exchange Commission on March 18, 2024 (the “Schedule 13D Filing”) with respect to the Reporting Persons’ beneficial ownership of shares of Hub Cyber Security Ltd. (the “Company”). In the Schedule 13D Filing, the Reporting Persons made several inaccurate statements regarding the Company. Notably, they alleged that on February 14, 2024, Dominion commenced insolvency proceedings against the Company under Israeli law. Contrary to this claim, the Company has not received any related motion at the time. The Company has filed a counterclaim against Dominion in the commercial litigation proceedings between the parties in the United States referenced in the Schedule 13D Filing. The Company maintains the right to hold the Reporting Persons accountable for their malicious and detrimental actions aimed at harming the Company. The claim by Dominion to initiate insolvency proceedings was actually filed by Dominion in Israel on April 9, 2024. 3. Qpoint Acquisition On April 3, 2024 the Company acquired for NIS 25,000 thousand in cash the shares of Qpoint. Payments were agreed to be carried out in three installments as follows: (i) NIS 4,000 thousand on the signing date; (ii) NIS 16,000 thousand on the closing date (which was April 8, 2024); (iii) an additional NIS 5,000 thousand no later than February 10, 2025 (of which NIS 2,500 thousand was already paid by June 5, 2024). Following this acquisition the Company holds 100% of Qpoint. This acquisition is strategically aligned with the Company’s mission to establish a leading global secure data fabric ecosystem. Qpoint, boasting a diverse customer base of over 100 renowned brand clients, including partnerships with Rafael Advanced Defense Systems, the developer of the “Iron Dome”, the Israel Airport Authority and the Ministry of Defense of Israel. Qpoint, which was established in 2009, comprises five subsidiaries and provides solutions and consulting across various verticals, including innovative data management and security solutions. The strategic integration enhances HUB’s capabilities in safeguarding sensitive information across various sectors. 4. Debt Arrangement with Comsec Creditors and Vendor Settlement The Comsec Group total liabilities sum up to NIS 55,000 thousand, but this amount is divided between different groups of creditors with different priorities, and includes provisions for employee’s vacation days, social benefits, liabilities for other subsidiaries and debts that their settlement is already happening. The Company assesses that it can pay 30% out of the total outstanding debt ( i.e. “ Hair cut” of 70%) over a period of 3 years, on a quarterly basis and negotiations for a settlement agreement with the creditors are currently in an advanced phase. Comsec and the Company have reached a settlement agreement with a vendor, which is one of the creditors, and whose debt is also covered by a guarantee by the Company. According to the settlement agreement, a vendor will receive an amount of NIS 13,656 thousand according to the following payment schedule: (i) NIS 5,000 thousand until April 7, 2024 (ii) NIS 4,328 thousand until May 15, 2024 (iii) NIS 4,328 thousand until July 15, 2024 As the Company was guarantor to the debt to a vendor, the Company has paid the first two payments, and is expected to pay the third one as well. 5. Amendments to Convertible Loan Agreements with Shayna Following the sale of most of the rights of Shayna LP (“ Shayna Akina First Amendment – March 31, 2024 ● An agreed upon conversion price ● Warrant coverage ● Limitation on Beneficial Ownership ● Condition to effectiveness Second Amendment – April 18, 2024 ● Shyana and Akina agreed that in case Akina defaults on its payment schedule to Shayna, then Shyana will be entitled to assume all of Shyana’s rights to convert any outstanding amount of the Loan to shares ● The Company agreed that upon receiving such written notice of default from Shyana, and in the absence of a contradictory judicial injunction within 7 days, to allocate to Shayna any outstanding amount of the Loan, upon receipt of a written conversion notice from Shayna Third Amendment – May 9, 2024 converting the cash payment of $1,151 thousand for Consulting Fee for under the Convertible Loan Agreements, to 1,278,666 ordinary shares of the Company (calculated under a conversion rate of $0.9) and 1,278,666 Warrants (with an Exercise Price of $0.8 and an exercise period of up to 6 months); and (ii) Approving the sale of Shyana rights under the Convertible Loan Agreements to receive certain converted shares and to exercise certain warrants from Shayna to the Lender 6. SPA with Akina Holding Limited The Company has signed an SPA with Akina on May 9, 2024 the principal conditions of which are as follows: (i) Investment Amount – up to $5,000 thousand; (ii) Price Per Share - $1.00; (iii) 50% Warrant Coverage; (iv) Warrants Exercise Price Per Share - $1.00 (equal to share purchase price per share); (v) Warrants have a 12 months expiration date. 7. Credit Line to Blackswan The Company entered into a Loan and Security Agreement with Blackswan Technologies, Inc., a Delaware corporation (“BST”), with an effective date of December 4, 2023 (the “BST Loan Agreement”). Under the BST Loan Agreement, the Company may make, at its sole discretion, cash advances to BST, from time to time, until June 30, 2024, in an aggregate principal amount of up to $6,000 thousand. The principal amounts the Company lends to BST under the BST Loan Agreement accrue interest at a fixed rate per annum equal to fifteen percent (15%) and are repayable on January 1, 2025, provided that BST has the right to prepay the any outstanding loan amounts upon at least two days prior notice. Upon the occurrence of certain customary events of default, any outstanding loan amounts are immediately repayable and overdue obligation will carry interest at a fixed rate per annum equal to eighteen percent (18%). The Company has provided to Blackswan an aggregated amount of $2,012 thousand under the BST Loan Agreement, of which $1,023 thousand was provided until December 31, 2023, while $299 thousand were recorded as selling and marketing expenses and $724 presented as part of long-term receivables. In addition, $990 thousand was provided after that date.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Basis of presentation of the financial statements	a. Basis of presentation of the financial statements: These financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS” as issued by the International Accounting Standard Board (IASB)). The Company’s financial statements have been prepared on a cost basis, except for financial instruments measured at fair value through profit or loss. The Company has elected to present the profit or loss items using the function of expense method.
The operating cycle	b. The operating cycle: The Company’s operating cycle is one year.
Consolidated financial statements	c. Consolidated financial statements: The consolidated financial statements comprise the financial statements of companies that are controlled by the Company (subsidiaries). Control is achieved when the Company has power over the investee, is exposed or has rights to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. In assessing control, the effect of potential voting rights is considered only if they are substantive. Non-controlling interests in subsidiaries represent the equity in subsidiaries not attributable, directly or indirectly, to a parent. Non-controlling interests are presented in equity separately from the equity attributable to the equity holders of the Company. Profit or loss and components of other comprehensive income are attributed to the Company and to non-controlling interests. Losses are attributed to non-controlling interests even if they result in a negative balance of non-controlling interests in the consolidated statement of financial position.
Business combinations and goodwill	d. Business combinations and goodwill: To determine whether a transaction is accounted for as an asset acquisition or business combination, the Company applies a concentration test to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. If the test is met, the transaction is accounted for as an asset acquisition. If the concentration test is not Business combinations are accounted for by applying the acquisition method. The cost of the acquisition is measured at the fair value of the consideration transferred on the acquisition date with the addition of non-controlling interests in the acquiree. In each business combination, the Company chooses whether to measure the non-controlling interests in the acquiree based on their fair value on the acquisition date or at their proportionate share in the fair value of the acquiree’s net identifiable assets. Direct acquisition costs are carried to the statement of profit or loss as incurred. Goodwill is initially measured at cost which represents the excess of the acquisition consideration and the amount of non-controlling interests over the net identifiable assets acquired and liabilities assumed.
Functional currency, presentation currency and foreign currency	e. Functional currency, presentation currency and foreign currency: 1. Functional currency and presentation currency: The Group determines the functional currency of each Group entity, including companies accounted for at equity. Items included in the financial statements of each of the Company’s entities are measured using the currency of the primary economic environment in which the entity operates (the “functional currency”). The Company’s functional currency is NIS. The consolidated financial statements are presented in US dollar, which is the Company’s presentation currency. The results and financial position of foreign operations (none of which has the currency of a hyperinflationary economy) that have a functional currency different from the presentational currency are translated into the presentational currency as follows: ● Assets and liabilities for each statement of financial position presented are translated at the closing rate at the date of that statement of financial position. ● Income and expenses for each statement of profit or loss and statement of comprehensive loss are translated at average exchange rates (unless this is not a reasonable approximation of the cumulative effect of the rates prevailing on the transaction dates, in which case income and expenses are translated at the rate on the dates of the transactions), and ● All resulting exchange differences are recognized in other comprehensive income (loss). 2. Transactions, assets and liabilities in foreign currency: Transactions denominated in foreign currency (other than the functional currency) are recorded upon initial recognition at the exchange rate at the date of the transaction. After initial recognition, monetary assets and liabilities denominated in foreign currency are translated at each reporting date into the functional currency at the exchange rate at that date. Exchange rate differences, other than those capitalized to qualifying assets or accounted for as hedging transactions in equity, are recognized in profit or loss. Non-monetary assets and liabilities denominated in foreign currency and measured at cost are translated at the exchange rate at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currency and measured at fair value are translated into the functional currency using the exchange rate prevailing at the date when the fair value was determined.
Revenue recognition	f. Revenue recognition: Revenue from contracts with customers is recognized when the control over the goods or services is transferred to the customer. The transaction price is the amount of the consideration that is expected to be received based on the contract terms, excluding amounts collected on behalf of third parties (such as taxes). Revenue from rendering of services: Revenue from rendering of services is recognized over time, during the period the customer simultaneously receives and consumes the benefits provided by the Company’s performance. The Company charges its customers based on payment terms agreed upon in specific agreements. When payments are made before or after the service is performed, the Company recognizes the resulting contract asset or liability. Contract balances: The Company charges customers as the work progresses in accordance with the contractual terms. Amounts billed are classified as trade receivables in the statement of financial position. When revenue from performance of a contract are recognized in profit or loss before the customer is charged, the amounts recognized are recorded as trade receivables. Amounts received from customers in advance of performance by the Company are recorded as contract liabilities and recognized as revenue in profit or loss when the work is performed. Determining the transaction Price The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). Costs of obtaining a contract: The Company has elected to apply the practical expedient allowed by IFRS 15 according to which incremental costs of obtaining a contract are recognized as an expense when incurred if the amortization period of the asset is one year or less.
Taxes on income	g. Taxes on income: Deferred taxes: Deferred taxes are computed in respect of temporary differences between the carrying amounts in the financial statements and the amounts attributed for tax purposes. Deferred taxes are measured at the tax rate that is expected to apply when the asset is realized or the liability is settled, based on tax laws that have been enacted or substantively enacted by the reporting date. Deferred tax assets are reviewed at each reporting date and reduced to the extent that it is not probable that they will be utilized. Deductible carryforward losses and temporary differences for which deferred tax assets had not been recognized are reviewed at each reporting date and a respective deferred tax asset is recognized to the extent that their utilization is probable. Taxes that would apply in the event of the disposal of investments in investees have not been taken into account in computing deferred taxes, as long as the disposal of the investments in investees is not probable in the foreseeable future. Also, deferred taxes that would apply in the event of distribution of earnings by investees as dividends have not been taken into account in computing deferred taxes, since the distribution of dividends does not involve an additional tax liability or since it is the Company’s policy not to initiate distribution of dividends from a subsidiary that would trigger an additional tax liability. Deferred taxes are offset if there is a legally enforceable right to offset a current tax asset against a current tax liability and the deferred taxes relate to the same taxpayer and the same taxation authority.
Intangible assets	h. Intangible assets: Separately acquired intangible assets are measured on initial recognition at cost including directly attributable costs. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Expenditures relating to internally generated intangible assets, are recognized in profit or loss when incurred. Intangible assets with a finite useful life are amortized over their useful life on a straight-line basis and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for an intangible asset are reviewed at least at each year end. Patents: The patents are for a period of ten years with an option for renewal at the end of the period. The useful life of intangible assets is as follows: Years Patents 10 Customer relations 3.5-10 Order backlog 1 Technology 2-4 Gains or losses from the derecognition of an intangible asset are measured as the difference between the net disposal proceeds and the cost of the asset and carried to profit or loss.
Impairment of non-financial assets	i. Impairment of non-financial assets: The Company evaluates the need to record an impairment of non-financial assets whenever events or changes in circumstances indicate that the carrying amount is not recoverable. If the carrying amount of non-financial assets exceeds their recoverable amount, the assets are reduced to their recoverable amount. The recoverable amount is the higher of fair value less costs of sale and value in use. In measuring value in use, the expected future cash flows are discounted using a pre-tax discount rate that reflects the risks specific to the asset. The recoverable amount of an asset that does not generate independent cash flows is determined for the cash-generating unit to which the asset belongs. Impairment losses are recognized in profit or loss. An impairment loss of an asset, other than goodwill, is reversed only if there have been changes in the estimates used to determine the asset’s recoverable amount since the last impairment loss was recognized. Reversal of an impairment loss, as above, shall not be increased above the lower of the carrying amount that would have been determined (net of depreciation or amortization) had no impairment loss been recognized for the asset in prior years and its recoverable amount. The reversal of impairment loss of an asset presented at cost is recognized in profit or loss. A reversal of an impairment loss for each cash generating unit shall be allocated to the assets of the unit, except for goodwill, pro rata with the carrying amount to each of the assets within the measurement scope of IAS 36. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years. The following criteria are applied in assessing impairment of these specific assets: Goodwill in respect of subsidiaries: The Company reviews goodwill for impairment at least once a year, on December 31, or more frequently if events or changes in circumstances indicate that there is an impairment. Goodwill is tested for impairment by assessing the recoverable amount of the cash-generating unit (or group of cash-generating units) to which the goodwill has been allocated. Each cash-generating unit to which the goodwill is allocated shall represent the lowest level within the Company at which the goodwill is monitored for internal management purposes and not be larger than an operating segment. An impairment loss is recognized if the recoverable amount of the cash-generating unit (or group of cash-generating units) to which goodwill has been allocated is less than the carrying amount of the cash-generating unit (or group of cash-generating units). Any impairment loss is allocated first to goodwill. Impairment losses recognized for goodwill cannot be reversed in subsequent periods.
Financial instruments	j. Financial instruments: 1. Financial liabilities: a) Financial liabilities measured at amortized cost: Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability. After initial recognition, the Company measures all financial liabilities at amortized cost. b) Financial liabilities measured at fair value through profit or loss: At initial recognition, the Company measures financial liabilities that are not measured at amortized cost at fair value. Transaction costs are recognized in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss. 2. Derecognition of financial liabilities: A financial liability is derecognized only when it is extinguished, that is when the obligation specified in the contract is discharged or cancelled or expires. A financial liability is extinguished when the debtor discharges the liability by paying in cash, other financial assets, goods or services; or is legally released from the liability. When there is a modification in the terms of an existing financial liability, the Company evaluates whether the modification is substantial. If the terms of an existing financial liability are substantially modified, such modification is accounted for as an extinguishment of the original liability and the recognition of a new liability. The difference between the carrying amounts of the above liabilities is recognized in profit or loss. If the modification is not substantial, the Company recalculates the carrying amount of the liability by discounting the revised cash flows at the original effective interest rate and any resulting difference is recognized in profit or loss. When evaluating whether the modification in the terms of an existing liability is substantial, the Company considers both quantitative and qualitative factors. 3. Warrants to ordinary shares: According to IAS 32, “Financial Instruments: Presentation”, derivatives which will be settled only by the issuer exchanging fixed amounts of cash to fixed numbers of the Company’s ordinary shares will be classified as equity. Otherwise, the instrument should be classified as a financial liability. Therefore, the Group has classified such warrants as a financial liability. The warrant instrument is initially recognized at fair value, and subsequently measured at fair value. Changes in fair value are recognized in profit or loss.
Fair value measurement	k. Fair value measurement: Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value measurement is based on the assumption that the transaction will take place in the asset’s or the liability’s principal market, or in the absence of a principal market, in the most advantageous market. The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest. Fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use. The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data is available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs. All assets and liabilities measured at fair value or for which fair value is disclosed are categorized into levels within the fair value hierarchy based on the lowest level input that is significant to the entire fair value measurement: Level 1 - quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 - inputs other than quoted prices included within Level 1 that are observable directly or indirectly. Level 3 - inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).
Provisions	l. Provisions: A provision in accordance with IAS 37 is recognized when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. When the Group expects part or all of the expense to be reimbursed, for example under an insurance contract, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. The expense is recognized in the statement of profit or loss net of any reimbursement. Following are the types of provisions included in the financial statements: A provision for claims is recognized when the Group has a present legal or constructive obligation as a result of a past event, that it is more likely than not that an outflow of resources embodying economic benefits will be required by the Group to settle the obligation and a reliable estimate can be made of the amount of the obligation.
Employee benefit liabilities	m. Employee benefit liabilities: The Group has several employee benefit plans: 1. Short-term employee benefits: Short-term employee benefits are benefits that are expected to be settled wholly before twelve months after the end of the annual reporting period in which the employees render the related services. These benefits include salaries, paid annual leave, paid sick leave, recreation and social security contributions and are recognized as expenses as the services are rendered. A liability in respect of a cash bonus or a profit-sharing plan is recognized when the Group has a legal or constructive obligation to make such payment as a result of past service rendered by an employee and a reliable estimate of the amount can be made. 2. Post-employment benefits: The plans are normally financed by contributions to insurance companies and classified as defined contribution plans or as defined benefit plans. The Group has defined contribution plans pursuant to section 14 to the Severance Pay Law under which the Group usually pays fixed contributions and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient amounts to pay all employee benefits relating to employee service in the current and prior periods. Contributions to the defined contribution plan in respect of severance or retirement pay are recognized as an expense when contributed concurrently with performance of the employee’s services. The Group also operates a defined benefit plan in respect of severance pay pursuant to the Severance Pay Law. According to the Law, employees are entitled to severance pay upon dismissal or retirement. The liability for termination of employment is measured using the projected unit credit method. The actuarial assumptions include expected salary increases and rates of employee turnover based on the estimated timing of payment. The amounts are presented based on discounted expected future cash flows using a discount rate determined by reference to market yields at the reporting date on high quality corporate bonds that are linked to the Consumer Price Index with a term that is consistent with the estimated term of the severance pay obligation. In respect of its severance pay obligation to certain of its employees, the Company usually makes current deposits in severance pay funds and insurance companies (“the plan assets”). Plan assets comprise assets held by a long-term employee benefit fund or qualifying insurance policies. Plan assets are not available to the Group’s own creditors and cannot be returned directly to the Group. The liability for employee benefits shown in the statement of financial position reflects the present value of the defined benefit obligation less the fair value of the plan assets. Remeasurements of the net liability are recognized in other comprehensive income in the period in which they occur.

Significant Accounting Polici_2

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2023
Significant Accounting Policies [Abstract]
Schedule of Useful Life of Intangible Assets	The useful life of intangible assets is as follows: Years Patents 10 Customer relations 3.5-10 Order backlog 1 Technology 2-4

Merger Agrrement with Special_2

Merger Agrrement with Special Purpose Acquisition Company (“Spac”) (Tables)	12 Months Ended
	Dec. 31, 2023
Disclosure of New Standards in the Period [Abstract]
Schedule of Fair Value of the Identifiable Net Assets	Amount Number of USD in thousands except to share amount Shares issued to RNER shareholders 453,321 Closing price of the Company’s share on Nasdaq as of March 1, 2023 ($) 15.9 (A) Fair value of the Company’s shares issued to RNER shareholders 7,208 Public Warrants issued to RNER shareholders 1,550,784 Closing price of the Company’s warrants on Nasdaq as of March 1, 2023 ($) 1.7 Private Warrants issued to RNER shareholders 53,599 Fair Value of the Company’s warrants on as of March 1, 2023 ($) 1.33 (B) Fair value of the Company’s warrants issued to RNER shareholders 2,711 RNER assets 588 RNER liabilities (2,981 ) (C) Net liabilities of RNER (2,393 ) IFRS 2 Listing expenses (A+B-C) 12,312 *) Shares and per shares amounts have been retroactively adjusted to reflect the reverse stock splits as described in note 20a.

Cash and Cash Equivalents (Tabl

Cash and Cash Equivalents (Tables)	12 Months Ended
	Dec. 31, 2023
Cash and Cash Equivalents [Abstract]
Schedule of Cash and Cash Equivalents	December 31, 2023 2022 USD in thousands Cash and cash equivalents in NIS 3,201 3,112 Cash and cash equivalents in USD 227 765 Cash and cash equivalents in Euro 2 104 Cash and cash equivalents in other currency 92 13 3,522 3,994

Trade Receivables, Net (Tables)

Trade Receivables, Net (Tables)	12 Months Ended
	Dec. 31, 2023
Trade Receivables, Net [Abstract]
Schedule of Trade Receivables, Net	December 31, 2023 2022 USD in thousands Account receivable 10,051 23,317 Unbilled receivable 902 1,020 Checks collectible 27 405 Allowance for doubtful debt (1,113 ) (685 ) Trade receivables, net 9,867 24,057
Schedule of Credit Risk Exposure of the Company’s Trade Receivables	Following is information about the credit risk exposure of the Company’s trade receivables: Past due trade receivables Not past due < 30 31-60 60-90 90-120 >120 Total USD in thousands Trade receivables before allowance for doubtful accounts 4,349 1,838 1,341 989 520 1,944 10,980 Allowance for doubtful accounts - - - - - 1,113 1,113 December 31, 2023 4,349 1,838 1,341 989 520 742 9,867 December 31, 2022 21,147 1,850 349 183 145 383 24,057

Other Assets (Tables)

Other Assets (Tables)	12 Months Ended
	Dec. 31, 2023
Other Assets [Abstract]
Schedule of Other Assets	December 31, 2023 2022 USD in thousands Government authorities 1,604 1,127 Prepaid expenses 1,483 460 Grants receivables (1) 1,159 - Other assets 837 85 5,083 1,672 (1) In November 2023, the Company has been granted $1,159 thousand war grants associated with Israel-Hamas war.

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2023
Disclosure of Leases Text Block [Abstract]
Schedule of Information on Leases	Information on leases: Year ended December 31, 2023 2022 2021 USD in thousands Interest expense on lease liabilities 181 258 210 Total cash outflow for leases 1,711 2,240 1,175
Schedule of Right-of-Use Assets, Net	Disclosures in respect of right-of-use assets, net: Office lease Motor Total USD in thousands Cost: Balance as of January 1, 2023 7,231 1,794 9,025 Additions during the year: New leases - 643 643 Terminated lease (2,961 ) (80 ) (3,041 ) Classification - 71 71 Adjustments arising from indexation 137 - 137 Other (19 ) - (19 ) Adjustments arising from translating financial statements from functional currency to presentation currency (264 ) (10 ) (274 ) Balance as of December 31, 2023 4,124 2,418 6,542 Accumulated depreciation: Balance as of January 1, 2023 1,528 990 2,518 Additions during the year: Depreciation in the year 1,033 530 1,563 Adjustments arising from translating financial statements from functional currency to presentation currency (28 ) (20 ) (49 ) Balance as of December 31, 2023 2,533 1,500 4,032 Depreciated cost as of December 31, 2023 1,591 918 2,510 Office lease Motor Total USD in thousands Cost: Balance as of January 1, 2022 7,510 1,262 8,772 Additions during the year: New leases 243 711 954 Adjustments arising from indexation 379 - 379 Adjustments arising from translating financial statements from functional currency to presentation currency (901 ) (179 ) (1,080 ) Balance as of December 31, 2022 7,231 1,794 9,025 Accumulated depreciation: Balance as of January 1, 2022 168 369 537 Additions during the year: Depreciation in the year 1,445 695 2,140 Adjustments arising from translating financial statements from functional currency to presentation currency (85 ) (74 ) (159 ) Balance as of December 31, 2022 1,528 990 2,518 Depreciated cost as of December 31, 2022 5,703 804 6,507

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2023
Property Plant And Equipment [Abstract]
Schedule of Composition and Movement of Property and Equipment	Composition and movement: Motor Office Computers Leasehold Total USD in thousands Cost: Balance as of January 1, 2023 197 235 798 598 1,828 Purchases in the year - 8 251 38 297 Disposals during the year (156 ) - - (97 ) (253 ) Adjustments arising from translating financial statements from functional currency to presentation currency (8 ) (7 ) (19 ) (19 ) (53 ) Balance as of December 31, 2023 33 236 1,030 520 1,819 Accumulated depreciation: Balance as of January 1, 2023 53 89 296 76 514 Depreciation in the year 21 21 239 60 341 Disposals during the year (43 ) - - (18 ) (61 ) Adjustments arising from translating financial statements from functional currency to presentation currency (1 ) (2 ) (5 ) (2 ) (10 ) Balance as of December 31, 2023 30 108 530 116 784 Depreciated cost as of December 31, 2023 3 128 500 404 1,035 Motor Office Computers Leasehold Total USD in thousands Cost: Balance as of January 1, 2022 258 291 572 272 1,393 Purchases in the year 1 99 412 373 885 Disposals during the year (35 ) (121 ) (105 ) - (261 ) Adjustments arising from translating financial statements from functional currency to presentation currency (27 ) (34 ) (81 ) (47 ) (189 ) Balance as of December 31, 2022 197 235 798 598 1,828 Accumulated depreciation: Balance as of January 1, 2022 19 20 180 28 247 Depreciation in the year 38 74 143 54 309 Adjustments arising from translating financial statements from functional currency to presentation currency (4 ) (5 ) (27 ) (6 ) (42 ) Balance as of December 31, 2022 53 89 296 76 514 Depreciated cost as of December 31, 2022 144 146 502 522 1,314

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets, Net (Tables)	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets, Net [Abstract]
Schedule of Composition and Movement	Composition and movement: Patents Goodwill Customer Technology (2) Total USD in thousands Cost: Balance as of January 1, 2022 20 31,992 22,273 1,207 55,492 Purchases in the year 13 - 9,453 500 9,966 Impairment recognized in the year - (14,618 ) (8,300 ) (438 ) (23,356 ) Adjustments arising from translating financial statements from functional currency to presentation currency (1 ) (3,672 ) (2,603 ) (143 ) (6,419 ) Balance as of December 31, 2022 32 13,702 20,823 1,126 35,683 Impairment recognized in the year (1) - (10,643 ) (4,615 ) - (15,258 ) Adjustments arising from translating financial statements from functional currency to presentation currency (1 ) (592 ) (613 ) (34 ) (1,240 ) Balance as of December 31, 2023 31 2,467 15,595 1,092 19,185 Accumulated amortization: Balance as of January 1, 2022 7 - 801 75 883 Amortization recognized in the year (1) 2 - 4,723 623 5,348 Adjustments arising from translating financial statements from functional currency to presentation currency * - (411 ) (37 ) (448 ) Balance as of December 31, 2022 9 - 5,113 661 5,783 Amortization recognized in the year (1) 9 - 5,278 446 5,733 Adjustments arising from translating financial statements from functional currency to presentation currency * - (199 ) (15 ) (214 ) Balance as of December 31, 2023 18 - 10,192 1,092 11,302 Net balance: As of December 31, 2023 13 2,467 5,403 - 7,883 As of December 31, 2022 23 13,702 15,710 465 29,900 * Less than 1 thousand US dollars. (1) Customer relations, order backlog and brand amortization expenses are classified in the statement of profit or loss under sales and marketing expenses. (2) Technology and supplier relationships amortization expenses are classified in the statement of profit or loss under cost of sales expenses. Patents amortization expenses are classified in the statement of profit or loss under General and administrative expenses.
Schedule of Purchase Price Allocation	The purchase price allocation was as follow (in thousands): Technology 500 Customer relationships 9,453 Total consideration 9,953
Schedule of the Goodwill and the Intangible Assets	The carrying amount as of December 31, 2023 of the goodwill and the intangible assets which were allocated to each cash-generating unit: Professional ALD Dstorm Consulting Total USD in thousands Patents 13 - - - 13 Goodwill 1,422 1,045 - - 2,467 Customer relationship, Suppliers relationship and Backlog 2,513 1,171 - 4,199 7,883 Total 13 - - - 13

Discontinued Operations (Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2023
Discontinued Operations [Abstract]
Schedule of Operating Attributed to Discontinued Operation	Below are data of the operating results attributed to the discontinued operation: Year ended December 31, 2023 2022 2021 USD in thousands Revenues from sales 5,459 29,741 2,987 Cost of sales (5,931 ) (27,383 ) (2,713 ) Gross profit (loss) (472 ) 2,358 274 Sales and marketing expenses 351 1,126 91 General and administrative expenses 851 308 54 Operating income (loss) (1,674 ) 924 129 Finance expenses, net 356 317 22 Income before taxes on income (2,030 ) 607 107 Taxes on income - 37 - Income (loss) after taxes on income (2,030 ) 569 107
Schedule of Net Cash Flows Provided by (used in) the Discontinued Operation	Below are data of the net cash flows provided by (used in) the discontinued operation: Year ended December 31, 2023 2022 2021 USD in thousands Net cash provided by (used in) discontinued operating activities 1,917 1,867 (638 ) Net cash provided by (used in) discontinued investing activities (1,026 ) 949 730 Net cash used in discontinued financing activities (1,375 ) (2,429 ) - Total net cash provided by (used in) discontinued operation (484 ) 387 92

Short-Term Loan (Tables)

Short-Term Loan (Tables)	12 Months Ended
	Dec. 31, 2023
Short Term Loan [Abstract]
Schedule of Composition	Composition: December 31, 2023 2022 USD in thousands Short-term loan (1)-(8) 11,750 13,417 Accrued interest 128 15 11 ,878 13,432 (1) Loan received in July 2020, by Comsec Distribution (fully owned subsidiary), with an original principal amount of NIS 5,000 thousand $)1,452 thousand), bearing annual interest of Prime (Bank of Israel intrabank plus 1.5%) + 1.95%. and repayable in 24 instalments from July 2022. As of December 31, 2023 the remaining principal amount is $906 thousand. (2) Loan received in September 2021, by Comsec Ltd (fully owned subsidiary), with an original principal amount of NIS 980 thousand ($309 thousand), unlinked and bearing annual interest of Prime (Bank of Israel intrabank) + 1.5%. As of December 31, 2023 the remaining principal amount is $110 thousand. (3) Loan received in September 2021, by Comsec Ltd (fully owned subsidiary), with an original principal amount of NIS 6,000 thousand ($1,934 thousand) and repayable in two annual instalments from September 2023, linked and bearing annual interest of Prime (Bank of Israel intrabank plus 1.5%) + 1.95%. As of December 31, 2023 the remaining principal amount is $831 thousand. (4) Loan received in August 2022, by Aginix, a second-tier subsidiary, with an original principal amount of NIS 1,000 thousand ($274 thousand) and repayable in 10 instalments from June 2023. The loan bearing interest of 7.25%. As of December 31, 2023 the remaining principal amount is $118 thousand. (5) On-call loans received by Comsec, in an aggregate principal amount of NIS 34,106 thousand ($9,692 thousand). As of December 31, 2023 the remaining principal amount is $5,497 thousand. (6) Loan received in May 2023, by Qpoint, with an original principal amount of NIS 1,700 thousand ($469 thousand) and repayable in 12 instalments from June 2023. The loan bearing interest of Prime + 1.01%. As of December 31, 2023 the remaining principal amount is $380 thousand. (7) Loan received in January 2023, by HUB, in an aggregate principal amount of NIS 3,300 thousand ($900 thousand) and repayable in one instalment in January 2026 in an amount of $1,000 thousand. (8) See information related to a loan received from Dominion in Note 20d.

Trade Payables (Tables)

Trade Payables (Tables)	12 Months Ended
	Dec. 31, 2023
Trade Payables [Abstract]
Schedule of Trade Payables	December 31, 2023 2022 USD in thousands Open debts 9,101 12,410 Checks payable 766 1,361 9,867 13,771

Other Accounts Payable (Tables)

Other Accounts Payable (Tables)	12 Months Ended
	Dec. 31, 2023
Other Accounts Payable [Abstract]
Schedule of Other Accounts Payable	December 31, 2023 2022 USD in thousands Employees and payroll accruals 4,691 5,797 Accrued vacation pay 1,225 1,510 Government authorities 1,282 1,997 Accrued expenses 23,067 12,636 Current liability of government grants 265 402 Liability on account of shares issuance - 2,289 Deferred revenues 1,205 611 Other 692 80 32,42 7 25,322

Long-Term Liabilities (Tables)

Long-Term Liabilities (Tables)	12 Months Ended
	Dec. 31, 2023
Other Long Term Liabilities [Abstract]
Schedule of Other Long Term Liabilities	Composition of other long-term liabilities: Effective Balance Balance % USD in thousands Liabilities for government grants 11.5 412 147 Effective Balance Balance % USD in thousands Liabilities for government grants 11.5 1,289 887
Schedule of Government Grants	Government grants: December 31, 2023 2022 USD in thousands Balance as of January 1, 1,289 961 Grants received during the year - 77 Liability revaluation (877 ) 251 Balance as of December 31, 412 1,289
Schedule of Presented in the Statement of Financial Position	Presented in the statement of financial position as follows: December 31, 2023 2022 USD in thousands In current liabilities 265 402 In non-current liabilities 147 887 412 1,289
Schedule of Lease Liabilities and Other Long Term Liabilities	The maturity profile of lease liabilities and other long-term liabilities: First Second Third Fourth Fifth Sixth Total USD in thousands Lease liabilities 382 382 382 382 - - 1,528 Liabilities for government grants 265 30 21 19 18 59 412 Total 647 412 403 401 18 59 1,940

Financials Liabilities (Tables)

Financials Liabilities (Tables)	12 Months Ended
	Dec. 31, 2023
Financials Liabilities [Abstract]
Schedule of Recurring Basis and Indicates the Fair Value Hierarchy of the Valuation Inputs	The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis as of December 31, 2023 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: December 31, 2023 Level 1 Level 2 Level 3 Public warrants 217 - - Private warrants - - 5,830 Conversion component of convertible loans - - 4,215 Total 217 - 10,045
Schedule of Conversion Component of Convertible Loans	The key inputs into the Black-Scholes model for the private warrants were as follows: December 31, Risk-free interest rate 3.91 % Expected term (years) 4.17 Expected volatility 86.60 % Exercise price 103.39 Underlying share price 2.17 December 31, Risk-free interest rate 4.38 % Expected term (years) 1.15 Expected volatility 132.85 % Underlying share price 2.17 December 31, Risk- free interest rate 4.27 % Expected term (years) 2 Expected volatility 124.9 % Exercise price 0.5 Underlying share price 2.17 December 31, Risk- free interest rate 4.34 % Expected term (years) 1.45 Expected volatility 122.86 % Underlying share price 2.17 December 31, Risk- free interest rate 4.33 % Expected term (years) 1.52 Expected volatility 121.43 % Underlying share price 2.17 December 31, Risk- free interest rate 4.33 % Expected term (years) 2 Expected volatility 124.9 % Exercise price 0.76 Underlying share price 2.17 December 31, Risk- free interest rate 5.09 % Expected term (years) 0.5 Expected volatility 157.17 % Underlying share price 2.17 December 31, Risk- free interest rate 3.9 % Expected term (years) 4.35 Expected volatility 112.38 % Exercise price 3.5 Underlying share price 2.17 December 31, Risk- free interest rate 5.13%-5.19 % IRR 20.63 % December 31, Risk- free interest rate 5.13%-5.19 % IRR 20.63 %
Schedule of Presents the Changes in the Fair Value of Liabilities	The following table presents the changes in the fair value of liabilities: Public Private Conversion Total Fair value as of December 31, 2022 - - - - Warrants issued in related to the RNER transaction 2,639 71 - 2,710 Issuance of conversion component related to the convertible loans. - - 4,779 4,779 Issuance of warrants related to the convertible loans - 3,781 - 3,781 Conversion of convertible loans into ordinary shares - - (1,427 ) (1,427 ) Change in fair value (2,466 ) 1,928 785 247 Adjustments arising from translating financial statements from functional currency to presentation currency 44 50 78 172 Fair value as of December 31, 2023 217 5,830 4,215 10,262

Financial Instruments (Tables)

Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2023
Financial Instruments (Tables) [Line Items]
Schedule of Financial Assets at Amortized Cost	Financial assets at amortized cost: December 31, 2023 2022 USD in thousands Trade and other assets 14,950 25,729 Restricted bank deposit 61 1,516 Total current assets 15,011 27,245 Long-term deposit 328 3,002 Total non-current assets 328 3,002
Schedule of Other Financial Liabilities	Other financial liabilities: Other financial liabilities at amortized cost: Short-term loans (1) 11,878 13,432 Convertible loans 14,449 - Trade payables 9,867 13,771 Other accounts payable 32,427 25,322 Liabilities for government grants 412 1,289 Total other financial liabilities at amortized cost 69,033 53,814 Total current liabilities 68,886 52,927 Total non-current liabilities 147 887 (1) The interest rate is Prime (Bank of Israel intrabank plus 1.5%) + 0.7%-4.85%.

Net Employee Defined Benefit _2

Net Employee Defined Benefit Liabilities (Tables)	12 Months Ended
	Dec. 31, 2023
Net Employee Defined Benefit Liabilities [Abstract]
Schedule of Defined Contribution Plans	These contributions and contributions for benefits represent defined contribution plans. Year ended 2023 2022 USD in thousands Expenses in respect of defined contribution plans 2,264 2,562
Schedule of Defined Benefit Obligation and Fair Value of Plan Assets	Changes in the defined benefit obligation and fair value of plan assets: Expenses recognized in profit or loss Gain (loss) from remeasurement Contributions Balance Current Net Past Total Payments Return Actuarial Actuarial Actuarial Total Effect of by by Balance NIS in thousands Defined benefit obligation 3,163 152 150 (212 ) 90 (36 ) - - (24 ) 36 12 (94) - - 3,135 Fair value of plan assets (2,123 ) - (104 ) 111 7 29 (109 ) - - - (109 ) 60 (130 ) - (2,266 ) Net defined benefit liability (asset) 1,040 152 46 (101 ) 97 (7 ) (109 ) - (24 ) 36 (97 ) (34 ) (130 ) - 869 Expenses recognized in profit or loss Gain (loss) from remeasurement Contributions Balance Current Net Past Total Payments Return Actuarial Actuarial Actuarial Total Effect of by by Balance NIS in thousands Defined benefit obligation 4,838 198 120 - 318 (1,376 ) - - (258 ) 151 (107 ) (511 ) - - 3,163 Fair value of plan assets (3,398 ) - (56 ) 9 (47 ) 927 228 - - - 228 355 (187 ) - (2,123 ) Net defined benefit liability (asset) 1,440 198 64 9 271 (449 ) 228 - (258 ) 151 121 (156 ) (187 ) - 1,040
Schedule of Principal Assumptions Underlying the Defined Benefit Plan	The principal assumptions underlying the defined benefit plan: 2023 2022 % Discount rate (1) 5.57 5.22 Expected rate of salary increase 3.19 3.21 (1) The discount rate is based on high-quality CPI-linked corporate bonds.
Schedule of Amount, Timing and Uncertainty of Future Cash Flows	Amount, timing and uncertainty of future cash flows: Change in USD in thousands December 31, 2023 Sensitivity test for changes in the expected rate of salary increase: The change as a result of: 1% salary increase (28 ) 1% salary decrease 360 Sensitivity test for changes in the discount rate of the plan assets and liability: The change as a result of: 1% increase in discount rate 379 1% decrease in discount rate (49 )

Equity (Tables)

Equity (Tables)	12 Months Ended
	Dec. 31, 2023
Equity [Abstract]
Schedule of Share Capital	Composition of share capital: December 31, 2023 December 31, 2022 Authorized Issued and Authorized Issued and Number of shares in thousands Ordinary shares with no par value 142,487 11,853 142,487 8,879
Schedule of Issued and Outstanding Share Capital	Issued and outstanding share capital: Number of shares of no in thousands Balance as of January 1, 2023 8,879 Issuance of shares 2,848 Exercise of options and warrants 126 Balance as of December 31, 2023 11,853
Schedule of Interests Shares	The interests of the Company in the Company’s shares are as follows: December 31, 2023 2022 % % of issued share capital 0.54 1.0

Share-Based Payment (Tables)

Share-Based Payment (Tables)	12 Months Ended
	Dec. 31, 2023
Share-Based Payment [Abstract]
Schedule of Financial Statements for Services Received from Employees and Officers	The expense recognized in the financial statements for services received from employees and officers is shown in the following table: Year ended December 31, 2023 2022 2021 USD in thousands Equity-settled share-based payment plans 7,115 10,516 5,897
Schedule of Fair Value Measurement of the Share Options	The inputs used for the fair value measurement of the share options for the above grant based on the Black and Scholes model are as follows: Expected volatility of the share prices (%) 80.03 % Risk-free interest rate (%) 4.02 % Expected life of share options (years) 9.66 Share price (NIS) 8.29 $ (2.26 )
Schedule of Number of Share Options and the Weighted Average Exercise Prices	The following table presents the changes in the number of share options and the weighted average exercise prices of share options: 2023 2022 Number of Weighted Number of Weighted Share options outstanding at beginning of year 844,148 16.02 1,139,102 6.93 Share options granted during the year 128,238 1.14 29,650 18.61 Share options exercised during the year 145,874 12.8 161,187 4.69 Share options forfeited during the year 9,553 0.04 144,686 12.30 Share options expired during the year 445,384 17.91 18,731 0.65 Share options outstanding at end of year 371,575 10.01 844,148 15.94 Share options exercisable at end of year 359,688 9.95 781,073 16.54
Schedule of Status of RSUs	A summary of the status of RSUs under the Plan as of December 31, 2023 and changes during the relevant period ended on that date is presented below: Number of Outstanding at beginning of year 457,137 Granted* 1,697,743 Vested 278,580 Forfeited and cancelled 260,605 Outstanding at end of year 1,615,695 * This includes shares granted with performance obligations which were not fulfilled as of December 31, 2023.
Schedule of Total Equity-Based Compensation Expense	The total equity-based compensation expense related to all of the Company’s equity-based awards recognized for the years ended December 31, 2023, 2022 and 2021, was comprised as follows: Year ended December 31, 2023 2022 2021 Cost of revenues 35 206 - Research and development expenses 3,010 603 3,122 Sales and marketing expenses 211 1,504 2,775 General and administrative expenses 3,859 8,203 - Total share-based payment 7,115 10,516 5,897

Additional Information to Pro_2

Additional Information to Profit or Loss Items (Tables)	12 Months Ended
	Dec. 31, 2023
Additional Information to Profit or Loss Items [Abstract]
Schedule of Additional Information to Profit or Loss	Year ended December 31, 2023 2022 2021 USD in thousands a. Cost of revenue: Salaries and related expenses 28,098 29,972 11,506 Subcontractors and consultants 8,359 12,980 8,658 Depreciation, amortization and impairment 4,757 1,659 372 Material - 461 3,701 Impairment expenses - 438 - Other 693 401 474 41,907 45,911 24,711 b. Research and development expenses: Salaries and related expenses 6,879 5,201 5,468 Other 298 406 328 7,177 5,607 5,796 Less – government grants (1,291 ) (33 ) - 5,886 5,574 5,796 c. Sales and marketing expenses: Salaries and related expenses 4,239 7,972 1,910 Advertising and public relations 236 306 37 Depreciation, amortization and impairment 6,026 12,688 727 Other 193 708 9 10,694 21,674 2,683 d. General and administrative expenses: Salaries and related expenses 8,409 16,089 4,844 Depreciation and amortization 1,463 1,680 884 Office Maintenance 1,392 1,410 303 Consulting 16,716 16,627 1,149 Legal expenses 2,713 2,157 411 Impairment expenses 10,643 14,618 - Audit and accounting 773 1,418 249 Insurance 1,622 26 (45 ) Board fees 1,168 396 131 Other 4,273 2,850 1,473 49,172 57,271 9,313 Year ended December 31, 2023 2022 2021 USD in thousands e. Other expenses, net: Governmental grants income (1,159 ) - - ELOC 1,570 RNER listing expenses 12,312 - - 12,723 - - f. Finance income and expenses: Finance income: Gain from exchange rate differences 271 19 - Interest income 213 450 5 484 469 5 Finance expenses: Loss from exchange rate differences - - 105 Bank fees 109 145 105 Changes in fair value of financial instruments 247 - - Interest expenses 6,838 1,239 86 7,194 1,384 296

Taxes on Income (Tables)

Taxes on Income (Tables)	12 Months Ended
	Dec. 31, 2023
Taxes on Income [Abstract]
Schedule of Composition and Movement in Deferred Taxes	Composition and movement in deferred taxes: In non-current In non-current USD in thousands Balance as of January 1, 2022 (4,734 ) 3,469 Charged to profit or loss 787 215 Adjustments arising from translating financial statements from functional currency to presentation currency 515 (413 ) Balance as of December 31, 2022 (3,432 ) 3,271 Charged to profit or loss 1,725 (1,686 ) Adjustments arising from translating financial statements from functional currency to presentation currency 132 (126 ) Balance as of December 31, 2023 (1,575 ) 1,459 As shown on balance sheet (2): (116 ) - (1) The deferred taxes are computed at a tax rate of 23%. (2) The deferred tax shown above is not netted off within companies. The balance sheet shows the net position.
Schedule of Taxes on Income Included in Profit or Loss	Taxes on income included in profit or loss: Year ended December 31, 2023 2022* 2021* USD in thousands Current taxes 210 131 197 Deferred taxes (39 ) (1,039 ) 65 Tax previous years - 132 - 171 (776 ) 262 * Comparative figures including the discontinued operation results.
Schedule of Reconciliation Between the Tax Expense, Assuming that all the Income and Expenses, Gains and Loss	The reconciliation between the tax expense, assuming that all the income and expenses, gains and losses in profit or loss were taxed at the statutory tax rate and the taxes on income recorded in profit or loss, is as follows: * Comparative figures including the discontinued operation results. Year ended December 31, 2023 2022 2021 USD in thousands Loss before taxes on income (84,435 ) (80,739 )* (13,153 )* Statutory tax rate 23 % 23 % 23 % Tax computed at the statutory tax rate (19,420 ) (18,570 ) (3,025 ) Increase (decrease) in taxes on income resulting from the following factors: Different tax rate applicable to foreign subsidiary (2 ) (225 ) 1 Utilization of carryforward losses for which no deferred taxes were computed in the past (98 ) - (32 ) Other losses and temporary differences for which no deferred taxes were computed 19,026 17,699 3,433 Tax previous years - 132 - Other, net 665 225 93 Taxes on income 171 (739 ) 470

Balances and Transactions wit_2

Balances and Transactions with Interested and Related Parties (Tables)	12 Months Ended
	Dec. 31, 2023
Balances and Transactions with Interested and Related Parties [Abstract]
Schedule of Balances with Interested and Related Parties	Balances with interested and related parties: For Directors Key Note USD in thousands Other accounts payable 15 200 18 Loan 66 For Controlling Key Note USD in thousands Other accounts payable 15 40 25 For Directors Key Note USD in thousands Other accounts payable 15 223 18 Highest balance of current debts during the year - 66 - For Controlling Key Note USD in thousands Other accounts payable 15 40 25 Highest balance of current debts during the year - 0 -
Schedule of Salaries and Benefits to Interested and Related Parties	Salaries and benefits to interested and related parties: Year ended December 31, 2023 2022 2021 USD in thousands Cost of sales, research and development expenses, sales and marketing expenses and general and administrative expenses, net: Salary and related benefits to CEO and director employed by the Company (controlling shareholder) including cost of share-based payment (1) 132 - - Fees of directors not employed by the Company including cost of share-based payment (7) 566 312 289 Salary and related benefits to formerly Deputy CEO including cost of share-based payment (2) 811 3,872 1,571 Salary and related benefits to the former VP Human Resources including cost of share-based payment (4) 28 1,140 544 Salary and related benefits to formerly Chairman of the Board including cost of share-based payment (3) (6) - 2,355 832 Salary and related benefits to formerly Deputy CEO and COO including cost of share-based payment (5) (6) - 1,777 803 1,537 9,456 4,039 (1) Relates to the cost of employment of Mr. Noah Hershkovitz, director of the Company as of October 3, 2023 and CEO of the Company as of December 4, 2023. (2) Relates to the cost of employment of Mr. Uzi Moskowitz director and former CEO in the Company, who no longer serves as the CEO of Company since December 4, 2023. and Eyal Moshe former director and former CEO of the Company who is also controlling shareholder in the Company, excluding any misappropriates expenses. Mr. Moshe ceased his role as CEO on February 2, 2023, and his employment was terminated effective July 24, 2023 for cause in connection with these unauthorized expenses. (3) Relates to the cost of employment of Dr. Zigmund Bluvband, formerly the Chairman of the Company’s Board. Dr. Zigmund no longer works at the Company since April 30, 2022. (4) Relates to the cost of employment of Ms. Ayelet Bitan, Chief of Staff in the Company and the spouse of Mr. Eyal Moshe, a controlling shareholder in the Company, excluding any allegedly misappropriated expenses as detailed in Note 1e. Ms. Bitan resigned in February 2023. (5) Relates to the cost of employment of Mr. Dotan Moshe, former Deputy CEO and COO in the Company, who is also the son-in-law of Dr. Zigmund Bluvband. Mr. Dotan no longer works at the Company since May 15, 2022. In February 2023 he began consulting the Company. (6) Key management personnel. (7) Other interested and related parties. * The salary and related benefits amounts including the additional expenses of the extension in 2022 of the expiry date of options as detailed in note 18f.
Schedule of Transactions with Interested and Related Parties	Transactions with interested and related parties: Controlling Key Other Total USD in thousands General and administrative expenses 141 829 566 1,537 141 829 566 1,537 Controlling Key Other Total USD in thousands General and administrative expenses 5,012 4,132 312 9,456 5,012 4,132 312 9,456

Segments (Tables)

Segments (Tables)	12 Months Ended
	Dec. 31, 2023
Segments [Abstract]
Schedule of Operations Under a Single Segment of Products and Technology	Below is data relating to business segments – before the business combination date (see Note 1 above), the Company reported its business operations under a single segment of products and technology. Year ended December 31, 2023 Professional Products Unallocated* Total USD in thousands Revenues from external customers 41,589 1,068 - 42,657 Total revenues 41,589 1,068 - 42,657 Segment results (operating loss)** (30,690 ) (33,153 ) (13,882 ) (77,725 ) Finance expenses, net 6,710 Loss before taxes on income (84,435 ) * Expenses related to RNER merger transaction)see Note 5) and ELOC (see Note 20). ** In the year ended December 31, 2023, the Company recorded impairment of goodwill and intangible assets related to professional service and product and technology segments in the amount of $12,735 thousand and $2,523 thousand, respectively. Year ended December 31, 2022 Professional Products Unallocated* Total USD in thousands Revenues from external customers 48,263 1,739 - 50,002 Total revenues 48,263 1,739 - 50,002 Segment results (operating loss) (21,582 ) (43,019 ) (15,829 ) (80,430 ) Finance expenses, net (915 ) Loss before taxes on income (81,345 ) * Expenses related to a merger transaction in 2022.
Schedule of Revenues	Israel America Europe Asia Pacific Total USD in thousands Revenues 40,364 334 1,669 290 42,657 Israel America Europe Asia Pacific Total USD in thousands Revenues 46,386 339 2,983 294 50 ,002
Schedule of Turnover with Main Customers	Main customers: USD Turnover with main customers (1): Customer A 7,602 Customer B 4,726 12,328 % of Customer A 17.82 % Customer B 11.07 % 28.89 % Year ended USD in thousands Turnover with main customers (1): Customer A 10,257 Customer B 6,706 16,963 % of 2022 Customer A 21 % Customer B 13 % 34 %

General (Details)

General (Details) ₪ in Thousands			1 Months Ended	12 Months Ended
	Apr. 20, 2023 USD ($)	Apr. 20, 2023 ILS (₪)	Jun. 30, 2021	Dec. 31, 2023 USD ($)	Dec. 31, 2023 ILS (₪)	Dec. 31, 2023 ILS (₪)
General (Details) [Line Items]
Percentage of shares			51%
Converted into ordinary share split				0.712434	0.712434
Converted into option purchase ordinary share split				0.712434	0.712434
Exercise price divided by share split				0.712434	0.712434
Share listing expense				$ 12,312
Incurred losses in the amount				186,488,000
Working capital amount				54,323,000
Operating activities				16,885,000
Loan agreement amount				16,000,000,000
Aggregated amount				2,012,000
Misappropriated amount from company account	$ 582,000	₪ 2,000
Credit card personal use amount				110,000		₪ 400
Additionally bonus amount (in New Shekels) | ₪					₪ 250
Value added tax payables (in New Shekels) | ₪						₪ 250
BST Loan Agreement [Member]
General (Details) [Line Items]
Aggregated amount				1,023,000
AKINA Capital [Member]
General (Details) [Line Items]
Warrant exercised				$ 5,000,000,000

Significant Accounting Polici_3

Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2023
Significant Accounting Policies [Abstract]
Operating cycle year	1 year

Significant Accounting Polici_4

Significant Accounting Policies (Details) - Schedule of Useful Life of Intangible Assets	12 Months Ended
	Dec. 31, 2023
Patents [Member]
Schedule of Useful Life of Intangible Assets [Line Items]
Useful life of intangible assets	10 years
Order backlog [Member]
Schedule of Useful Life of Intangible Assets [Line Items]
Useful life of intangible assets	1 year
Bottom of range [Member] | Customer relations [Member]
Schedule of Useful Life of Intangible Assets [Line Items]
Useful life of intangible assets	3 years 6 months
Bottom of range [Member] | Technology [Member]
Schedule of Useful Life of Intangible Assets [Line Items]
Useful life of intangible assets	2 years
Top of range [Member] | Customer relations [Member]
Schedule of Useful Life of Intangible Assets [Line Items]
Useful life of intangible assets	10 years
Top of range [Member] | Technology [Member]
Schedule of Useful Life of Intangible Assets [Line Items]
Useful life of intangible assets	4 years

Merger Agrrement with Special_3

Merger Agrrement with Special Purpose Acquisition Company (“Spac”) (Details) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended		12 Months Ended
	Mar. 01, 2024	Jan. 11, 2023	Mar. 31, 2023	Mar. 22, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Merger Agrrement with Special Purpose Acquisition Company (“Spac”) (Details) [Line Items]
Market value				$ 175,000,000
Enterprise value					$ 1,280,000
Options					225,000,000
Invest gross value					$ 50,000,000
Outstanding ordinary price per share (in Dollars per share)		$ 10
Pre reverse stock split	1:10
Shareholders percentage		99%
Investment value		$ 175,000,000
Amount received from investors			$ 4,000,000
Advance issuance expense						$ 872
Aggregate value percentage					1%
Shares issued					$ 1,280,000
Amount owed					12,800,000
Recorded expenses					7,194	1,384	$ 296
Business Combination [Member]
Merger Agrrement with Special Purpose Acquisition Company (“Spac”) (Details) [Line Items]
Recorded expenses					12,800	$ 5,120
Share-based Share listing expense					$ 12,312

Merger Agrrement with Special_4

Merger Agrrement with Special Purpose Acquisition Company (“Spac”) (Details) - Schedule of Fair Value of the Identifiable Net Assets - RNER [Member] $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($) $ / shares shares	[1]
Schedule of Fair Value of the Identifiable Net Assets [Line Items]
Shares issued to RNER shareholders (in Shares) | shares	453,321
Closing price of the Company’s share on Nasdaq as of March 1, 2023 (in Dollars per share) | $ / shares	$ 15.9
Fair value of the Company’s shares issued to RNER shareholders	$ 7,208
Public Warrants issued to RNER shareholders (in Shares) | shares	1,550,784
Closing price of the Company’s warrants on Nasdaq as of March 1, 2023 (in Dollars per share) | $ / shares	$ 1.7
Private Warrants issued to RNER shareholders (in Shares) | shares	53,599
Fair Value of the Company’s warrants on as of March 1, 2023 (in Dollars per share) | $ / shares	$ 1.33
Fair value of the Company’s warrants issued to RNER shareholders	$ 2,711
RNER assets	588
RNER liabilities	(2,981)
Net assets of RNER	(2,393)
IFRS 2 Listing expenses	$ 12,312
[1] Shares and per shares amounts have been retroactively adjusted to reflect the reverse stock splits as described in note 20a.

Cash and Cash Equivalents (Deta

Cash and Cash Equivalents (Details) - Schedule of Cash and Cash Equivalents - Cash and Cash Equivalents [Member] - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Schedule of Cash and Cash Equivalents [Line Items]
Total Cash and Cash Equivalents	$ 3,522	$ 3,994
Cash and cash equivalents in NIS [Member]
Schedule of Cash and Cash Equivalents [Line Items]
Total Cash and Cash Equivalents	3,201	3,112
Cash and cash equivalents in USD [Member]
Schedule of Cash and Cash Equivalents [Line Items]
Total Cash and Cash Equivalents	227	765
Cash and cash equivalents in Euro [Member]
Schedule of Cash and Cash Equivalents [Line Items]
Total Cash and Cash Equivalents	2	104
Cash and cash equivalents in other currency [Member]
Schedule of Cash and Cash Equivalents [Line Items]
Total Cash and Cash Equivalents	$ 92	$ 13

Trade Receivables, Net (Details

Trade Receivables, Net (Details)	12 Months Ended
	Dec. 31, 2023
Trade Receivables, Net [Abstract]
Outstanding debt period	120 years

Trade Receivables, Net (Detai_2

Trade Receivables, Net (Details) - Schedule of Trade Receivables, Net - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Schedule of Trade Receivables Net [Abstract]
Account receivable	$ 10,051	$ 23,317
Unbilled receivable	902	1,020
Checks collectible	27	405
Allowance for doubtful debt	(1,113)	(685)
Trade receivables, net	$ 9,867	$ 24,057

Trade Receivables, Net (Detai_3

Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables [Line Items]
Trade receivables before allowance for doubtful accounts	$ 10,980
Allowance for doubtful accounts	1,113
Past due trade receivables	9,867	$ 24,057
Past Due Trade Receivables Not past due [Member]
Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables [Line Items]
Trade receivables before allowance for doubtful accounts	4,349
Allowance for doubtful accounts
Past due trade receivables	4,349	21,147
Past Due Trade Receivables 30 days [Member]
Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables [Line Items]
Trade receivables before allowance for doubtful accounts	1,838
Allowance for doubtful accounts
Past due trade receivables	1,838	1,850
Past Due Trade Receivables 31-60 days [Member]
Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables [Line Items]
Trade receivables before allowance for doubtful accounts	1,341
Allowance for doubtful accounts
Past due trade receivables	1,341	349
Past Due Trade Receivables 60-90 days [Member]
Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables [Line Items]
Trade receivables before allowance for doubtful accounts	989
Allowance for doubtful accounts
Past due trade receivables	989	183
Past Due Trade Receivables 90-120 days [Member]
Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables [Line Items]
Trade receivables before allowance for doubtful accounts	520
Allowance for doubtful accounts
Past due trade receivables	520	145
Past Due Trade Receivables More than 120 days [Member]
Trade Receivables, Net (Details) - Schedule of Credit Risk Exposure of the Company’s Trade Receivables [Line Items]
Trade receivables before allowance for doubtful accounts	1,944
Allowance for doubtful accounts	1,113
Past due trade receivables	$ 742	$ 383

Other Assets (Details)

Other Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2023		Nov. 30, 2023	Dec. 31, 2022
Other Assets [Abstract]
Grants receivables	$ 1,159	[1]	$ 1,159		[1]
[1]In November 2023, the Company has been granted $1,159 thousand war grants associated with Israel-Hamas war.

Other Assets (Details) - Schedu

Other Assets (Details) - Schedule of Other Assets - USD ($) $ in Thousands	Dec. 31, 2023		Nov. 30, 2023	Dec. 31, 2022
Schedule Of Other Assets Abstract
Government authorities	$ 1,604			$ 1,127
Prepaid expenses	1,483			460
Grants receivables (1)	1,159	[1]	$ 1,159		[1]
Other receivables	837			85
Other assets	$ 5,083			$ 1,672
[1]In November 2023, the Company has been granted $1,159 thousand war grants associated with Israel-Hamas war.

Leases (Details)

Leases (Details) ₪ in Thousands, $ in Thousands			12 Months Ended
	May 31, 2017 USD ($) m²	May 31, 2017 ILS (₪) m²	Dec. 31, 2023 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2021 ILS (₪)	Dec. 31, 2019 USD ($)	Dec. 31, 2019 ILS (₪)
Leases (Details) [Line Items]
Leases term	10 years	10 years		5 years	5 years	2 years	2 years
Extension options term	5 years	5 years	5 years	5 years	5 years	2 years	2 years
lease of offices area (in Square Meters)	1,600	1,600
Monthly lease fees	$ 30	₪ 110	$ 13	$ 81	₪ 300	$ 5	₪ 18
Lease agreement terms						2 years	2 years
Motor Vehicles [Member]
Leases (Details) [Line Items]
Leases term			12 months
Bottom of range [Member]
Leases (Details) [Line Items]
Leases term			3 years
Bottom of range [Member] | Buildings [Member]
Leases (Details) [Line Items]
Leases term			2 years
Bottom of range [Member] | Motor Vehicles [Member]
Leases (Details) [Line Items]
Leases term			3 years
Top of range [Member]
Leases (Details) [Line Items]
Leases term			10 years
Top of range [Member] | Buildings [Member]
Leases (Details) [Line Items]
Leases term			10 years
Top of range [Member] | Motor Vehicles [Member]
Leases (Details) [Line Items]
Leases term			4 years

Leases (Details) - Schedule of

Leases (Details) - Schedule of Information on Leases - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule of Information on Leases [Abstract]
Interest expense on lease liabilities	$ 181	$ 258	$ 210
Total cash outflow for leases	$ 1,711	$ 2,240	$ 1,175

Leases (Details) - Schedule o_2

Leases (Details) - Schedule of Right-of-Use Assets, Net - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Jan. 01, 2022
Cost [Member]
Leases (Details) - Schedule of Right-of-Use Assets, Net [Line Items]
Beginning balance	$ 9,025	$ 8,772
Additions during the year:
New leases	643	954
Terminated lease	(3,041)
Classification	71
Adjustments arising from indexation	137	379
Other	(19)
Adjustments arising from translating financial statements from functional currency to presentation currency and indexation	(274)	(1,080)
Ending balance	6,542	9,025
Cost [Member] | Office lease [Member]
Leases (Details) - Schedule of Right-of-Use Assets, Net [Line Items]
Beginning balance	7,231	7,510
Additions during the year:
New leases		243
Terminated lease	(2,961)
Classification
Adjustments arising from indexation	137	379
Other	(19)
Adjustments arising from translating financial statements from functional currency to presentation currency and indexation	(264)	(901)
Ending balance	4,124	7,231
Cost [Member] | Motor Vehicles [Member]
Leases (Details) - Schedule of Right-of-Use Assets, Net [Line Items]
Beginning balance	1,794	1,262
Additions during the year:
New leases	643	711
Terminated lease	(80)
Classification	71
Adjustments arising from indexation
Other
Adjustments arising from translating financial statements from functional currency to presentation currency and indexation	(10)	(179)
Ending balance	2,418	1,794
Accumulated depreciation [Member]
Leases (Details) - Schedule of Right-of-Use Assets, Net [Line Items]
Beginning balance	2,518	537
Additions during the year:
Depreciation in the year	1,563	2,140
Adjustments arising from translating financial statements from functional currency to presentation currency and indexation	(49)	(159)
Ending balance	4,032	2,518
Depreciated cost as of December 31, 2022		6,507	$ 2,510
Accumulated depreciation [Member] | Office lease [Member]
Leases (Details) - Schedule of Right-of-Use Assets, Net [Line Items]
Beginning balance	1,528	168
Additions during the year:
Depreciation in the year	1,033	1,445
Adjustments arising from translating financial statements from functional currency to presentation currency and indexation	(28)	(85)
Ending balance	2,533	1,528
Depreciated cost as of December 31, 2022		5,703	1,591
Accumulated depreciation [Member] | Motor Vehicles [Member]
Leases (Details) - Schedule of Right-of-Use Assets, Net [Line Items]
Beginning balance	990	369
Additions during the year:
Depreciation in the year	530	695
Adjustments arising from translating financial statements from functional currency to presentation currency and indexation	(20)	(74)
Ending balance	$ 1,500	990
Depreciated cost as of December 31, 2022		$ 804	$ 918

Property and Equipment (Details

Property and Equipment (Details) - Schedule of Composition and Movement of Property and Equipment - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Cost [Member]
Cost:
Balance	$ 1,828	$ 1,393
Purchases in the year	297	885
Disposals during the year	(253)	(261)
Adjustments arising from translating financial statements from functional currency to presentation currency	(53)	(189)
Balance	1,819	1,828
Cost [Member] | Motor vehicles [Member]
Cost:
Balance	197	258
Purchases in the year		1
Disposals during the year	(156)	(35)
Adjustments arising from translating financial statements from functional currency to presentation currency	(8)	(27)
Balance	33	197
Cost [Member] | Office furniture and equipment [Member]
Cost:
Balance	235	291
Purchases in the year	8	99
Disposals during the year		(121)
Adjustments arising from translating financial statements from functional currency to presentation currency	(7)	(34)
Balance	236	235
Cost [Member] | Computers and peripheral equipment [Member]
Cost:
Balance	798	572
Purchases in the year	251	412
Disposals during the year		(105)
Adjustments arising from translating financial statements from functional currency to presentation currency	(19)	(81)
Balance	1,030	798
Cost [Member] | Leasehold improvements [Member]
Cost:
Balance	598	272
Purchases in the year	38	373
Disposals during the year	(97)
Adjustments arising from translating financial statements from functional currency to presentation currency	(19)	(47)
Balance	520	598
Accumulated depreciation [Member]
Cost:
Balance	514	247
Depreciation in the year	341	309
Disposals during the year	(61)
Adjustments arising from translating financial statements from functional currency to presentation currency	(10)	(42)
Balance	784	514
Depreciated cost	1,035	1,314
Accumulated depreciation [Member] | Motor vehicles [Member]
Cost:
Balance	53	19
Depreciation in the year	21	38
Disposals during the year	(43)
Adjustments arising from translating financial statements from functional currency to presentation currency	(1)	(4)
Balance	30	53
Depreciated cost	3	144
Accumulated depreciation [Member] | Office furniture and equipment [Member]
Cost:
Balance	89	20
Depreciation in the year	21	74
Disposals during the year
Adjustments arising from translating financial statements from functional currency to presentation currency	(2)	(5)
Balance	108	89
Depreciated cost	128	146
Accumulated depreciation [Member] | Computers and peripheral equipment [Member]
Cost:
Balance	296	180
Depreciation in the year	239	143
Disposals during the year
Adjustments arising from translating financial statements from functional currency to presentation currency	(5)	(27)
Balance	530	296
Depreciated cost	500	502
Accumulated depreciation [Member] | Leasehold improvements [Member]
Cost:
Balance	76	28
Depreciation in the year	60	54
Disposals during the year	(18)
Adjustments arising from translating financial statements from functional currency to presentation currency	(2)	(6)
Balance	116	76
Depreciated cost	$ 404	$ 522

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets, Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets [Line Items]
Goodwill	$ 1
Acquired assets	10,000
Additional contingent consideration	$ 12,000
Agreement terms	2 years 6 months
Remaining consideration liability	$ 5,078	$ 3,839
Other liabilities		375
Impairment loss	$ 1,900	$ 8,738
Discount rate	20%
Growth rate	2%
Professional services CGU [Member]
Goodwill and Intangible Assets [Line Items]
Impairment amount	$ 8,336
ALD Software [Member]
Goodwill and Intangible Assets [Line Items]
Discount rate	20%
Impairment amount	$ 651
Consulting and Distributions and Dstorm [Member]
Goodwill and Intangible Assets [Line Items]
Discount rate	17%
Growth rate	2%
Impairment amount	$ 4,399
Consulting and Distributions and Dstorm [Member] | ALD Software [Member]
Goodwill and Intangible Assets [Line Items]
Impairment amount	1,872
Growth rate used to extrapolate cash flows beyond the forecast period [Member]
Goodwill and Intangible Assets [Line Items]
Impairment amount	$ 219
Key Managements Personnel of Entity or Parent [Member]
Goodwill and Intangible Assets [Line Items]
Discount rate	17%
Consulting and distribution and Dstorm [Member]
Goodwill and Intangible Assets [Line Items]
Impairment amount	$ 1,047
key Assumption [Member]
Goodwill and Intangible Assets [Line Items]
Impairment amount	$ 707
Long-term growth rate	1%

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023		Dec. 31, 2022		Dec. 31, 2021
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Purchases in the year				$ 5,405
Net balance		7,883		29,900
Patents [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Net balance		13		23
Goodwill [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Net balance		2,467		13,702
Customer Relations order Backlog [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Net balance		5,403		15,710
Technology [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Net balance	[1]			465
At cost [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Balance as of beginning		35,683		55,492
Purchases in the year				9,966
Impairment recognized in the year		(15,258)	[2]	(23,356)
Adjustments arising from translating financial statements from functional currency to presentation currency		(1,240)		(6,419)
Balance as of ending		19,185		35,683		55,492
At cost [Member] | Patents [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Balance as of beginning		32		20
Purchases in the year				13
Impairment recognized in the year			[2]
Adjustments arising from translating financial statements from functional currency to presentation currency		(1)		(1)
Balance as of ending		31		32		20
At cost [Member] | Goodwill [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Balance as of beginning		13,702		31,992
Purchases in the year
Impairment recognized in the year		(10,643)	[2]	(14,618)
Adjustments arising from translating financial statements from functional currency to presentation currency		(592)		(3,672)
Balance as of ending		2,467		13,702		31,992
At cost [Member] | Customer Relations order Backlog [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Balance as of beginning		20,823		22,273
Purchases in the year				9,453
Impairment recognized in the year		(4,615)	[2]	(8,300)
Adjustments arising from translating financial statements from functional currency to presentation currency		(613)		(2,603)
Balance as of ending		15,595		20,823		22,273
At cost [Member] | Technology [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Balance as of beginning	[1]	1,126		1,207
Purchases in the year				500
Impairment recognized in the year			[1],[2]	(438)
Adjustments arising from translating financial statements from functional currency to presentation currency	[1]	(34)		(143)
Balance as of ending		1,092		1,126	[1]	1,207	[1]
Accumulated amortization [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Balance as of beginning		5,783		883
Amortization recognized in the year	[2]	5,733		5,348
Adjustments arising from translating financial statements from functional currency to presentation currency		(214)		(448)
Balance as of ending		11,302		5,783		883
Accumulated amortization [Member] | Patents [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Balance as of beginning		9		7
Amortization recognized in the year	[2]	9		2
Adjustments arising from translating financial statements from functional currency to presentation currency
Balance as of ending		18		9		7
Accumulated amortization [Member] | Goodwill [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Balance as of beginning
Amortization recognized in the year	[2]
Adjustments arising from translating financial statements from functional currency to presentation currency
Balance as of ending
Accumulated amortization [Member] | Customer Relations order Backlog [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Balance as of beginning		5,113		801
Amortization recognized in the year	[2]	5,278		4,723
Adjustments arising from translating financial statements from functional currency to presentation currency		(199)		(411)	[1]
Balance as of ending		10,192		5,113		801
Accumulated amortization [Member] | Technology [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Composition and Movement [Line Items]
Balance as of beginning	[1]	661		75
Amortization recognized in the year	[1],[2]	446		623
Adjustments arising from translating financial statements from functional currency to presentation currency		(15)	[1]	(37)
Balance as of ending	[1]	$ 1,092		$ 661		$ 75
[1] Technology and supplier relationships amortization expenses are classified in the statement of profit or loss under cost of sales expenses. Patents amortization expenses are classified in the statement of profit or loss under General and administrative expenses. Customer relations, order backlog and brand amortization expenses are classified in the statement of profit or loss under sales and marketing expenses.

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets, Net (Details) - Schedule of Purchase Price Allocation $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Goodwill and Intangible Assets, Net (Details) - Schedule of Purchase Price Allocation [Line Items]
Total consideration	$ 9,953
Technology [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Purchase Price Allocation [Line Items]
Total consideration	500
Customer relationship [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of Purchase Price Allocation [Line Items]
Total consideration	$ 9,453

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets, Net (Details) - Schedule of the Goodwill and the Intangible Assets ₪ in Thousands, $ in Thousands			12 Months Ended
	May 31, 2017 USD ($)	May 31, 2017 ILS (₪)	Dec. 31, 2023 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2021 ILS (₪)	Dec. 31, 2019 USD ($)	Dec. 31, 2019 ILS (₪)
Goodwill and Intangible Assets, Net (Details) - Schedule of the Goodwill and the Intangible Assets [Line Items]
Professional Services	$ 30	₪ 110	$ 13	$ 81	₪ 300	$ 5	₪ 18
ALD Software
Dstorm
Consulting and Distribution
Total			13
Patent [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of the Goodwill and the Intangible Assets [Line Items]
Professional Services			13
ALD Software
Dstorm
Consulting and Distribution
Total			13
Goodwill [member]
Goodwill and Intangible Assets, Net (Details) - Schedule of the Goodwill and the Intangible Assets [Line Items]
Professional Services			1,422
ALD Software			1,045
Dstorm
Consulting and Distribution
Total			2,467
Customer relationship, suppliers Relationship and backlog [Member]
Goodwill and Intangible Assets, Net (Details) - Schedule of the Goodwill and the Intangible Assets [Line Items]
Professional Services			2,513
ALD Software			1,171
Dstorm
Consulting and Distribution			4,199
Total			$ 7,883

Discontinued Operations (Detail

Discontinued Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Discontinued Operations (Details) [Line Items]
Impairment loss	$ 1,900	$ 8,738
Discontinued operations [Member]
Discontinued Operations (Details) [Line Items]
Account receivables	$ 431

Discontinued Operations (Deta_2

Discontinued Operations (Details) - Schedule of Operating Attributed to Discontinued Operation - Discontinued operations [member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Discontinued Operations (Details) - Schedule of Operating Attributed to Discontinued Operation [Line Items]
Revenues from sales	$ 5,459	$ 29,741	$ 2,987
Cost of sales	(5,931)	(27,383)	(2,713)
Gross profit (loss)	(472)	2,358	274
Sales and marketing expenses	351	1,126	91
General and administrative expenses	851	308	54
Operating income (loss)	(1,674)	924	129
Finance expenses, net	356	317	22
Income before taxes on income	(2,030)	607	107
Taxes on income		37
Income (loss) after taxes on income	$ (2,030)	$ 569	$ 107

Discontinued Operations (Deta_3

Discontinued Operations (Details) - Schedule of Net Cash Flows Provided by (used in) the Discontinued Operation - Discontinued operations [member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Condensed Cash Flow Statements, Captions [Line Items]
Net cash provided by (used in) discontinued operating activities	$ 1,917	$ 1,867	$ (638)
Net cash provided by (used in) discontinued investing activities	(1,026)	949	730
Net cash used in discontinued financing activities	(1,375)	(2,429)
Total net cash provided by (used in) discontinued operation	$ (484)	$ 387	$ 92

Short-Term Loan (Details)

Short-Term Loan (Details) ₪ in Thousands, $ in Thousands

12 Months Ended

Sep. 30, 2023

May 30, 2023 USD ($)

Jan. 30, 2023 USD ($)

Jan. 30, 2023 ILS (₪)

Aug. 31, 2022 USD ($)

Sep. 30, 2021 USD ($)

Jul. 31, 2020 USD ($)

Dec. 31, 2023 USD ($)

Dec. 31, 2023 ILS (₪)

May 30, 2023 ILS (₪)

Aug. 31, 2022 ILS (₪)

Sep. 30, 2021 ILS (₪)

Jul. 31, 2020 ILS (₪)

Short Term Loan [Line Items]

Principal amount

$ 1,934

$ 1,452

₪ 6,000

₪ 5,000

Remaining principal amount

$ 118

Interest of Prime

12%

12%

7.25%

Aggregate principal amount

6,000,000

Loan interest

$ 112

Bank loans | ₪

₪ 428

Subsidiary’s adjusted equity (in New Shekels) | ₪

₪ 500

Interest lower

10%

10%

Comsec Ltd [Member]

Short Term Loan [Line Items]

Principal amount

$ 309

$ 110

₪ 980

Annual interest

1.50%

Comsec [Member]

Short Term Loan [Line Items]

Principal amount

906

Remaining principal amount

5,497

Aggregate principal amount

9,692

₪ 34,106

Aginix [Member]

Short Term Loan [Line Items]

Principal amount

$ 274

₪ 1,000

Qpoint [Member]

Short Term Loan [Line Items]

Principal amount

$ 469

₪ 1,700

Remaining principal amount

380

Interest of Prime

1.01%

HUB Israel [Member]

Short Term Loan [Line Items]

Remaining principal amount

1,041

Aggregate principal amount

$ 900

₪ 3,300

Repayable of instalment of debt

$ 1,000,000

Instalments One [Member]

Short Term Loan [Line Items]

Annual interest

1.50%

1.50%

Instalments Two [Member]

Short Term Loan [Line Items]

Annual interest

1.95%

1.95%

Remaining principal amount

831

Financial covenants [Member]

Short Term Loan [Line Items]

Bank loans

118

Bank Loans [Member]

Short Term Loan [Line Items]

Bank loans

$ 7,345

₪ 26,642

Short-Term Loan (Details) - Sch

Short-Term Loan (Details) - Schedule of Composition - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
Short Term Loan [Abstract]
Short-term loan	[1],[2],[3],[4],[5],[6],[7],[8]	$ 11,750	$ 13,417
Accrued interest		128	15
Total short term loan		$ 11,878	$ 13,432
[1] Loan received in August 2022, by Aginix, a second-tier subsidiary, with an original principal amount of NIS 1,000 thousand ($274 thousand) and repayable in 10 instalments from June 2023. The loan bearing interest of 7.25%. As of December 31, 2023 the remaining principal amount is $118 thousand. Loan received in January 2023, by HUB, in an aggregate principal amount of NIS 3,300 thousand ($900 thousand) and repayable in one instalment in January 2026 in an amount of $1,000 thousand. Loan received in July 2020, by Comsec Distribution (fully owned subsidiary), with an original principal amount of NIS 5,000 thousand $)1,452 thousand), bearing annual interest of Prime (Bank of Israel intrabank plus 1.5%) + 1.95%. and repayable in 24 instalments from July 2022. As of December 31, 2023 the remaining principal amount is $906 thousand. Loan received in May 2023, by Qpoint, with an original principal amount of NIS 1,700 thousand ($469 thousand) and repayable in 12 instalments from June 2023. The loan bearing interest of Prime + 1.01%. As of December 31, 2023 the remaining principal amount is $380 thousand. Loan received in September 2021, by Comsec Ltd (fully owned subsidiary), with an original principal amount of NIS 6,000 thousand ($1,934 thousand) and repayable in two annual instalments from September 2023, linked and bearing annual interest of Prime (Bank of Israel intrabank plus 1.5%) + 1.95%. As of December 31, 2023 the remaining principal amount is $831 thousand. Loan received in September 2021, by Comsec Ltd (fully owned subsidiary), with an original principal amount of NIS 980 thousand ($309 thousand), unlinked and bearing annual interest of Prime (Bank of Israel intrabank) + 1.5%. As of December 31, 2023 the remaining principal amount is $110 thousand. On-call loans received by Comsec, in an aggregate principal amount of NIS 34,106 thousand ($9,692 thousand). As of December 31, 2023 the remaining principal amount is $5,497 thousand.

Trade Payables (Details) - Sche

Trade Payables (Details) - Schedule of Trade Payables - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Schedule of Trade Payables [Abstract]
Open debts	$ 9,101	$ 12,410
Checks payable	766	1,361
Total Trade Payables	$ 9,867	$ 13,771

Other Accounts Payable (Details

Other Accounts Payable (Details) - Schedule of Other Accounts Payable - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Schedule of Other Accounts Payable [Abstract]
Employees and payroll accruals	$ 4,691	$ 5,797
Accrued vacation pay	1,225	1,510
Government authorities	1,282	1,997
Accrued expenses	23,067	12,636
Current liability of government grants	265	402
Liability on account of shares issuance		2,289
Deferred revenues	1,205	611
Other	692	80
Total other accounts payable	$ 32,427	$ 25,322

Long-Term Liabilities (Details)

Long-Term Liabilities (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Long-Term Liabilities (Details) [Line Items]
Payment percentage	3.50%
Grants received percentage	100%
Expected term	10 years
Discount rate	11.50%
HUB [Member]
Long-Term Liabilities (Details) [Line Items]
Grant received	$ 973
ALD [Member]
Long-Term Liabilities (Details) [Line Items]
Grant received	1,873
ALD Software [Member]
Long-Term Liabilities (Details) [Line Items]
Payable amount	$ 467

Long-Term Liabilities (Detail_2

Long-Term Liabilities (Details) - Schedule of Other Long Term Liabilities - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Other Long Term Liabilities [Abstract]
Effective interest rate liabilities for government grants	11.50%	11.50%
Balance liabilities for government grants	$ 412	$ 1,289
Balance less current maturities liabilities for government grants	$ 147	$ 887

Long-Term Liabilities (Detail_3

Long-Term Liabilities (Details) - Schedule of Government Grants - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Government Grants [Abstract]
Balance at beginning	$ 1,289	$ 961
Grants received during the year		77
Liability revaluation	(877)	251
Balance at ending	$ 412	$ 1,289

Long-Term Liabilities (Detail_4

Long-Term Liabilities (Details) - Schedule of Presented in the Statement of Financial Position - Long Term Liabilities [Member] - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Schedule of Presented in the Statement of Financial Position [Line Items]
In current liabilities	$ 265	$ 402
In non-current liabilities	147	887
Total	$ 412	$ 1,289

Long-Term Liabilities (Detail_5

Long-Term Liabilities (Details) - Schedule of Lease Liabilities and Other Long Term Liabilities $ in Thousands	Dec. 31, 2023 USD ($)
Long-Term Liabilities (Details) - Schedule of Lease Liabilities and Other Long Term Liabilities [Line Items]
Lease liabilities	$ 1,528
Liabilities for government grants	412
Total	1,940
First year [Member]
Long-Term Liabilities (Details) - Schedule of Lease Liabilities and Other Long Term Liabilities [Line Items]
Lease liabilities	382
Liabilities for government grants	265
Total	647
Second year [Member]
Long-Term Liabilities (Details) - Schedule of Lease Liabilities and Other Long Term Liabilities [Line Items]
Lease liabilities	382
Liabilities for government grants	30
Total	412
Third year [Member]
Long-Term Liabilities (Details) - Schedule of Lease Liabilities and Other Long Term Liabilities [Line Items]
Lease liabilities	382
Liabilities for government grants	21
Total	403
Fourth year [Member]
Long-Term Liabilities (Details) - Schedule of Lease Liabilities and Other Long Term Liabilities [Line Items]
Lease liabilities	382
Liabilities for government grants	19
Total	401
Fifth year [Member]
Long-Term Liabilities (Details) - Schedule of Lease Liabilities and Other Long Term Liabilities [Line Items]
Lease liabilities
Liabilities for government grants	18
Total	18
Sixth year and onwards [Member]
Long-Term Liabilities (Details) - Schedule of Lease Liabilities and Other Long Term Liabilities [Line Items]
Lease liabilities
Liabilities for government grants	59
Total	$ 59

Financials Liabilities (Details

Financials Liabilities (Details) $ / shares in Units, ₪ in Thousands												1 Months Ended	2 Months Ended	12 Months Ended
	May 09, 2024 USD ($) $ / shares	Sep. 30, 2023 USD ($)	Aug. 17, 2023 $ / shares	Aug. 10, 2023 USD ($)	Jun. 11, 2023	May 08, 2023 USD ($) shares	May 04, 2023 USD ($)	Feb. 28, 2023 $ / shares	Feb. 23, 2023 USD ($)	Feb. 23, 2023 ILS (₪)	May 26, 2010	Sep. 30, 2022 USD ($)	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2023 ILS (₪) shares	Dec. 31, 2022 $ / shares	Mar. 31, 2022 shares
Financials Liabilities (Details) [Line Items]
Convertible loan agreement									$ 500,000	₪ 5,000
Percentage of annual rate									8%	8%
Conversion price per share (in Dollars per share) | $ / shares			$ 2											$ 1.5
Legal and commitment fee		3.50%			35%
Trading days					5,000,000
Conversion price discount					40%
Average price percentage					40%
Pay a commission	$ 1,151			$ 1,151,000										$ 125,000	₪ 467
Consulting fee				$ 96,000
Warrants to purchase (in New Shekels) | ₪															₪ 375
Issuance and sale price						$ 6,000,000
Issuance of warrants						$ 7,200,000
Ordinary shares (in Shares) | shares						2,458,210							2,215,373	1,412,925	1,412,925
Initial funding		$ 4,500,000
Commitment fee received		$ 1,500,000										$ 50
Issuance and sale price														$ 3,781,000
Issuance of additional warrants														12,000,000
Repayment amount														600,000
Increase monthly payment														$ 1,500,000
Percentage of repayment share price														90%	90%
Converted an aggregated amount													$ 4,800,000
Purchased an aggregate principal amount														$ 2,700,000
Weighted average price per share (in Dollars per share) | $ / shares														$ 1.83
Weighted average price, percentage														75%	75%
Issued ordinary shares (in Shares) | shares																	40,000
Weighted average exercise price (in Dollars per share) | $ / shares														$ 12.8		$ 4.69
Owned ordinary shares											7%			4.99%	4.99%
Total consideration amount														$ 4,779,000
Loan amount													$ 10,604,000	$ 10,604,000
Warrant exercise price (in Dollars per share) | $ / shares	$ 0.8							$ 11.5
Warrant issued and outstanding of ordinary shares (in Dollars per share) | $ / shares														$ 0.899
Converted warrant (in Dollars per share) | $ / shares														$ 0.899
Warrants to purchase share (in Shares) | shares														1,604,383	1,604,383
Exercise price per share (in Dollars per share) | $ / shares													$ 127.9	$ 127.9
Ordinary shares [Member]
Financials Liabilities (Details) [Line Items]
Ordinary shares (in Shares) | shares														1	1
Repayment amount of shares (in Shares) | shares														1.05	1.05
Weighted average price per share (in Dollars per share) | $ / shares														$ 2.5
Issued ordinary shares (in Shares) | shares													1,150,217	1,150,217
Private Warrants [Member]
Financials Liabilities (Details) [Line Items]
Warrant issued (in Shares) | shares														53,599	53,599
Public Warrants [Member]
Financials Liabilities (Details) [Line Items]
Warrant issued (in Shares) | shares														1,550,784	1,550,784
Convertible Loans [Member]
Financials Liabilities (Details) [Line Items]
Convertible loan agreement									$ 2,800,000	₪ 10,000
Pay a commission | ₪															₪ 375
Warrants to purchase							$ 16,000,000
Convertible Loan Agreements [Member]
Financials Liabilities (Details) [Line Items]
Convertible loan agreement									$ 1,400,000	₪ 1,850
Loan commitments [member]
Financials Liabilities (Details) [Line Items]
Pay a commission														$ 105,000	₪ 375
Second Tranche [Member]
Financials Liabilities (Details) [Line Items]
Issuance and sale price														$ 10,000,000
Exercise Price [Member]
Financials Liabilities (Details) [Line Items]
Weighted average exercise price (in Dollars per share) | $ / shares														$ 2.43

Financials Liabilities (Detai_2

Financials Liabilities (Details) - Schedule of Recurring Basis and Indicates the Fair Value Hierarchy of the Valuation Inputs $ in Thousands	Dec. 31, 2023 USD ($)
Level 1 [Member]
Financials Liabilities (Details) - Schedule of Recurring Basis and Indicates the Fair Value Hierarchy of the Valuation Inputs [Line Items]
Public warrants	$ 217
Total	217
Level 3 [Member]
Financials Liabilities (Details) - Schedule of Recurring Basis and Indicates the Fair Value Hierarchy of the Valuation Inputs [Line Items]
Public warrants	5,830
Conversion component of convertible loans	4,215
Total	$ 10,045

Financials Liabilities (Detai_3

Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans - 12 months ended Dec. 31, 2023	$ / shares	₪ / shares
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Exercise price (in Dollars per share) | ₪ / shares		₪ 67.48
Underlying share price (in Dollars per share)	$ 5.13
IRR	20.63%	20.63%
Private Warrants [Member]
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Risk-free interest rate	3.91%	3.91%
Expected term (years)	4 years 2 months 1 day	4 years 2 months 1 day
Expected volatility	86.60%	86.60%
Exercise price (in Dollars per share)	$ 103.39
Underlying share price (in Dollars per share)	$ 2.17
Shyana- February Loan Agreement [Member]
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Risk-free interest rate	4.38%	4.38%
Expected term (years)	1 year 1 month 24 days	1 year 1 month 24 days
Expected volatility	132.85%	132.85%
Underlying share price (in Dollars per share)	$ 2.17
Shyana February Loan Agreement Black Scholes Option [Member]
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Risk-free interest rate	4.27%	4.27%
Expected term (years)	2 years	2 years
Expected volatility	124.90%	124.90%
Exercise price (in Dollars per share)	$ 0.5
Underlying share price (in Dollars per share)	$ 2.17
Shyana June Loan Agreement Monte Carlo Conversion component [Member]
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Risk-free interest rate	4.34%	4.34%
Expected term (years)	1 year 5 months 12 days	1 year 5 months 12 days
Expected volatility	122.86%	122.86%
Underlying share price (in Dollars per share)	$ 2.17
Shyana July Loan Agreement Monte Carlo Conversion component [Member]
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Risk-free interest rate	4.33%	4.33%
Expected term (years)	1 year 6 months 7 days	1 year 6 months 7 days
Expected volatility	121.43%	121.43%
Underlying share price (in Dollars per share)	$ 2.17
Shyana July Loan Agreement Black Scholes option [Member]
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Risk-free interest rate	4.33%	4.33%
Expected term (years)	2 years	2 years
Expected volatility	124.90%	124.90%
Exercise price (in Dollars per share)	$ 0.76
Underlying share price (in Dollars per share)	$ 2.17
Lind- Conversion Component [Member]
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Risk-free interest rate	5.09%	5.09%
Expected term (years)	6 months	6 months
Expected volatility	157.17%	157.17%
Underlying share price (in Dollars per share)	$ 2.17
Bottom of range [member]
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Exercise price (in Dollars per share) | (per share)	$ 0.04	₪ 0.14
Bottom of range [member] | AGP- Conversion Component [Member]
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Risk-free interest rate	3.90%	3.90%
Expected term (years)	4 years 4 months 6 days	4 years 4 months 6 days
Expected volatility	112.38%	112.38%
Exercise price (in Dollars per share)	$ 3.5
Underlying share price (in Dollars per share)	2.17
Bottom of range [member] | Vendor- Conversion Component [Member]
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Underlying share price (in Dollars per share)	5.13
Top of range [member]
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Exercise price (in Dollars per share) | (per share)	0.04	₪ 18.6
Top of range [member] | AGP- Conversion Component [Member]
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Underlying share price (in Dollars per share)	$ 5.19
IRR	20.63%	20.63%
Top of range [member] | Vendor- Conversion Component [Member]
Financials Liabilities (Details) - Schedule of Conversion Component of Convertible Loans [Line Items]
Underlying share price (in Dollars per share)	$ 5.19

Financials Liabilities (Detai_4

Financials Liabilities (Details) - Schedule of Presents the Changes in the Fair Value of Liabilities	12 Months Ended
	Dec. 31, 2023 USD ($)
Financials Liabilities (Details) - Schedule of Presents the Changes in the Fair Value of Liabilities [Line Items]
Fair value as of December 31, 2022
Warrants issued in related to the RNER transaction	2,710,000
Issuance of conversion component related to the convertible loans.	4,779,000
Issuance of warrants related to the convertible loans	3,781,000
Conversion of convertible loans into ordinary shares	(1,427,000)
Change in fair value	247,000
Adjustments arising from translating financial statements from functional currency to presentation currency	172,000
Fair value as of December 31, 2023	10,262,000
Public Warrants [Member]
Financials Liabilities (Details) - Schedule of Presents the Changes in the Fair Value of Liabilities [Line Items]
Fair value as of December 31, 2022
Warrants issued in related to the RNER transaction	2,639
Issuance of conversion component related to the convertible loans.
Issuance of warrants related to the convertible loans
Conversion of convertible loans into ordinary shares
Change in fair value	(2,466)
Adjustments arising from translating financial statements from functional currency to presentation currency	44
Fair value as of December 31, 2023	217
Private Warrants [Member]
Financials Liabilities (Details) - Schedule of Presents the Changes in the Fair Value of Liabilities [Line Items]
Fair value as of December 31, 2022
Warrants issued in related to the RNER transaction	71,000
Issuance of conversion component related to the convertible loans.
Issuance of warrants related to the convertible loans	3,781,000
Conversion of convertible loans into ordinary shares
Change in fair value	1,928,000
Adjustments arising from translating financial statements from functional currency to presentation currency	50,000
Fair value as of December 31, 2023	5,830,000
Conversion Component [Member]
Financials Liabilities (Details) - Schedule of Presents the Changes in the Fair Value of Liabilities [Line Items]
Fair value as of December 31, 2022
Warrants issued in related to the RNER transaction
Issuance of conversion component related to the convertible loans.	4,779,000
Issuance of warrants related to the convertible loans
Conversion of convertible loans into ordinary shares	(1,427,000)
Change in fair value	785,000
Adjustments arising from translating financial statements from functional currency to presentation currency	78,000
Fair value as of December 31, 2023	$ 4,215,000

Financial Instruments (Details)

Financial Instruments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Financial Instruments (Details) [Line Items]
Interest rate	11.50%	11.50%
Cash and cash equivalents amount (in Dollars)	$ 3,522
Israel [Member]
Financial Instruments (Details) [Line Items]
Interest rate	1.50%
Israel [Member] | Top of range [Member]
Financial Instruments (Details) [Line Items]
Interest rate	0.70%
Israel [Member] | Top of range [member]
Financial Instruments (Details) [Line Items]
Interest rate	4.85%

Financial Instruments (Detail_2

Financial Instruments (Details) - Schedule of Financial Assets at Amortized Cost - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Schedule of Financial Assets At Amortized Cost [Abstract]
Trade and other assets	$ 14,950	$ 25,729
Restricted bank deposit	61	1,516
Total current assets	15,011	27,245
Long-term deposit	328	3,002
Total non-current assets	$ 328	$ 3,002

Financial Instruments (Detail_3

Financial Instruments (Details) - Schedule of Other Financial Liabilities - USD ($) $ in Thousands		Dec. 31, 2023	Dec. 31, 2022
Schedule of Other Financial Liabilities [Abstract]
Short-term loans	[1]	$ 11,878	$ 13,432
Convertible loans		14,449
Trade payables		9,867	13,771
Other accounts payable		32,427	25,322
Liabilities for government grants		412	1,289
Total other financial liabilities at amortized cost		69,033	53,814
Total current liabilities		68,886	52,927
Total non-current liabilities		$ 147	$ 887
[1] The interest rate is Prime (Bank of Israel intrabank plus 1.5%) + 0.7%-4.85%.

Net Employee Defined Benefit _3

Net Employee Defined Benefit Liabilities (Details) - Schedule of Defined Contribution Plans - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Defined Contribution Plans [Abstract]
Expenses in respect of defined contribution plans	$ 2,264	$ 2,562

Net Employee Defined Benefit _4

Net Employee Defined Benefit Liabilities (Details) - Schedule of Defined Benefit Obligation and Fair Value of Plan Assets - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Defined benefit obligation [Member]
Schedule of Defined Benefit Obligation and Fair Value of Plan Assets [Line Items]
Balance at beginning	$ 3,163	$ 4,838
Current service cost	152	198
Net interest expense	150	120
Past service cost and effect of settlements	(212)
Total expense recognized in profit or loss for the period	90	318
Payments from the plan	(36)	(1,376)
Return on plan assets (excluding amounts included in net interest expenses)
Actuarial gain (loss) arising from changes in demographic assumptions
Actuarial gain (loss) arising from changes in financial assumptions	(24)	(258)
Actuarial gain (loss) arising from experience adjustments	36	151
Total effect on other comprehensive income for the period	12	(107)
Effect of changes in foreign exchange rates	(94)	(511)
by employer
by plan’s participants
Balance at ending	3,135	3,163
Fair value of plan assets [Member]
Schedule of Defined Benefit Obligation and Fair Value of Plan Assets [Line Items]
Balance at beginning	(2,123)	(3,398)
Current service cost
Net interest expense	(104)	(56)
Past service cost and effect of settlements	111	9
Total expense recognized in profit or loss for the period	7	(47)
Payments from the plan	29	927
Return on plan assets (excluding amounts included in net interest expenses)	(109)	228
Actuarial gain (loss) arising from changes in demographic assumptions
Actuarial gain (loss) arising from changes in financial assumptions
Actuarial gain (loss) arising from experience adjustments
Total effect on other comprehensive income for the period	(109)	228
Effect of changes in foreign exchange rates	60	355
by employer	(130)	(187)
by plan’s participants
Balance at ending	(2,266)	(2,123)
Net defined benefit liability (asset) [Member]
Schedule of Defined Benefit Obligation and Fair Value of Plan Assets [Line Items]
Balance at beginning	1,040	1,440
Current service cost	152	198
Net interest expense	46	64
Past service cost and effect of settlements	(101)	9
Total expense recognized in profit or loss for the period	97	271
Payments from the plan	(7)	(449)
Return on plan assets (excluding amounts included in net interest expenses)	(109)	228
Actuarial gain (loss) arising from changes in demographic assumptions
Actuarial gain (loss) arising from changes in financial assumptions	(24)	(258)
Actuarial gain (loss) arising from experience adjustments	36	151
Total effect on other comprehensive income for the period	(97)	121
Effect of changes in foreign exchange rates	(34)	(156)
by employer	(130)	(187)
by plan’s participants
Balance at ending	$ 869	$ 1,040

Net Employee Defined Benefit _5

Net Employee Defined Benefit Liabilities (Details) - Schedule of Principal Assumptions Underlying the Defined Benefit Plan		Dec. 31, 2023	Dec. 31, 2022
Schedule of Principal Assumptions Underlying the Defined Benefit Plan [Abstract]
Discount rate	[1]	5.57%	5.22%
Expected rate of salary increase		3.19%	3.21%
[1] The discount rate is based on high-quality CPI-linked corporate bonds.

Net Employee Defined Benefit _6

Net Employee Defined Benefit Liabilities (Details) - Schedule of Amount, Timing and Uncertainty of Future Cash Flows $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
The change as a result of:
1% salary increase	$ (28)
1% salary decrease	360
The change as a result of:
1% increase in discount rate	379
1% decrease in discount rate	$ (49)

Net Employee Defined Benefit _7

Net Employee Defined Benefit Liabilities (Details) - Schedule of Amount, Timing and Uncertainty of Future Cash Flows (Parentheticals)	12 Months Ended
	Dec. 31, 2023
Schedule of Amount Timing and Uncertainty of Future Cash Flows [Abstract]
Salary increase percentage	1%
Salary decrease percentage	1%
Increase in discount rate	1%
Decrease in discount rate	1%

Equity (Details)

Equity (Details) ₪ / shares in Units, $ / shares in Units, ₪ in Thousands, $ in Thousands		1 Months Ended								12 Months Ended
	Jul. 01, 2010 shares	Mar. 31, 2024 shares	Dec. 31, 2023 USD ($) shares	Nov. 30, 2023 USD ($) shares	Mar. 31, 2023	Mar. 28, 2023 USD ($) shares	Oct. 31, 2022 USD ($) $ / shares shares	Oct. 31, 2022 ILS (₪) ₪ / shares shares	Mar. 23, 2022 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) shares		Dec. 31, 2021 USD ($) shares		Mar. 31, 2022 USD ($) shares
Equity (Details) [Line Items]
Effective equity description					the Company’s shares were split in a ratio of 1:0.712434.
Investors to purchase									5,000,000
Issued per share (in Dollars per share) | $ / shares									$ 10
Gross proceeds (in Dollars) | $									$ 50,000
Total shares															40,000
Investment agreement shares							91,192	91,192
Share price | (per share)							$ (24.7)	₪ 86.3
Ordinary share		1	2,215,373	2,215,373			1	1		13,000
Share warrants							1	1
Exercise price per share | (per share)							$ (26)	₪ 94.9
Aggregate amount				$ 4,800			$ 2,250	₪ 7,900		$ 2,500
Issuance cost (in Dollars) | $							$ 224			$ 41,907	$ 45,914		$ 24,711
Repayment of additional interest							10%	10%
Allocated shares	174									20,000
Issue value (in Dollars) | $						$ 100,000
Share issued						100,000
Expense (in Dollars) | $						$ 1,570				$ 1,570
Interest rate										10%
Pay to interest rate			24%							24%
Warrants exercised										13,000
Ordinary shares										9,686,000	8,529,000	[1]	7,751,000	[1]
Total consideration (in Dollars) | $			$ 234							$ 234
Share Option										1,507,231
Warrants exercisable price (in Dollars per share) | $ / shares										$ 22.32
PIPE Financing [Member]
Equity (Details) [Line Items]
Received amount (in Dollars) | $															$ 4,000
Ordinary shares [member]
Equity (Details) [Line Items]
Received amount (in Dollars) | $															$ 50,000
Lior Tamar Investments [Member]
Equity (Details) [Line Items]
Allocated shares										25,000
SPAC [Member]
Equity (Details) [Line Items]
Warrants exercised										13,001
Ordinary shares										13,001
Total consideration (in Dollars) | $			$ 233							$ 233
Provident Funds Ltd [Member]
Equity (Details) [Line Items]
Ordinary share										1,507,231
[1] Shares and per shares amounts have been retroactively adjusted to reflect the reverse stock splits as described in note 20a.

Equity (Details) - Schedule of

Equity (Details) - Schedule of Share Capital - shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Share Capital [Abstract]
Ordinary shares with no par value, Authorized	142,487	142,487
Ordinary shares with no par value, Issued and outstanding	11,853	8,879

Equity (Details) - Schedule o_2

Equity (Details) - Schedule of Issued and Outstanding Share Capital $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($) shares
Schedule of Issued and Outstanding Share Capital [Abstract]
Balance | $	$ 8,879
Issuance of shares | shares	2,848
Exercise of options and warrants | shares	126
Balance | $	$ 11,853

Equity (Details) - Schedule o_3

Equity (Details) - Schedule of Interests Shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Interests Shares [Abstract]
% of issued share capital	0.54%	1%

Share-Based Payment (Details)

Share-Based Payment (Details) ₪ / shares in Units, $ / shares in Units, ₪ in Thousands, $ in Thousands	1 Months Ended			12 Months Ended
	Feb. 27, 2023 $ / shares shares	Feb. 27, 2023 ₪ / shares shares	Jun. 21, 2021 shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2023 ILS (₪) ₪ / shares shares
Share-Based Payment (Details) [Line Items]
Share options (in Shares)	128,238	128,238	1,781,085
Share options for share price | (per share)	$ 1.2	₪ 4.2
Fair value option grant				$ 2,826	₪ 10,378
Share options outstanding				4 years 1 month 2 days	4 years 1 month 2 days
Exercise price per share | ₪ / shares					₪ 67.48
Bottom of range [Member]
Share-Based Payment (Details) [Line Items]
Exercise price per share | (per share)				$ 0.04	0.14
Top of Range [Member]
Share-Based Payment (Details) [Line Items]
Exercise price per share | (per share)				$ 0.04	₪ 18.6
Share Option [Member]
Share-Based Payment (Details) [Line Items]
Share options (in Shares)				1,068,651	1,068,651

Share-Based Payment (Details) -

Share-Based Payment (Details) - Schedule of Financial Statements for Services Received from Employees and Officers - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule of Financial Statements for Services Received from Employees and Officers [Abstract]
Equity-settled share-based payment plans	$ 7,115	$ 10,516	$ 5,897

Share-Based Payment (Details)_2

Share-Based Payment (Details) - Schedule of Fair Value Measurement of the Share Options - Hull-White model [Member]	12 Months Ended
	Dec. 31, 2023 $ / shares
Bottom of range [member]
Share-Based Payment (Details) - Schedule of Fair Value Measurement of the Share Options [Line Items]
Expected volatility of the share prices (%)	80.03%
Share price	$ 2,260
Bottom of range [member]
Share-Based Payment (Details) - Schedule of Fair Value Measurement of the Share Options [Line Items]
Risk-free interest rate (%)	4.02%
Expected life of share options (years)	9 years 7 months 28 days
Share price	$ 8,290

Share-Based Payment (Details)_3

Share-Based Payment (Details) - Schedule of Number of Share Options and the Weighted Average Exercise Prices - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Schedule of Number of Share Options and the Weighted Average Exercise Prices [Abstract]
Number of options, Share options outstanding at beginning of year	844,148	1,139,102
Weighted average exercise price, Share options outstanding at beginning of year	$ 16.02	$ 6.93
Number of options, Share options granted during the year	128,238	29,650
Weighted average exercise price, Share options granted during the year	$ 1.14	$ 18.61
Number of options, Share options exercised during the year	145,874	161,187
Weighted average exercise price, Share options exercised during the year	$ 12.8	$ 4.69
Number of options, Share options forfeited during the year	9,553	144,686
Weighted average exercise price, Share options forfeited during the year	$ 0.04	$ 12.3
Number of options, Share options expired during the year	445,384	18,731
Weighted average exercise price, Share options expired during the year	$ 17.91	$ 0.65
Number of options, Share options outstanding at end of year	371,575	844,148
Weighted average exercise price, Share options outstanding at end of year	$ 10.01	$ 15.94
Number of options, Share options exercisable at end of year	359,688	781,073
Weighted average exercise price, Share options exercisable at end of year	$ 9.95	$ 16.54

Share-Based Payment (Details)_4

Share-Based Payment (Details) - Schedule of Status of RSUs - RSU [Member]	12 Months Ended
	Dec. 31, 2023 shares
Schedule of Status of RSUs [Abstract]
Outstanding at beginning of year	457,137
Granted	1,697,743	[1]
Vested	278,580
Forfeited and cancelled	260,605
Outstanding at end of year	1,615,695
[1]This includes shares granted with performance obligations which were not fulfilled as of December 31, 2023.

Share-Based Payment (Details)_5

Share-Based Payment (Details) - Schedule of Total Equity-Based Compensation Expense - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule of Total Equity-Based Compensation Expense [Abstract]
Cost of revenues	$ 35	$ 206
Research and development expenses	3,010	603	3,122
Sales and marketing expenses	211	1,504	2,775
General and administrative expenses	3,859	8,203
Total share-based payment	$ 7,115	$ 10,516	$ 5,897

Commitments, Guarantees, Char_2

Commitments, Guarantees, Charges and Contingent Liabilities (Details) $ / shares in Units, ₪ in Thousands

1 Months Ended

12 Months Ended

Nov. 06, 2023 USD ($)

Sep. 30, 2023 USD ($)

Aug. 17, 2023 $ / shares

Jan. 30, 2023 ILS (₪)

Oct. 20, 2022 USD ($)

Oct. 20, 2022 ILS (₪)

Mar. 29, 2022 USD ($)

Mar. 29, 2022 ILS (₪)

Mar. 27, 2022

Mar. 31, 2023 USD ($) $ / shares

Jan. 31, 2023 USD ($)

Dec. 31, 2022 USD ($) $ / shares

Sep. 30, 2022 USD ($)

Jul. 31, 2021

Dec. 31, 2023 USD ($) $ / shares shares

Dec. 31, 2023 ILS (₪) shares

Dec. 31, 2022 USD ($) $ / shares

Dec. 31, 2021 USD ($)

Mar. 31, 2024 $ / shares

Jun. 12, 2023 USD ($)

Commitments, Guarantees, Charges and Contingent Liabilities (Details) [Line Items]

Pledge charge amounts

$ 1,575,000

$ 1,788,000

$ 1,575,000

Aggregate amount

1,839,000

Bank guarantees amount

1,839,000

Revenue

$ 250,000

₪ 800

42,657,000

$ 50,002,000

$ 29,533,000

Percentage of ordinary price

35%

Total damages

70,000,000,000

₪ 229,000

Reduced claimed amount (in New Shekels) | ₪

₪ 229,440,000

Damage claim amount

$ 1,480,000,000

Principal amount

$ 12,000,000,000

Failed to repay amount

2,500,000,000

Debt paid

$ 71,615

Cumulative amount

$ 350

Percentage of committed to pay fee amount

5%

Warrants to purchase shares percentage

5%

Commission amount

$ 1,500,000

$ 50

Purchase warrants (in Shares) | shares

4,076,923

4,076,923

Additional amount

$ 70,000

Marketing budget

$ 280

Non-refundable fee percentage

5%

5%

Cash payments

$ 4,200

Converted price per share (in Dollars per share) | $ / shares

$ 2

$ 1.5

Exercise price (in Dollars per share) | $ / shares

$ 4.81

$ 4.81

$ 1.5

Warrant exercisable period

4 years

Total service amount

$ 140

Bottom of Range [Member]

Commitments, Guarantees, Charges and Contingent Liabilities (Details) [Line Items]

Damage claim amount | ₪

₪ 5,440,000

A-Labs Agreement [Member]

Commitments, Guarantees, Charges and Contingent Liabilities (Details) [Line Items]

Commission amount

$ 4,200,000,000

Nonadjusting Events After Reporting Period [Member]

Commitments, Guarantees, Charges and Contingent Liabilities (Details) [Line Items]

Loss Contingency damages value increased amount (in New Shekels) | ₪

₪ 64,000

Commission amount

$ 50

Additionally total amount

$ 2,200,000,000

Converted price per share (in Dollars per share) | $ / shares

$ 10

Purchase of ordinary shares value

$ 20,000,000,000

Exercise price (in Dollars per share) | $ / shares

$ 0.9

Investments in Investees (Detai

Investments in Investees (Details) ₪ in Thousands, $ in Thousands						12 Months Ended
	Sep. 27, 2021 USD ($)	Sep. 27, 2021 ILS (₪)	Jul. 01, 2010 shares	May 26, 2010 USD ($)	Dec. 28, 2007	Dec. 31, 2023 USD ($) shares	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Apr. 30, 2024	Sep. 27, 2021 ILS (₪)	May 26, 2010 ILS (₪)
Investments in Investees (Details) [Line Items]
Percentage of ordinary shares owned				7%		4.99%
Percentage of voting rights				60%
Total investment				$ 312							₪ 1,200
Allocated share (in Shares)			174			20,000
Percentage of issued and outstanding share capital			46.52%
Percentage of management fees						3%
Purchase price	$ 21,848	₪ 70,000
Cash	12,484									₪ 40,000
Company shares	$ 9,363	₪ 30,000				$ 2,379	$ 18,836	$ 34,571
ALD Software [Member]
Investments in Investees (Details) [Line Items]
Percentage of investment holding					98.63%
QPoint [Member]
Investments in Investees (Details) [Line Items]
Percentage of investment holding				46.52%		25%
Forecast [Member]
Investments in Investees (Details) [Line Items]
Company acquired holds percentage									100%

Additional Information to Pro_3

Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total cost of sales and services	$ 41,907	$ 45,911	$ 24,711
Total Research and development expenses	5,886	5,574	5,796
Total Sales and marketing expenses	10,694	21,674	2,683
Total General and administrative expenses	49,172	57,271	9,313
e. Other expenses, net:
Total Other expenses, net	12,723
f. Finance income and expenses:
Finance income	484	469	5
Finance expenses	7,194	1,384	296
Salaries and related expenses [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total cost of sales and services	28,098	29,972	11,506
Total Research and development expenses	6,879	5,201	5,468
Total Sales and marketing expenses	4,239	7,972	1,910
Total General and administrative expenses	8,409	16,089	4,844
Subcontractors and consultants [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total cost of sales and services	8,359	12,980	8,658
Depreciation and amortization [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total cost of sales and services	4,757	1,659	372
Total Sales and marketing expenses	6,026	12,688	727
Total General and administrative expenses	1,463	1,680	884
Material [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total cost of sales and services		461	3,701
Impairment expenses [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total cost of sales and services		438
Total General and administrative expenses	10,643	14,618
Other [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total cost of sales and services	693	401	474
Total Research and development expenses	298	406	328
Total Sales and marketing expenses	193	708	9
Total General and administrative expenses	4,273	2,850	1,473
Research and development expenses gross [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total Research and development expenses	7,177	5,607	5,796
Less – government grants [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total Research and development expenses	(1,291)	(33)
Advertising and public relations [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total Sales and marketing expenses	236	306	37
Office Maintenance [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total General and administrative expenses	1,392	1,410	303
Consulting [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total General and administrative expenses	16,716	16,627	1,149
Legal expenses [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total General and administrative expenses	2,713	2,157	411
Audit and accounting [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total General and administrative expenses	773	1,418	249
Insurance [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total General and administrative expenses	1,622	26	(45)
Directors fees [Member]
Additional Information to Profit or Loss Items (Details) - Schedule of Additional Information to Profit or Loss [Line Items]
Total General and administrative expenses	1,168	396	131
Governmental grants income [Member]
e. Other expenses, net:
Total Other expenses, net	(1,159)
ELOC [Member]
e. Other expenses, net:
Total Other expenses, net	1,570
Fair market value related expenses (ELOC) [Member]
e. Other expenses, net:
Total Other expenses, net	12,312
Gain from exchange rate differences [Member]
f. Finance income and expenses:
Finance income	271	19
Interest income [Member]
f. Finance income and expenses:
Finance income	213	450	5
Loss from exchange rate differences [Member]
f. Finance income and expenses:
Finance expenses			105
Bank fees [Member]
f. Finance income and expenses:
Finance expenses	109	145	105
Changes in fair value of financial instruments [Member]
f. Finance income and expenses:
Finance expenses	247
Interest expenses [Member]
f. Finance income and expenses:
Finance expenses	$ 6,838	$ 1,239	$ 86

Taxes on Income (Details)

Taxes on Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Taxes on Income (Details) [Line Items]
Business losses (in Dollars)	$ 140
Percentage of deferred tax	23%
Israel, New Shekels [Member]
Taxes on Income (Details) [Line Items]
Tax rate	23%	23%	23%
United States [Member]
Taxes on Income (Details) [Line Items]
Tax rate	25%
United Kingdom [Member]
Taxes on Income (Details) [Line Items]
Tax rate	19%

Taxes on Income (Details) - Sch

Taxes on Income (Details) - Schedule of Composition and Movement in Deferred Taxes - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022
In non-current liabilities [Member]
Taxes on Income (Details) - Schedule of Composition and Movement in Deferred Taxes [Line Items]
Balance beginning	[1]	$ (3,432)	$ (4,734)
Charged to profit or loss	[1]		787
Adjustments arising from translating financial statements from functional currency to presentation currency	[1]		515
Charged to profit or loss	[1]	1,725
Adjustments arising from translating financial statements from functional currency to presentation currency	[1]	132
Balance ending	[1]	(1,575)	(3,432)
As shown on balance sheet :	[1],[2]	(116)
In non-current assets [Member]
Taxes on Income (Details) - Schedule of Composition and Movement in Deferred Taxes [Line Items]
Balance beginning	[1]	3,271	3,469
Charged to profit or loss	[1]		215
Adjustments arising from translating financial statements from functional currency to presentation currency	[1]		(413)
Charged to profit or loss	[1]	(1,686)
Adjustments arising from translating financial statements from functional currency to presentation currency	[1]	(126)
Balance ending	[1]	1,459	$ 3,271
As shown on balance sheet :	[1],[2]
[1] The deferred taxes are computed at a tax rate of 23%. The deferred tax shown above is not netted off within companies. The balance sheet shows the net position.

Taxes on Income (Details) - S_2

Taxes on Income (Details) - Schedule of Taxes on Income Included in Profit or Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	[1]	Dec. 31, 2021	[1]
Schedule of Taxes on Income Included In Profit or Loss [Abstract]
Current taxes	$ 210	$ 131		$ 197
Deferred taxes	(39)	(1,039)		65
Tax previous years		132
Total	$ 171	$ (776)		$ 262
[1]Comparative figures including the discontinued operation results.

Taxes on Income (Details) - S_3

Taxes on Income (Details) - Schedule of Reconciliation Between the Tax Expense, Assuming that all the Income and Expenses, Gains and Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule Of Reconciliation Between The Tax Expense Assuming That All The Income And Expenses Gains And Loss Abstract
Loss before taxes on income	$ (84,435)	$ (80,739)	$ (13,153)
Statutory tax rate	23%	23%	23%
Tax computed at the statutory tax rate	$ (19,420)	$ (18,570)	$ (3,025)
Increase (decrease) in taxes on income resulting from the following factors:
Different tax rate applicable to foreign subsidiary	(2)	(225)	1
Utilization of carryforward losses for which no deferred taxes were computed in the past	(98)		(32)
Other losses and temporary differences for which no deferred taxes were computed	19,026	17,699	3,433
Tax previous years		132
Other, net	665	225	93
Taxes on income	$ 171	$ (739)	$ 470

Net Loss Per Share (Details)

Net Loss Per Share (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Net Loss Per Share [Abstract]
Exercise of employee	$ 362
Investors stock options	$ 6,330

Balances and Transactions wit_3

Balances and Transactions with Interested and Related Parties (Details)	12 Months Ended
	Dec. 31, 2023
Mr. Hershkoviz [Member]
Balances and Transactions with Interested and Related Parties (Details) [Line Items]
Service, percentage	9.99%

Balances and Transactions wit_4

Balances and Transactions with Interested and Related Parties (Details) - Schedule of Balances with Interested and Related Parties - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Transactions with interested and related parties [Member]
Balances and Transactions with Interested and Related Parties (Details) - Schedule of Balances with Interested and Related Parties [Line Items]
Other accounts payable	$ 25
Directors [Member] | Balances with interested and related parties [Member]
Balances and Transactions with Interested and Related Parties (Details) - Schedule of Balances with Interested and Related Parties [Line Items]
Other accounts payable	15
Directors [Member] | Transactions with interested and related parties [Member]
Balances and Transactions with Interested and Related Parties (Details) - Schedule of Balances with Interested and Related Parties [Line Items]
Other accounts payable	15
Key management personnel [Member] | Balances with interested and related parties [Member]
Balances and Transactions with Interested and Related Parties (Details) - Schedule of Balances with Interested and Related Parties [Line Items]
Other accounts payable	200	$ 40
Loan	66
Key management personnel [Member] | Transactions with interested and related parties [Member]
Balances and Transactions with Interested and Related Parties (Details) - Schedule of Balances with Interested and Related Parties [Line Items]
Other accounts payable	223	40
Highest balance of current debts during the year	$ 66	0
Controlling Shareholder [Member] | Balances with interested and related parties [Member]
Balances and Transactions with Interested and Related Parties (Details) - Schedule of Balances with Interested and Related Parties [Line Items]
Other accounts payable		15
Controlling Shareholder [Member] | Transactions with interested and related parties [Member]
Balances and Transactions with Interested and Related Parties (Details) - Schedule of Balances with Interested and Related Parties [Line Items]
Other accounts payable		$ 15

Balances and Transactions wit_5

Balances and Transactions with Interested and Related Parties (Details) - Schedule of Salaries and Benefits to Interested and Related Parties - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule Of Salaries And Benefits To Interested And Related Parties Abstract
Salary and related benefits to CEO and director employed by the Company (controlling shareholder) including cost of share-based payment	[1]	$ 132
Fees of directors not employed by the Company including cost of share-based payment	[2]	566	312	289
Salary and related benefits to formerly Deputy CEO including cost of share-based payment	[3]	811	3,872	1,571
Salary and related benefits to the former VP Human Resources including cost of share-based payment	[4]	28	1,140	544
Salary and related benefits to formerly Chairman of the Board including cost of share-based payment	[5],[6]		2,355	832
Salary and related benefits to formerly Deputy CEO and COO including cost of share-based paymen	[5],[7]		1,777	803
Total salary		$ 1,537	$ 9,456	$ 4,039
[1]Relates to the cost of employment of Mr. Noah Hershkovitz, director of the company as of October 3, 2023 and CEO of the Company as of December 4, 2023.[2] Other interested and related parties. Relates to the cost of employment of Mr. Uzi Moskowitz director and former CEO in the Company, who no longer serves as the CEO of Company since December 4, 2023. and Eyal Moshe former director and former CEO of the Company who is also controlling shareholder in the Company, excluding any misappropriates expenses. Mr. Moshe ceased his role as CEO on February 2, 2023, and his employment was terminated effective July 24, 2023 for cause in connection with these unauthorized expenses. Relates to the cost of employment of Ms. Ayelet Bitan, Chief of Staff in the Company and the spouse of Mr. Eyal Moshe, a controlling shareholder in the Company, excluding any allegedly misappropriated expenses as detailed in Note 1e. Ms. Bitan resigned in February 2023. Key management personnel. Relates to the cost of employment of Dr. Zigmund Bluvband, formerly the Chairman of the Company’s Board. Dr. Zigmund no longer works at the Company since April 30, 2022.

Balances and Transactions wit_6

Balances and Transactions with Interested and Related Parties (Details) - Schedule of Transactions with Interested and Related Parties - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Balances and Transactions with Interested and Related Parties (Details) - Schedule of Transactions with Interested and Related Parties [Line Items]
General and administrative expenses	$ 1,537	$ 9,456
Total	1,537	9,456
Controlling shareholder [Member]
Balances and Transactions with Interested and Related Parties (Details) - Schedule of Transactions with Interested and Related Parties [Line Items]
General and administrative expenses	141	5,012
Total	141	5,012
Key management personnel [Member]
Balances and Transactions with Interested and Related Parties (Details) - Schedule of Transactions with Interested and Related Parties [Line Items]
General and administrative expenses	829	4,132
Total	829	4,132
Other interested and related parties [Member]
Balances and Transactions with Interested and Related Parties (Details) - Schedule of Transactions with Interested and Related Parties [Line Items]
General and administrative expenses	566	312
Total	$ 566	$ 312

Segments (Details)

Segments (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($)
Segments (Details) [Line Items]
Professional service	$ 2,523
Goodwill [member]
Segments (Details) [Line Items]
Professional service	$ 12,735

Segments (Details) - Schedule o

Segments (Details) - Schedule of Operations Under a Single Segment of Products and Technology - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023		Dec. 31, 2022
Segments (Details) - Schedule of Operations Under a Single Segment of Products and Technology [Line Items]
Revenues from external customers	$ 42,657		$ 50,002
Total revenues	42,657		50,002
Segment results (operating loss)	(77,725)	[1]	(80,430)
Finance expenses, net	6,710		(915)
Loss before taxes on income	(84,435)		(81,345)
Professional Services [Member]
Segments (Details) - Schedule of Operations Under a Single Segment of Products and Technology [Line Items]
Revenues from external customers	41,589		48,263
Total revenues	41,589		48,263
Segment results (operating loss)	(30,690)	[1]	(21,582)
Products and Technology [Member]
Segments (Details) - Schedule of Operations Under a Single Segment of Products and Technology [Line Items]
Revenues from external customers	1,068		1,739
Total revenues	1,068		1,739
Segment results (operating loss)	(33,153)	[1]	(43,019)
Unallocated amounts [member]
Segments (Details) - Schedule of Operations Under a Single Segment of Products and Technology [Line Items]
Revenues from external customers		[2]		[3]
Total revenues		[2]		[3]
Segment results (operating loss)	$ (13,882)	[1],[2]	$ (15,829)	[3]
[1]In the year ended December 31, 2023, the Company recorded impairment of goodwill and intangible assets related to professional service and product and technology segments in the amount of $12,735 thousand and $2,523 thousand, respectively.[2] Expenses related to RNER merger transaction)see Note 5) and ELOC (see Note 20). Expenses related to a merger transaction in 2022.

Segments (Details) - Schedule_2

Segments (Details) - Schedule of Revenues - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Segments (Details) - Schedule of Revenues [Line Items]
Revenues	$ 42,657	$ 50,002
Israel [Member]
Segments (Details) - Schedule of Revenues [Line Items]
Revenues	40,364	46,386
America [Member]
Segments (Details) - Schedule of Revenues [Line Items]
Revenues	334	339
Europe [Member]
Segments (Details) - Schedule of Revenues [Line Items]
Revenues	1,669	2,983
Asia Pacific [Member]
Segments (Details) - Schedule of Revenues [Line Items]
Revenues	$ 290	$ 294

Segments (Details) - Schedule_3

Segments (Details) - Schedule of Turnover with Main Customers - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Customer A [Member]
Turnover with main customers (1):
Customer A	$ 7,602	$ 10,257
Customer B	17.82%	21%
Customer B [Member]
Turnover with main customers (1):
Customer A	$ 4,726	$ 6,706
Customer B	11.07%	13%
Customer [Member]
Turnover with main customers (1):
Customer A	$ 12,328	$ 16,963
Customer B	28.89%	34%

Subsequent Events (Details)

Subsequent Events (Details)

1 Months Ended

4 Months Ended

12 Months Ended

Sep. 24, 2024

Aug. 10, 2024

May 09, 2024 USD ($) $ / shares shares

Apr. 03, 2024

Mar. 31, 2024 $ / shares

Aug. 10, 2023 USD ($)

Feb. 28, 2023 $ / shares

Mar. 31, 2024 USD ($) $ / shares shares

Dec. 31, 2023 USD ($) shares

Nov. 30, 2023 shares

Oct. 31, 2022 shares

Jun. 30, 2024 USD ($) $ / shares

Dec. 31, 2023 USD ($) shares

Dec. 31, 2023 ILS (₪) shares

Jul. 15, 2024 ILS (₪)

May 15, 2024 ILS (₪)

Apr. 07, 2024 ILS (₪)

Dec. 31, 2023 ILS (₪)

Dec. 31, 2022 $ / shares

Subsequent Events (Details) [Line Items]

Closing amount (in Dollars)

$ 25,000

Description of repayment

(a) with respect to $8,000 thousand of the principal amount, (i) for the principal amount repaid on or prior to May 12, 2024, 7%, (ii) for the principal amount repaid following May 12, 2024 and on or prior to June 12, 2024, a rate between 7% and 8.5% of such principal amount computed by adding to 7% the result obtained by multiplying 1.5 by the quotient of the number of days elapsed in such period until (and including) the repayment date divided by the number of days in such period, and (iii) for the principal amount repaid following June 12, 2024, 8.5% of such principal amount plus 15% per annum, on the basis of the actual number of days elapsed commencing from the date following June 12, 2024 and ending on the repayment date; and (b) with respect to $2,000 thousand of the principal amount, (i) for the principal amount repaid on or prior to September 24, 2024, 10%, and (ii) for the principal amount repaid following September 24, 2024, 10% of such principal amount plus 15% per annum, on the basis of the actual number of days elapsed commencing from the date following September 24, 2024 and ending on the repayment date.

(a) with respect to $8,000 thousand of the principal amount, (i) for the principal amount repaid on or prior to May 12, 2024, 7%, (ii) for the principal amount repaid following May 12, 2024 and on or prior to June 12, 2024, a rate between 7% and 8.5% of such principal amount computed by adding to 7% the result obtained by multiplying 1.5 by the quotient of the number of days elapsed in such period until (and including) the repayment date divided by the number of days in such period, and (iii) for the principal amount repaid following June 12, 2024, 8.5% of such principal amount plus 15% per annum, on the basis of the actual number of days elapsed commencing from the date following June 12, 2024 and ending on the repayment date; and (b) with respect to $2,000 thousand of the principal amount, (i) for the principal amount repaid on or prior to September 24, 2024, 10%, and (ii) for the principal amount repaid following September 24, 2024, 10% of such principal amount plus 15% per annum, on the basis of the actual number of days elapsed commencing from the date following September 24, 2024 and ending on the repayment date.

Conversion rate (in Dollars per share) | $ / shares

$ 1.5

$ 0.5

Description of purchase agreement

(i) March-June 2024 Warrants exercisable into 4,444,444 ordinary shares are exercisable at an exercise price equal to $0.70 per share until March 12, 2027, (ii) March-June 2024 Warrants exercisable into 4,000,000 ordinary shares are exercisable at an exercise price equal to $0.70 per share until April 3, 2027, (iii) March-June 2024 Warrants exercisable into 1,000,000 ordinary shares are exercisable at an exercise price equal to $0.50 per share until June 26, 2027 and (iv) March-June 2024 Warrants exercisable into 2,000,000 ordinary shares are exercisable at an exercise price equal to $0.70 per share until June 26, 2027.

(i) March-June 2024 Warrants exercisable into 4,444,444 ordinary shares are exercisable at an exercise price equal to $0.70 per share until March 12, 2027, (ii) March-June 2024 Warrants exercisable into 4,000,000 ordinary shares are exercisable at an exercise price equal to $0.70 per share until April 3, 2027, (iii) March-June 2024 Warrants exercisable into 1,000,000 ordinary shares are exercisable at an exercise price equal to $0.50 per share until June 26, 2027 and (iv) March-June 2024 Warrants exercisable into 2,000,000 ordinary shares are exercisable at an exercise price equal to $0.70 per share until June 26, 2027.

Warrants exercisable (in Dollars per share) | $ / shares

$ 0.5

Number of Ordinary share (in Shares) | shares

1

2,215,373

2,215,373

1

13,000

13,000

Warrants exercisable into ordinary shares (in Shares) | shares

200,000

Exercise price (in Dollars per share) | $ / shares

$ 1.5

$ 1.5

$ 4.81

QPoint percentage

100%

100%

Number of renowned brand clients

100

100

Number of subsidiaries

five

five

Total liabilities (in New Shekels) | ₪

₪ 55,000

Percentage of outstanding debt pay

30%

30%

Hair cut, percentage

70%

70%

Outstanding debt, term

3 years

3 years

Consulting fee (in Dollars)

$ 1,151

$ 1,151,000

$ 125,000

₪ 467,000

Ordinary shares (in Shares) | shares

1,278,666

Conversion rate (in Dollars per share) | $ / shares

$ 0.9

Warrants (in Shares) | shares

1,278,666

Exercise price (in Dollars per share) | $ / shares

$ 0.8

$ 11.5

Investment amount (in Dollars)

$ 5,000,000

Price per share (in Dollars per share) | $ / shares

$ 1

Warrant coverage

50%

Warrants exercise price per share (in Dollars per share) | $ / shares

$ 1

Warrant expiration date

12 months

Aggregate principal amount (in Dollars)

$ 6,000,000,000

Fixed rate per annum

11.50%

11.50%

11.50%

11.50%

Selling and marketing expenses (in Dollars)

$ 299,000

Long-term receivables (in Dollars)

724

Long-term receivables (in Dollars)

$ 990,000

Fixed interest rate [member]

Subsequent Events (Details) [Line Items]

Fixed rate per annum

18%

18%

18%

BST Loan Agreement [Member]

Subsequent Events (Details) [Line Items]

Fixed rate per annum

15%

15%

15%

Blackswan total amount (in Dollars)

$ 2,012

$ 2,012

Credit Line to Blackswan [Member]

Subsequent Events (Details) [Line Items]

Blackswan total amount (in Dollars)

$ 1,023

$ 1,023

Checkpoint Settlement [Member]

Subsequent Events (Details) [Line Items]

Receive amount (in New Shekels) | ₪

₪ 13,656

Nonadjusting Events After Reporting Period [Member]

Subsequent Events (Details) [Line Items]

Aggregate principal amount (in Dollars)

$ 550

$ 10,000

Loan, percentage

40%

Aggregate beneficially own percentage

4.99%

4.99%

Exercise price (in Dollars per share) | $ / shares

$ 0.9

$ 0.9

Description of convertible loan agreement

Shayna and Akina (who purchased from Shayna most of its rights under the Convertible Loan Agreement) will be entitled to convert the loan amounts in their entirety, for up to a total of 5,129,375 shares for the entire Loans (calculated under an agreed USD/NIS rate of 3.65, and at a conversion price of $0.9), of which Akina will be entitled to receive 3,897,455 shares, and Shayna will be entitled to receive 1,231,920 shares.

Nonadjusting Events After Reporting Period [Member] | Shayna and Akina [Member]

Subsequent Events (Details) [Line Items]

Beneficial ownership percentage

4.99%

Forecast [Member]

Subsequent Events (Details) [Line Items]

Loan, percentage

60%

Aggregate beneficially own percentage

4.99%

Qpoint Acquisition description

On April 3, 2024 the Company acquired for NIS 25,000 thousand in cash the shares of Qpoint. Payments were agreed to be carried out in three installments as follows: (i) NIS 4,000 thousand on the signing date; (ii) NIS 16,000 thousand on the closing date (which was April 8, 2024); (iii) an additional NIS 5,000 thousand no later than February 10, 2025 (of which NIS 2,500 thousand was already paid by June 5, 2024).

Receive amount (in New Shekels) | ₪

₪ 4,328

₪ 4,328

₪ 5,000